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ABSTRACT OF THE DISSERTATION
Deciphering mechanisms governing the development of the rod epigenome
by
Philip Andrew Ruzycki
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Genetics and Genomics
Washington University in St. Louis, 2017
Professor Shiming Chen, Chair
Precisely coordinated expression of distinct sets of genes is essential for cellular
development and function, especially in complex multicellular organisms. This regulation is
achieved by the action of transcription factors (TF), proteins that bind specific genomic locations
and alter the activity state and packaging of the DNA to promote or repress gene expression.
However, while tremendous effort has defined networks of transcription factors that work
together to drive specific phenotypes, little is known about their differential activity at the
hundreds or thousands of sites where they bind. There are also many questions regarding the
basic principles of the packaging of DNA within the nucleus, its influence on gene expression,
and how transcription factors regulate this process.
To address these questions, I have investigated gene regulatory mechanisms that control
the development of rod and cone photoreceptors. Photoreceptors are the neurons of the retina
responsible for the initial conversion of a visual stimulus into an electrical signal. Photoreceptors
are a complex, accessible, and highly disease relevant neuronal cell population, the lessons from
which are relevant for many other cell types across the body. A primary TF in photoreceptor
xiv

development is CRX. This TF when mutated in humans can cause severe vision loss, and its
deletion in mice leads to a severe condition with no functional photoreceptors.
First, I determined the functional consequences of human disease-causing variants when
modelled in mice. I functionally classified a new model as causing a previously un-determined
dominant disease, and discovered that all CRX diseases are the result of graded differences in
gene expression of the same core set of genes. Second, I examined the dependency of all
genomic binding sites on CRX activity and identified a core set of regulatory elements that
require CRX for activation of the target genes. Third, I interrogated the broader organization of
the rod photoreceptor epigenome and demonstrated that the rod packages its DNA according to
epigenomic activity state. Perturbations to this state can override this organization, resulting in
functional consequences on gene expression beyond the local sequence.
In summary, my in-depth investigation has uncovered new insights into the molecular
mechanisms controlling development and maintenance of the rod epigenome and its organization
in the nucleus. This new knowledge will provide 1) a new understanding of where and how
mutations in a key photoreceptor TF cause gene mis-regulation, and 2) guidance for future
human genetic studies to identify new disease-causing mutations affecting photoreceptor
integrity, not only in the protein coding sequences but also in specific non-coding regulatory
regions.

xv

Chapter 1
Introduction

Author: Philip Ruzycki
1

1.1 The Genome and Its Regulation
The genome is the evolutionary substrate of all life on earth. The precise order, or
sequence, of the nucleotides creates the diversity differentiating one individual from the next and
one species from the other. The most basic function of this sequence is to transmit instructions
for the generation of proteins. To this end, the genome must first be converted into a single
stranded RNA molecule, in a process called transcription. This message is subsequently
translated into the appropriate peptide units by other machinery in the cell.
Primitive organization of single celled organisms allows for the regulation of
transcription to be relatively simple. However, with added complexity through evolutionary time,
organisms have adopted highly complex body plans. It is only logical to assume that such an
increase in complexity would necessitate a more complex set of DNA instructions. Prior to the
sequencing of the human genome, it was thought that this increase in complexity would arise
from an increase in gene number and genetic material. While this is the case on the basis of gross
genome size, especially when compared to simple bacteria (E. coli) or the fly (D. melanogaster),
there is a surprisingly small increase in gene number between lower vertebrates and mammals
(Figure 1.1). The only logical conclusion, therefore, is that higher vertebrates have evolved new
methods to control the expression of these same genes to drive the increase in functional
complexity.

1.1.1 Transcription Factors Control Gene Expression
Gene expression is controlled by regulatory proteins called transcription factors (TFs).
These proteins bind to defined sites throughout the genome, and can direct the modification of
2

the local active state. Together, the activity and specificity of distinct combinations of TFs allow
a neuron and a fibroblast to have the exact same genomic sequence, but each only creates its own
set of proteins in the correct amount at the proper time.
The canonical TF is comprised of two domains; one binds DNA (DNA binding domain
or DBD) while the other regulates transcription (e.g. activation domain, or AD) by interacting
with other co-regulatory factors.[Ma & Ptashne, 1987] TFs fall within a number of broad
families (homeodomains, zinc-fingers, leucine zippers, among others) based on the structure of
their DNA binding domain.[Luscombe et al., 2000] Very subtle variation within a family can
have implications on the sequence specificity, precluding a priori prediction of the optimal DNA
targets. Many experimental methods have been employed to understand and classify sequence
specificity including promoter bashing reporter assays, binding assays such as EMSAs, or large
scale HT-SELEX experiments.[Chen et al., 1997, 2002; Jolma et al., 2010] However, the
knowledge of the optimal motif is not always indicative of in vivo activity. The analysis of the
genome-wide binding of a TF may discover complex binding features; Many bound sites contain
the characteristic cognate motif, but other bound sites lack that sequence, while some DNA
regions harboring even strong motifs are not bound.[Boyle et al., 2011; Neph et al., 2012;
Verfaillie et al., 2016; Zhu et al., 2009]
TFs rarely bind to a genomic location alone, and their binding is often primed by or
directly mediated by another factor (or factors). [Iwafuchi-Doi et al., 2016] This combinatorial
nature of TF binding and activity allows for both complexity and redundancy, all of which is
encoded in the sequence of the regulatory site by number, orientation and spacing of various TF
binding motifs. (reviewed in [Long et al., 2016; Slattery et al., 2014; Spitz & Furlong, 2012]
New methods such as Massively Parallel Reporter Assays (MPRAs) have begun to unravel such
3

regulatory logic,[Inoue & Ahituv, 2015; Santiago-Algarra et al., 2017] but unfortunately, this
technique is only currently available as a plasmid-based reporter assay. This is a major deficit in
the field, as the function of a TF once bound to the proper site is to recruit other general factors
and enzymes to modulate the local DNA regulatory environment that is not applicable on a
plasmid. New methods must be developed to understand the differential activity of a TF at its
thousands of binding sites in the genomic context.

1.2 Organizing the Genome
A single human genome stretches 6 feet in length which must be compacted into the
nucleus of every single cell in the body. To achieve this, there are a number of discrete levels at
which DNA compaction is organized. The double helix of DNA is first wrapped 1.65X around
an octamer of proteins called histones to create the nucleosome structure.[Hewish & Burgoyne,
1973; Richmond et al., 1984] Further compaction by the association and wrapping with other
adjacent nucleosomes creates a chromatin fiber. This fiber has been visualized by in vitro
methods,[Song et al., 2014] but many questions still remain as to the precise association between
nucleosomes and coiling in vivo.

1.2.1 Nucleosomes and modifications
At the level of the nucleosome, there is substantial control on the activity of the local
genomic environment.[Han & Grunstein, 1988] Histone proteins have extended N-terminal tails
that are well conserved, the loss of which causes the histone to lose its function.[Kayne et al.,
1988] Histone tails are highly modified within the nucleus.(reviewed in [Li et al., 2007]) These
modifications affect the interaction between DNA and the nucleosome [Zhao et al., 2005] and
4

determine the activity state of that site in the genome.[Strahl & Allis, 2000] Whole genome
methods have been used to map the locations of specific modifications and have determined the
regulatory logic that defines conventional promoters, enhancers, and other important
elements.[Birney et al., 2007; Dixon et al., 2015; Dunham et al., 2012; Heintzman et al., 2007;
Roadmap Epigenomics Consortium et al., 2015] The modification of histone H3 is highly
relevant for the active state of promoters and enhancers; tri-methylation of K4 is associated with
positive gene expression,[Santos-Rosa et al., 2002] the acetylation of K27 is associated with
gene expression and enhancer activity,[Creyghton et al., 2010] while the tri-methylation of the
same residue creates a strongly repressed environment.[Plath et al., 2002]
These modifications reflect a major element of the ‘epigenome,’ a layer of gene
regulation beyond the individual nucleotide bases. The epigenome is not static, and varies
dramatically between cell types and over development.[Birney et al., 2007] The epigenome has
been theorized to act as a barrier to ensure the continuous progression toward a mature cell (e.g.
Waddington’s Landscape) and an efficient means to ensure proper activity post
developmentally.[Moris et al., 2016; Waddington, 1942]
A number of enzymes are necessary to modify the epigenome and remodel promoters and
enhancers both over development and in response to environmental changes in adult cells.
General enzymes such as CBP/P300 have no sequence specificity, but rather are guided by cell
type specific TFs.[Vo & Goodman, 2001] Other chromatin modifying enzymes include lysine
methyl transferase enzymes MLL1-4 and the repressive PRC2 complex. All of these enzymes are
essential for cellular development and homeostasis and their disruption has been associated with
a multitude of diseases.[Attar & Kurdistani, 2017; Hess, 2004; Pasini et al., 2004] The specific

5

roles of these enzymes and their guidance by cell type specific TFs remain to be elucidated in the
development of many tissues.

1.2.2 Genome organization beyond the nucleosome
The notion that DNA is packaged at a scale beyond the molecular level has actually been
studied for decades in D. melanogaster. Cells within the fly salivary gland produce many copies
of their genome which fuse into microscopically visible polytene chromosomes that have a
distinct banding pattern. This pattern resembles the R/G bands visible in the mitotic genome of
other species such as humans and mice under higher magnification. Microscopically, postmitotic nuclei also show organizational principles. By DAPI staining, DNA clearly forms
densely packed dark clusters in the nucleus, but leaves other DNA less compact.
Immunohistochemical staining of epigenetic modifying enzymes, TFs, and histones further
support a stratified organization.[Corbo et al., 2010; Solovei et al., 2009]
The gold standard technique to study the localization of specific DNA fragments is
fluorescence in-situ hybridization (FISH). The method was originally developed using
radioactive probes to localize genes on polytene chromosomes,[M. L. Pardue & Gall, 1969; M.
Lou Pardue et al., 1970] but has since been adapted to use fluorescent probes and has been
shown to be effective within many cell types. Advances in molecular biology and high
throughput sequencing have only recently allowed for the interrogation of genomic organization
at the molecular level.[Dekker et al., 2002] Careful analysis that compared the results of FISH
and Chromosome Conformation Capture data suggests that they both faithfully report genome
organization, but their results can be complementary and both are still necessary to fully
understand the organizational state.[Williamson et al., 2014] There are a variety of Chromosome
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Conformation Capture (C) techniques (Table 1.1), each with its own particular benefits and
shortcomings.(reviewed in [Davies et al., 2017]) While targeted assays such as 3C can give very
high precision or resolution, lower sequencing costs are making genome wide assays such as 4C
and HiC accessible to answer global questions.
HiC has been instrumental in defining a new understanding of the packing of interphase
chromatin. By analyzing the data of this ‘all vs all’ approach, two primary concepts have
emerged; first the Topologically Associating Domain (TAD) has been defined as another unit of
genomic packaging, [Dixon et al., 2012] and second that the nucleus is generally organized into
A and B compartments.[Lieberman-Aiden et al., 2009; Rao et al., 2014] A TAD is defined as a
region of DNA, the sequences of which are more likely to interact with one another than with
DNA outside of the TAD. In fact, the analysis of the Drosophila polytene chromosomes
determined that TAD structure closely mirrored the order and distinction of banding patterns.
Although these chromosomes are so unique in size, their molecular organization was virtually
the same as that observed in normal diploid cells.[Eagen et al., 2015] TADs are largely
conserved between cell types and the boundaries of TADs are enriched for the binding of
CTCF,[Dixon et al., 2012; Hansen et al., 2017; Vietri Rudan et al., 2015] the loss of which
disrupts these units.[Rao et al., 2017]
The function of TADs is still under investigation, however they may serve to confine a
genomic segment and ensure proper promoter-enhancer interactions to regulate gene
expression.[Jin et al., 2013; Symmons et al., 2014; H. Zhang et al., 2013] They are largely
invariable between cell types with some exceptions; subtle changes in TAD boundary locations
are essential for some developmental processes.[Andrey et al., 2013] New genomic editing
methods have been employed to disrupt principles of this packaging to test their function. The
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HOX gene cluster that defines basic body plan in vertebrates has served as a robust and defined
test platform. By the deletion of a CTCF element that defined a TAD boundary, the important
strict delineation of active vs inactive chromatin was disrupted [Narendra et al., 2015] and gene
mis-regulation resulted in severe developmental abnormalities.[Narendra et al., 2016]
While the structure of TADs is quite stable across cell types, their locations within the
nucleus are not. TADs can be generally classified as belonging to either an active (A) or inactive
(B) compartment, the classification of which is strongly associated with the composition of
repetitive elements, replication timing, lamin association, gene density, and gene function.
[Dileep et al., 2015; Solovei et al., 2016] While the boundaries of A/B compartments do align
with TAD boundaries, the inclusion of any individual TAD in either compartment is dynamic
over development and highly cell type specific.[Dixon et al., 2015] The function of A/B
compartments is not well understood. It is likely that this organization maintains the proximity of
machinery to proper targets and separation from non-expressed genes.[Brown et al., 2008; Dorier
& Stasiak, 2010; Feuerborn & Cook, 2015; Lamond & Spector, 2003; Lawrence & Clemson,
2008; Razin et al., 2011; Shen et al., 2012] However, this segregation and any effects of its
disruption have not yet been tested. In fact, the mechanisms of compartment assembly are not
well understood. Recent studies that disrupted TAD formation globally discovered enhanced
compartmental segregation, suggesting that the formation of TADs and compartments are
somewhat opposed.[Rao et al., 2017; Schwarzer et al., 2017] More targeted analyses are
necessary to elucidate the functions of and relationship between TADs and A/B Compartments.
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1.3 The retina as model system
The mouse retina offers a tractable but complex and highly relevant neuronal system to
interrogate the principles of TF mediated gene regulation and genomic organization. The retina is
the neural tissue that lines the posterior surface of the eye. The function of the retina is to convert
a light stimulus into an electrical signal, perform some processing and filtering of the signal, and
pass this information to the brain. The retina consists of 6 neural and 1 glial cell type to perform
this function. These cells are organized into 3 layers; the outermost layer is comprised
exclusively of rod and cone photoreceptors that capture photons of light and initiate the electrical
response, the central layer contains 4 types of interneurons that perform basic signal processing,
and the third layer contains ganglion cells that relay the signal to the brain.
These cell types have been profiled extensively both morphologically and
transcriptionally; many subtypes of the 3 interneurons and ganglion cells have been
described.[Baden et al., 2016; Macosko et al., 2015; Shekhar et al., 2016; Siegert et al., 2012]
Rods and cones, however, are very well conserved in terms of structure and function, and there is
only a single type of rod photoreceptor. The mouse retina is composed of 80% rods,[Jeon et al.,
1998; Macosko et al., 2015] making the bulk analysis of the tissue highly representative of their
signal.
The retina develops over a 2-week period in the mouse. The cell types develop with a
highly stereotyped birth order that has been studied extensively.[Young, 1985] This order of
progenitor competence and cell fate specification is driven by a set of TFs that are still under
investigation, however, many have been shown to drive certain cell fates.[Livesey & Cepko,
2001; de Melo et al., 2016; Wang et al., 2014]
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Rod photoreceptors are born from a set of multipotent progenitors, although recent
evidence suggests that evolutionarily, rods were actually co-opted from cones and this derivation
is visible in their very early development.[Kim, Yang, Oel, et al., 2016] The structure of a rod is
highly specialized for the function of capturing photons of light by the photopigment Rhodopsin,
and converting this into an electrical signal by a G-protein coupled cascade called
phototransduction.(Reviewed in [Arshavsky et al., 2002; Kefalov, 2012] The signal is amplified
and the rod passes the signal to the interneurons. Rhodopsin is stored in specialized membranous
disc structures located in a modified cilia structure called the outer segment (OS). These discs are
shed nightly, making the cell constantly responsible for renewing the membrane and protein
components essential for phototransduction. To accomplish this, rods must produce an
extraordinary amount of Rhodopsin on a daily basis; Rhodopsin transcript represent more than
2% of the total RNA in the cell.[Blackshaw et al., 2001].

1.3.1 Retinal transcription factors and disease
Rod and cone cell fate specification and gene expression is determined by a cascade of
TF activation.(Reviewed in [Swaroop et al., 2010]) This cascade is initiated by a homeodomain
TF OTX2 that is necessary and (in the retina) sufficient for photoreceptor fate
specification.[Nishida et al., 2003] OTX2 initiates the expression of cone-rod homeobox
(CRX)[Nishida et al., 2003] that works with other TFs NRL and NR2E3 in rod photoreceptors to
actively drive rod fate. In mice, the loss of NRL results in a transfated state, where rod cells
instead adopt the S-cone cell fate.[Mears et al., 2001] The loss of NR2E3, which is activated
downstream of NRL,[Oh et al., 2008] results in a mid-fate, where many rod genes are properly
activated, but the cell did not properly repress cone related transcripts.[Cheng et al., 2006; G.-H.
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Peng et al., 2005] Both of these TFs also cause vision related disease in human
patients.[Jacobson et al., 1990; Milam et al., 2002; Wright et al., 2004]

1.3.2 CRX
CRX is a homeodomain TF expressed very early after the final mitotic event in
photoreceptors and this expression is maintained throughout adulthood.[Chen et al., 1997;
Furukawa et al., 1997] In humans, the mutation of CRX results in a number of diseases with
varying functional deficits.(reviewed in [Tran & Chen, 2014]). As a TF, the basic function of
CRX is to bind target sites throughout the genome to activate photoreceptor related transcripts.
CRX has a very simple domain structure with a N-terminal canonical OTX homeodomain region
and the C-terminal half of the protein comprises the activation domain.[Chau et al., 2000; Chen
et al., 2002]
Human disease causing mutations to CRX can be classified into 4 groups that are defined
by the type of mutation and describe the associated severity of symptoms.[Tran & Chen, 2014]
Class I mutations are the result of a point mutation to the homeodomain portion of the protein.
This mutation disrupts DNA binding,[Chen et al., 2002] and results in a recessive condition both
in humans and when modelled in mice (CrxR90W/W).[Tran et al., 2014] Class III mutants contain a
truncation mutation that causes the translated CRX protein to lack a significant portion of the
activation domain. Current models predict that mutant CRX retains the ability to bind DNA but
lacks the ability to transactivate. In the heterozygous state, Class III mutations cause severe
dominant disease, thought to be the result of mutant protein blocking the action of the WT
protein.[Occelli et al., 2016; Tran et al., 2014; Tran & Chen, 2014] With the highly divergent
nature of phenotypes as a result of mutation to CRX, experiments in Chapters 2-3 of this
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dissertation are designed to better understand Class III mutants and to understand the
downstream transcriptional effects of Class I and III mutations.
Many studies have probed the function of CRX in normal photoreceptor development.
ChIP experiments have determined sites throughout the genome bound by CRX and those cobound by NRL and/or NR2E3.[Corbo et al., 2010; Hao et al., 2012; Montana et al., 2011; G.-H.
Peng et al., 2005; G.-H. Peng & Chen, 2005] Binding sites of CRX are enriched for the canonical
homeodomain motif,[Corbo et al., 2010] and disruption of this site abolishes binding and
activity.[Chen et al., 1997; Lee et al., 2010; Montana et al., 2011; White et al., 2016, 2013]
Massively parallel reporter assays (MPRAs) have tremendously extended our knowledge of
CRX and its interactions with other factors. The assessment of sequences bound by CRX
discovered that bound sites activated transcription while unbound sites with a CRX motif did
not.[White et al., 2013] This result suggested that activity is encoded in the sequence and
depends not only on the presence of a CRX motif, but relies on neighboring sequence and the
binding of other factors. This same experiment also proposed that CRX may in some instances
act as a repressor; sites that displayed low expression in WT retinas expressed higher when tested
in Crx-/- retina.[White et al., 2013] Synthetic arrays of strong CRX sites also displayed
repressive activity, but the presence of NRL sites overrode this effect.[White et al., 2016] Such
negative activity has not yet been demonstrated to be relevant in vivo. Together, these
experiments suggest that gene regulation by CRX is not binary, but rather highly context
dependent.
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1.3.3 The photoreceptor epigenome
These TFs direct a photoreceptor progenitor over a two-week period of terminal
differentiation to become a functionally mature rod. This process requires a tremendous change
in gene expression, the result of a dramatic remodeling of the epigenome. This remodeling of the
WT rod epigenome has been characterized previously in terms of histone modifications, DNA
methylation, genome accessibility, and TF binding, all of which were shown to correlate well
with the changes to the transcriptome.[Aldiri et al., 2017; Hughes et al., 2017; Kim, Yang,
Brooks, et al., 2016; Mo et al., 2016] However, this epigenome has not been systematically
analyzed in mutant photoreceptors. For instance, very little is known about the state of the
chromatin environment upon loss of CRX. There is also a lack of understanding of the activity of
CRX in establishing an active chromatin state on a whole or at any individual site in the genome.
Chapter 4 in this dissertation aims to extend the knowledge of CRX by in vivo analysis.

1.3.4 Photoreceptor Genomic Organization
The organization of the mouse rod photoreceptor genome is distinguishable from other
retinal cell types simply by microscopic assessment. Condensed heterochromatin is packed into a
dense core, while more active euchromatin is located at the periphery of the nucleus. This
organization is not unique to the mouse. In fact, a very thorough analysis of many species
discovered that this phenomenon was correlated with the activity state of the animal. Nocturnal
animals across the evolutionary tree develop this nuclear organization. It was postulated that this
organization acts as a condensing lens for photons of light, in contrast to the normal distributed
organization of heterochromatin centers that would scatter light.[Solovei et al., 2009]

13

Further work suggested that this organization is the result of either the inactivation of
Lamin B receptor (LBR) or Lamn A/C (LMNA), proteins that would normally tether
heterochromatin to the nuclear membrane.[Solovei et al., 2013] Each cell type in the body
normally expresses one of these genes, and in mouse rod photoreceptors, the specific inactivation
of Lmna has been associated with this architecture change as compared to cones.[Hughes et al.,
2017] Genetic ablation of Lbr in cells that otherwise lack Lmna resulted in inverted nuclei
suggesting that this loss is sufficient to induce inversion, and the removal of both caused
dramatic expression changes in cell culture systems.[Solovei et al., 2013]
This unique organization is altered in mouse models of photoreceptor disease. Studies
have shown mis-organization in mutants of Crx, Nrl, Sca7, Rb, and Cbp/P300.[Helmlinger et al.,
2006; Hennig et al., 2013; Johnson et al., 2006; Roger et al., 2014; Tran et al., 2014; J. Zhang et
al., 2004] In the Sca7 mutant, timing of nuclear chromatin changes was determined to predate
functional deficits, suggesting that these changes could have resulted in expression
differences.[Helmlinger et al., 2006] The interpretation of cause in other mutants is unclear, as
photoreceptor precursor and other retinal cells display the normal chromatin state. It is difficult
to decouple a change in fate decision or lack of the cue to repress Lmna vs a direct result of the
disease.
This unique organization has been associated with large scale changes in the chromatin
landscape. Recent ATAC-seq data suggests that there are large regions of the genome that
completely lack the normal nominal open regulatory sites.[Hughes et al., 2017] These regions
largely correlate with traditional heterochromatin, and the interpretation must be that rod
condensation causes these regions to become virtually completely inaccessible. This suggests
that a rod nucleus is organized differently, or more strictly by chromatin state than observed in
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other cell types. Indeed, immunohistochemistry and in situ hybridization have shown strict
delineation of classes of chromatin. Activating TFs such as CRX are only located at the most
peripheral level,[Corbo et al., 2010] while euchromatin vs heterochromatin associated DNA
repeat sequences show very little overlap in the nuclear volume.[Solovei et al., 2009] Limited
FISH experiments that probed the locations of particular genes also showed active genes are
located at the far euchromatin periphery.[Aldiri et al., 2017; Solovei et al., 2009]
Rod genomic organization has only been analyzed locally at the molecular level. 3C
experiments described enhancer-promoter interactions and their dependency on cell type specific
TFs.[G. Peng & Chen, 2011, 2012] Another recent study used 4C to analyze local compaction of
a several Mb region. This work showed that genomic loci in that region clustered within the
nuclear volume based on chromatin activity status, irrelevant of linear genomic distance.[van de
Werken et al., 2017] Experiments presented in Chapter 5 of this dissertation are designed to
interrogate the organization of whole chromosomes in the rod nucleus and to test several
fundamental mechanisms and function of this packaging.
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Table 1.1. Summary of Chromosome Conformation Capture Techniques
Technique

Bait vs Capture

Data

3C
4C
5C
HiC

one vs one
one vs all
many vs many
all vs all

PCR
Seq
Seq
Seq

ChIA-PET

all vs all bound by
specific protein

Seq

adapted from [de Wit & de Laat, 2012]
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Number of Genes (approx.)

25,000

M. musculus
H. sapiens

20,000

C. elegans

15,000

D. melanogaster

10,000
S. cerevisiae
E. coli

5,000
0

0

1000

2000

3000

Genome size (Mb)
Figure 1.1: Humans and mice have more non-coding genomic sequence. Plot displays the
approximate size of the genome vs the number of coding genes for each of the labelled species.
Adapted from [Cooper, 2000].
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2.2 Abstract
Purpose: The Cone-Rod Homeobox (CRX) transcription factor is essential for photoreceptor
gene expression, differentiation and survival. Human CRX mutations can cause dominant
retinopathies of varying onset and phenotype severity. In animal models, dominant frameshift
CRX mutations introduce a premature termination codon (PTC), producing inactive truncated
proteins that interfere with normal CRX function. Previously, a mutant mouse, TVRM65, was
reported to carry a recessive late PTC mutation, Crx-L253X. More detailed phenotype analysis of
Crx-L253X’s pathogenicity sheds new light on the variability of CRX-linked diseases.
Methods: Homozygous (L253X/X), heterozygous (L253X/+), Crx-/- and control C57BL/6J (WT)
mice were analyzed at various ages for changes in retinal function (ERG), morphology
(histology) and photoreceptor gene expression (qRT-PCR).
Results: L253X/X mice lack visual function at 1 month, show greater reductions in retinal
thickness and distinct gene expression changes relative to Crx-/-, suggesting that L253X/X’s
phenotype is more severe than Crx-/-. L253X/+ mice have reduced rod/cone function, but normal
retinal morphology at all ages tested. qRT-PCR assays described a complex phenotype in which
both developing and mature photoreceptors are unable to maintain proper gene expression.
L253X mRNA/protein is overexpressed relative to normal Crx, suggesting a pathogenic
mechanism similar to early PTC mutations. However, the overexpression is less pronounced,
correlating with a relatively mild dominant phenotype.
Conclusions: The L253X mouse provides a valuable model for CRX-associated retinopathy.
The pathogenicity of CRX frameshift mutations depends on the position of the PTC, which in
turn determines the degree of mutant mRNA/protein overproduction.
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2.3 Introduction
The Cone-Rod Homeobox protein (CRX) is a transcription factor (TF) that regulates
expression of many photoreceptor genes essential for the development and maintenance of both
rod and cone photoreceptors.[Freund et al., 1997; Furukawa et al., 1997; Hennig et al., 2008;
Swaroop et al., 2010] Human CRX mutations are associated with various diseases, including
Retinitis Pigmentosa (RP), Cone-Rod Dystrophy (CoRD) and Leber Congenital Amaurosis
(LCA).[Rivolta et al., 2001; Swain et al., 1997] CRX-linked diseases are largely inherited in an
autosomal dominant fashion or arise de novo, and vary widely in severity and age of
onset.[Jacobson et al., 1998; Koenekoop et al., 2002; Nichols et al., 2010; Rivolta et al., 2001;
Sohocki et al., 1998] Since CRX mutations can be detected with early genetic testing, we need to
be able to predict their effects and to define effective treatment and gene therapy
regimens.[Sohocki et al., 1998]
Previous research has divided disease causing CRX mutations into four classes.[Tran &
Chen, 2014] Classes I and II are missense mutations that fall within or near the region coding for
the DNA-binding homeodomain; Class I mutations reduce the binding of CRX to its DNA
targets.[Chen et al., 2002] Previous work has shown by a variety of metrics that heterozygous
mice carrying the Class I R90W mutation suffer from a mild form of CoRD, similar to human
patients with such mutations, while homozygotes exhibit a LCA-like condition.[Tran et al.,
2014] Class III and IV mutations represent frameshift mutations caused by insertions or
deletions in the region coding for CRX’s transactivation domains.[Chen et al., 2002] Class IV
mutations, modeled by the RIP mouse, cause translation of a much longer peptide sequence due
to a frameshift and extension of the open reading frame (ORF) into the 3’ untranslated region
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(3’UTR).[Roger et al., 2014] In contrast to this extended peptide sequence, Class III mutations
truncate CRX’s ORF with a premature termination codon (PTC) that results in a CRX protein
with a shortened transactivation domain and lead to a severe dominant degenerative phenotype
(LCA or CoRD).[Tran et al., 2014] This phenotype has been modeled by the E168d2 mouse
[Tran et al., 2014] and Rdy (A182d1) cat [Occelli et al., 2016] (Figure 2.1A). In vitro DNA
binding and transactivation experiments determined that the E168d2 protein has a similar affinity
for CRX target DNA sequences as normal CRX, but is unable to activate transcription on its own
or in combination with other retinal TFs that normally synergize with CRX.[Chen et al., 2002;
Tran et al., 2014] Furthermore, when tested together with normal CRX, E168d2 protein
interfered with normal CRX transactivation in a dominant-negative manner.[Tran et al., 2014]
Class III PTC-causing CRX mutations also result in a novel untranslated region between
the PTC and normal stop codon, which becomes a part of the mutant mRNA transcript’s 3’UTR
(Figure 2.1A).[Tran & Chen, 2014] In the E168d2 mouse and the Rdy (A182d1) cat, longitudinal
studies showed gradual accumulation of mutant protein and mRNA.[Tran et al., 2014],[Occelli et
al., 2016] The mechanism for this accumulation is unknown, but was postulated to arise from
decreased mutant RNA degradation,[Tran et al., 2014] possibly due to the presence of cryptic
stabilizing elements within the PTC-expanded mutant 3’UTR. Therefore, the position of the PTC
(relative to the normal termination codon) could determine the stability, and thus abundance of
mutant RNA.
Previously, another PTC mutant mouse, TVRM65 (Crx-L253X), was discovered in a
chemical-induced mutagenesis screen conducted by The Jackson Laboratory[Won et al., 2011]
(see Appendix 2 Methods section for nomenclature specifics). The L253X mutation (Figure
2.1A) occurs later (closer to the normal termination codon) than E168d2 and A182d1. L253X
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would be a candidate to model late PTC Class III mutations, such as L237i1 [Huang et al., 2012]
and Q256X [Lu et al., 2015] associated with dominant CoRD. However, the initial histological
assessments suggested that the L253X mouse phenocopies the recessive null (Crx-/-)
condition.[Won et al., 2011] Here, we describe more detailed phenotypic analysis of L253X
mice, which demonstrates that this mouse models a new dominant but mild form of Class III
disease. Our results support the hypothesis that Class III mutation pathogenicity depends on the
position of the mutation-induced PTC (a late PTC produces a less severe phenotype than an early
PTC), which correlates with the abundance of mutant protein products. These findings have
implications for predicting human CRX disease severity and progression.
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2.4 Results
2.4.1 L253X overproduces mutant mRNA/protein in affected retinas
A hallmark of Class III CRX frameshift mutations is the overexpression of the mutant
allele.[Occelli et al., 2016; Tran et al., 2014] To determine if L253X retinas accumulate mutant
protein, we performed quantitative Western blots on total protein extracts from retinas of WT and
heterozygous L253X/+ mice at postnatal day 10 (P10), 1 and 2 months old (mo), and
homozygous L253X/X mice at P10 only (because photoreceptors degenerate before later
ages).[Won et al., 2011] Immunoblotting with an anti-CRX antibody revealed a truncated L253X
protein that ran faster than the normal full-length CRX protein in samples from both
heterozygous and homozygous mutant retinas (Figure 2.1B). We quantified the total amount of
CRX protein and of each isoform. Both L253X/+ and L235X/X displayed a 1.5 to 2.2-fold
increase in total CRX protein compared to the WT retinas (Figure 2.1C). The increases can be
attributed to an accumulation of mutant protein (black bar), since normal CRX protein levels
(grey bar) in L253X/+ retinas with one normal allele were roughly half of the total CRX protein
present in WT retinas with two alleles.
To determine if the increased mutant protein corresponded with an increase in mutant
mRNA, we quantified the relative allelic expression of L253X and normal Crx mRNA using
droplet digital PCR (ddPCR). First, using mutant and WT mouse DNA, we developed a ddPCR
assay that clearly distinguished the L253X and normal Crx sequences (Figure 2.1D, DNA
control). This assay was then used to quantify allele-specific mRNA species. At all ages tested,
the mutant transcript was overrepresented, accounting for 57% of total Crx mRNA (Figure
2.1D). Total Crx transcript levels quantified by conventional qRT-PCR (Supplemental Figure
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2.1) showed a statistically significant total Crx mRNA increase in 1 mo L253X/+ retinas relative
to WT, although levels were comparable to WT retinas during development at P10 and by 3 mo.
Overall, L253X/+ retinas develop and maintain an elevated level of mutant mRNA that translates
into an imbalance of the two protein forms, but this misregulation is not as severe as observed in
other Class III mutants. These results identify Crx-L253X as a bona fide Class III mutation, but
suggest that the position of the PTC determines the toxicity of the allele.

2.4.2 L253X/X mice have no detectable rod and cone function
Homozygous animals carrying Class III or null Crx mutations lack measurable
photoreceptor function.[Furukawa et al., 1999; Occelli et al., 2016; Tran et al., 2014] To confirm
that L253X/X photoreceptors are functionally compromised, we quantified rod/cone light
responses in L253X/X and WT control mice at 1 mo using electroretinogram (ERG). Even at the
highest light intensity stimuli, L253X/X retinas displayed very little response (Figure 2.2A-C).
These results confirm that, like other Class III models, homozygous L253X/X animals lack
photoreceptor visual responses, resembling human LCA.

2.4.3 L253X/X photoreceptors degenerate earlier than Crx-/Other Class III mutations show a greater impact on retina morphology and function than
seen in Crx-/- mice.[Furukawa et al., 1999; Occelli et al., 2016; Tran et al., 2014] The original
report noted that degeneration was more rapid in L253X/X than Crx-/- retinas, but suggested
differences in mouse background might be a factor.[Won et al., 2011] To directly compare the
impact of the L253X mutation with that of complete loss of Crx, we collected retinas from 1 and
3 mo WT, L253X/X, and Crx-/- mice (all backcrossed 10 generations onto C57BL/6J) and
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assessed morphological changes in H&E stained sagittal sections through the optic nerve head
(Figure 2.2D-K). At 1 mo both L253X/X and Crx-/- retinas lacked photoreceptor outer segments
(OS) and had thinner Outer Nuclear Layers (ONL) than the WT control (Figure 2.2E&F vs. D).
However, thinning was more pronounced in L253X/X than Crx-/-: L253X/X retina had only 4-5
rows of ONL nuclei, while Crx-/- maintained 7-8 rows at the same age (Figure 2.2E vs. F).
Quantitative morphometry measures showed that the ONL of L253X/X was significantly thinner
than that of Crx-/- at multiple positions (Figure 2.2G, black vs. sold grey). By 3 mo, both
models had similarly degenerated retinas with only 2-3 rows of ONL cells left (Figure 2.2I vs. J;
2K). Since both mutants showed normal ONL thickness at P7-P10 (Supplemental Figure
2.2A&B and Tran et al.[Tran et al., 2014]), these results suggest that ONL degeneration occurs
earlier or at a faster pace in L253X/X mice than in Crx-/-.
In addition to progressive ONL loss, L253X/X also underwent age-dependent thinning of
the Outer Plexiform Layer (OPL) (Figure 2.2E&I, Supplemental Figure 2.2D, I, N, and Won et
al.[Won et al., 2011]). In contrast, non-photoreceptor cell layers (e.g. INL, GCL) were largely
unchanged in L253X/X compared to WT controls at various ages (Supplemental Figure 2.2C-Q).
These results suggest that the L253X mutation mainly affects photoreceptor structural integrity
and survival.

2.4.4 L235X/X mice exhibit photoreceptor gene misregulation distinct from
Crx-/To further examine if the more severe morphological phenotype of L253X/X retinas
reflected greater changes in CRX target gene expression, we collected RNA from L253X/X and
Crx-/- retinas at P10 during photoreceptor terminal differentiation prior to cell death.[Tran et al.,
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2014] Transcripts of 14 known CRX-dependent genes were quantified by qRT-PCR and
compared both with WT levels (Supplemental Figure 2.2R) and between the two models (Figure
2.3A). Although most of these genes were dysregulated in both mutants compared to WT mice
(Supplemental Figure 2.2R), half of them showed statistically significant expression differences
between L253X/X and Crx-/- (Figure 2.3A).[Ruzycki et al., 2015; Tran et al., 2014] Three of
these, Gnat1, Grk1, and especially Rho differed markedly (>2 fold) between the two models
(Figure 2.3A). Such differences in essential photoreceptor gene expression likely contribute to
the morphological and phenotype differences between the two models.
To confirm qRT-PCR results at the protein level, we performed immuno-fluorescent
(IHC) staining for RHO on retinal sections of 1 mo L253X/X, Crx-/- and WT control mice. RHO
was chosen because it displayed the largest difference in the RNA level between L253X/X and
Crx-/-. As expected, in WT retina, RHO was predominantly localized to the rod outer segments
(OS) with faint staining seen in ONL cell bodies (Figure 2.3B). In contrast, L253X/X retina
displayed no detectable RHO immunostaining (Figure 2.3C), while Crx-/- retina still had weak
and spotty RHO signals localized to individual ONL cell bodies and inner segments (Figure
2.3D). These results supported the RNA expression data and suggest that L253X mutant
protein negatively affects transcription.
Overall, the comparison between L253X/X and Crx-/- indicates that L253X/X disease is
more severe than that resulting from loss of Crx, supporting a dominant effect of the
mutation.[Jacobson et al., 1998; Tran et al., 2014] The more severe photoreceptor deficits in
L253X/X thus presumably result from antimorphic activity of the truncated CRX protein.
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2.4.5 Heterozygous L253X/+ mice show mild decreases in rod and cone
function
The L253X (TVRM65) mutation was originally reported to cause recessive retinal
disease.[Won et al., 2011] However, if the mutant protein possesses antimorphic activity, we
would hypothesize that one copy would produce a photoreceptor phenotype. To test this, we
investigated photoreceptor function in L253X/+ retinas by assessing electrical responses to
whole retina light stimulation. ERGs recorded at 1, 2, 3, and 5 mo revealed L253X/+ mice
exhibit mild but significant reductions in ERG amplitudes compared to WT mice (Figure 2.4). At
all ages tested, dark-adapted A-waves were reduced in L253X/+ mice, especially at high stimulus
intensities (Figure 2.4A-D, black line vs. grey line). Dark-adapted B-waves of L253X/+ mice
were comparable to WT at 1 mo (Figure 2.4E), but significantly reduced at 2, 3, and 5 mo (Figure
2.4F-H, black line vs. grey line). The degree of A-wave or B-wave reductions appeared to be
constant, suggesting that the defects were unlikely a result of progressive degeneration.
Reduction in cone function was also observed: Light-adapted B-waves were significantly
decreased in L253X/+ mice at 2, 3 and 5 mo (Figure 2.4J-L), but not at 1 mo (Figure 2.4I).
These results suggest that L253X/+ mice have deficits in both rod and cone function, resembling
a mild retinopathy.

2.4.6 L253X/+ retinas do not degenerate
To test whether the functional defects correspond to morphological changes, we
measured retinal thickness in H&E stained retinal sections, comparing L253X/+ and L253X/X
with WT mice at three ages (Figure 2.5). Despite the progressive retinal degeneration seen in
L253X/X mice (Figure 2.5C, D, G, H, K & L; Supplemental Figure 2.2C-Q), L253X/+ showed
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no degeneration or morphological abnormalities compared to WT controls up to 3 mo of age
(Figure 2.5B, D, F, H, J, & L; Supplemental Figure 2.2C-Q).

2.4.7 L253X/+ retinas display dynamic changes of photoreceptor gene
expression
To examine developmentally regulated photoreceptor gene expression in L253X/+ vs.
WT mice, we performed qRT-PCR analyses at two early ages: P10, when rods/cones are still
terminally differentiating, and 1 mo when rods/cones are fully mature in normal retinas. The
genes tested were previously shown to dramatically change in expression during WT rod and
cone development.[Kim et al., 2016] Figure 2.6A shows expression changes of these genes in
L253X/+ relative to WT mice at both ages. Gene expression conformed to three general trends in
addition to the slight increase in total Crx expression (dashed black line) noted above: Gnat1,
Rho, and Sop (solid black lines), markers of mature photoreceptors, were significantly decreased
in L253X/+ at P10 but attained WT levels by 1 mo. Rxrg (dotted grey line), which in WT retina
loses expression over development,[Kim et al., 2016] was elevated in L253X/+ at P10 but
decreased closer to WT levels by 1 mo. The other genes tested, which increase over development
in WT retina, showed similar relative expression levels at both ages that did not vary
considerably from WT (solid grey lines). Together, these gene expression trends suggest that
L253X/+ retinas exhibit altered gene expression early in photoreceptor development, similar to
other Crx mutant models.[Ruzycki et al., 2015]
To determine if L253X/+ retinas maintain photoreceptor gene expression after
differentiation, we used qRT-PCR to examine expression of 17 essential rod and cone genes in
WT and L253X mutants at other adult ages. The results at 1, 2, 3 and 5 mo (presented in a
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heatmap in Figure 2.6B) suggest a complex phenotype. Genes coding for transcription factors
Crx, Rxrg, Otx2, and Nrl were upregulated at many of the time points tested. The expression of
essential rod and cone phototransduction genes showed a less clear pattern across ages, but in
general all exhibit phases of reduced expression relative to WT.

2.4.8 Late PTC-caused C-terminal truncation reduces CRX’s transactivation
function
As an initial step to understand the molecular mechanism underlying mis-regulation of
gene expression in L253X mutant retinas, we asked whether a short C-terminal truncation caused
by a late PTC affects CRX’s ability to transactivate target gene expression. This was tested
using transient transfection assays in HEK293T cells with a Rhodopsin (Rho) promoterluciferase reporter (BR130-luc) .[Chen et al., 2002] Vectors expressing either the full-length
(normal) or truncated CRX1-254 were co-transfected with a NRL vector to measure their ability to
transactivate the BR130-luc reporter. CRX1-254 did show some dose-dependent ability to activate
the Rho promoter, suggesting that it does bind DNA and interacts with NRL, but the maximum
activity was greatly reduced compared to the normal CRX protein (~30% of normal activity)
(Figure 2.7).

38

2.5 Discussion
2.5.1 L253X mouse provides a new Class III model for mild dominant conerod dystrophy
Although L253X (TVRM65) was originally identified as a recessive Crx mutation[Won et
al., 2011] several pieces of evidence suggest that L253X is antimorphic with dominant
inheritance. First, L253X retinas overexpress the mutant gene product, a hallmark of Class III
mutations that amplifies the mutation’s effects. Second, the photoreceptors in homozygous
L253X/X mice degenerate earlier than Crx-/-, and show patterns of photoreceptor gene
dysregulation that are distinct from Crx-/-. Thus, the presence of the mutant L253X protein
causes more severe pathology than absence of CRX altogether, which is consistent with the
antimorphic effect of other Class III mutations[Occelli et al., 2016; Tran et al., 2014; Tran &
Chen, 2014] Furthermore, heterozygous L253X/+ mice have early gene expression differences
that largely resolve by 1 mo, suggesting that full maturation may be delayed in these retinas.
Although gene expression changes in adults were modest, rod and cone functional deficits were
detectable as early as 1 mo. Previous work on Class III mutants has emphasized the effects that
small changes in gene expression over a large number of genes can have on photoreceptor
function.[Ruzycki et al., 2015] Collectively, these findings identify L253X as a Class III Crx
mutation with the phenotypes summarized in Table 2.1.
Compared to previously reported Class III mutations, L253X’s pathogenicity is relatively
mild. Unlike E168d2/+ photoreceptors, which lose their OS and undergo progressive
degeneration,[Tran et al., 2014] L253X/+ photoreceptors show normal morphology and do not
degenerate. The ERG deficits do not worsen with age relative to C57BL/6J controls. The gene
expression changes are also relatively modest with a multiphasic nature. This evolving
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expression pattern with increased levels of many TFs, but modest depletion of phototransduction
cascade components, likely reflects an inability of the cells to maintain a proper homeostasis.
This data would suggest that unknown feedback mechanisms are operational but unable to
achieve the necessary precision. In adults, L253X/+ photoreceptors are alive and functional
through 5 mo, but it remains to be determined if the phenotype worsens at older ages or if the
retina is more susceptible to environmental insults as reported with other Class III mutants.
Nevertheless, given the huge phenotypic variability of human CRX diseases, the L253X mouse
provides a valuable animal model for understanding the pathogenesis of Class III mutations and
the underlying molecular mechanisms that determine phenotype severity, age of onset and
disease progression.

2.5.2 The molecular mechanism(s) underlying L253X pathogenicity
The pathogenicity of Class III mutations is generally determined by two factors, the
activity and dose of the mutant protein. L253X protein contains an intact DNA binding domain
but lacks a portion of the C-terminal activation domain (Figure 2.1A). Thus, it likely retains the
ability to bind DNA, but loses some aspect of transactivation function. Transient transfection
assays showed that CRX1-254, a truncated CRX protein similar to L253X, retained only 30% of
the normal CRX activity, very similar to the published reports.[Chen et al., 2002; Roger et al.,
2014] By comparison, the Class III mutant protein E168d2 showed 25-30% of the transactivation
activity under similar conditions.[Chen et al., 2002; Tran et al., 2014] Previous reports have also
shown CRX1-254 binds appropriate DNA sequence elements very similar to full-length
CRX.[Roger et al., 2014] It is conceivable that, as previously reported for E168d2,[Tran et al.,
2014] L253X protein may compete with normal CRX to bind to target genes, interfering with
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normal CRX function in heterozygous mice. However, transient transfection assays testing this
hypothesis did not show this effect on the Rho-promoter luciferase reporter (data not shown).
The antimorphic competition may not be limited to CRX but could also affect other
homeodomain transcription factors that bind to similar DNA targets, and as such transient cell
transfection assays on a single reporter that lacks the native chromatin context and regulatory
architecture may not be the proper experiment. Supporting this possibility, the retinas of
L253X/X mutants, like E168d2/d2,[Tran et al., 2014] showed more severe degeneration and
biochemical defects than Crx-/- retinas. Other potential targets could include OTX2,[Samuel et
al., 2014] which is upregulated in L253X retinas (Figure 2.6B). Additional experiments are
required to demonstrate L253X’s dominant-negative activity on CRX and OTX2. Despite the
similarity between L253X and E168d2, L253X/+ mice have a remarkably milder phenotype than
E168d2/+; it is unlikely that the <10% difference in transactivation activity can account entirely
for the significant difference between the two models. We therefore propose that the relative
amounts of mutant and normal CRX protein must also play a role in phenotype severity.

2.5.3 L253X allele-specific overproduction of mutant mRNA and protein has
implications for the PTC position effect
Careful analysis of Crx mRNA and protein in L253X/+ and L253X/X retinas clearly
shows an increased ratio of mutant/normal protein and mRNA. This finding supports the
hypothesis that, like other Class III models, L253X retinas accumulate mutant transcripts, leading
to overproduction of the CRX mutant protein. Interestingly, however, the degree of mutant RNA
accumulation in L253X/+ is lower than that of the other Class III models carrying early PTC
mutations. L253X mice only display a modest accumulation (57% mutant / 43% normal),
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especially when compared to that observed in E168d2/+ mice at the same age (85% mutant /
15% normal).[Tran et al., 2014] Also, when considered with the quantification of total Crx
mRNA, the L253X/+ must result in a downregulation of the normal allele as there is no
aggregate overproduction of Crx. This suggests that the L253X mRNA is still ‘sensed’ by the
feedback regulatory mechanism, which functions normally in the mutant retina. Future studies
could probe this feedback mechanism by comparing to the E168d2/+ retinas where although
there is a gross increase in total Crx mRNA, the normal allele maintains normal expression
levels.[Tran et al., 2014] Both mouse models show overproduction of mutant protein relative to
WT, but L253X accumulates at a slower rate than E168d2.
The mechanism for allele-specific overproduction of mutant Crx in Class III models is
not well understood, but likely stems from increased RNA stability due to the presence of the
PTC in the last exon. This hypothesis further predicts that the position of the PTC influences the
rate of mutant RNA accumulation. Indeed, L253X with a later PTC showed less RNA
accumulation than the two early PTC alleles, E168d2 and A182d1 (Figure 2.1). Thus, the earlier
the PTC is, the more mutant product accumulates. These differences between early vs. late PTCs
may be attributed to the length of PTC-determined 3’UTR, within which multiple discrete
elements could independently and additively contribute to mRNA hyperstability. Future
identification of novel RNA regulatory elements shared among different PTC mutations may
shed light on the mechanisms for mutant transcript hyperstability and phenotype variability in
Class III CRX disease. It is also notable that the accumulation of mutant protein in L253X retinas
is more prominent than mutant RNA, raising the new possibility that altered protein turnover rate
could also contribute to mutant protein accumulation.
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In conclusion, our in-depth characterization of the Crx-L253X (TVRM65) mouse supports
the classification of L253X as a dominant Class III Crx mutation and provides a new animal
model for understanding CRX-associated dominant retinopathies. The insights gained will
hopefully lead to new treatment strategies for this complex disease.
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Table 2.1. Summary of L253X related phenotypes

Phenotype

Crx-L253X/X

Crx-L253X/+

Morphology (histology)

ONL degeneration earlier
than Crx-/-

No detectable abnormality
up to 5 mo

Function (ERG)

Lack of rod and cone
responses to light

Minor reductions in rod
and cone function

Gene expression
(qRT-PCR)

Altered gene expression
distinct from Crx-/-

Dynamic changes from
WT

CRX protein/RNA
levels

L253X protein/RNA
overproduction

Increased ratio of L253X
vs Normal
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Figure 2.1: Class III Crx mutations introduce a premature termination codon (PTC),
resulting in accumulation of truncated CRX proteins and mutant mRNA with variable
extended 3’UTR. (A) Schematic representation of normal and mutant CRX mRNA species,
showing untranslated (UTR, grey/black lines) and protein-coding (open/striped boxes) with their
relative sizes (bp, base pairs), based on mouse (Normal, E168d2[Tran et al., 2014] and L253X)
and cat (A182d1)[Occelli et al., 2016] models. The DNA-binding homeodomain (HD, dark
strips) and the activation domain (AD, light strips) sequences[Chen et al., 2002] are indicated.
All three mutant mRNAs encode the complete HD, but ADs are truncated at different positions
due to their PTC (indicated as the right-hand end of the protein coding box) induced by the
mutation (marked by *). These PTCs also expand the 3’UTR to include different lengths of the
original coding region (indicated by black line) in front of the normal 3’UTR (grey line). The
position of the PTC relative to the normal stop codon determines the length of expanded 3’UTR:
Early PTC mutants, E168d2 and A182d1 (Rdy cat mutation) produce a longer 3’UTR than the
late PTC mutant L253X. Since 5’UTR and 3’UTR sequences of feline Crx mRNA are not
available, these regions of the A182d1 transcript are indicated by dotted lines. (B) Immunoblot of
CRX in the retinas of WT, L253X/+, and L253X/X mutants at 1 month old (mo) with GAPDH as
a protein loading control. Black arrows indicate the running position for the normal and mutant
(truncated) forms of CRX. (C) Quantification of relative amounts of normal and mutant CRX
proteins in the indicated retinas at three ages (mean ± SEM, n ≥ 3; * p<0.05, **p<0.01; 2-Way
Anova with Tukey’s Multiple Comparisons Test). (D) Droplet digital PCR (ddPCR)
quantification of Mutant (L253X) and Normal Crx mRNA as percentage of total Crx. The
specificity of the two allele-specific ddPCR assays was established using triplicate tail DNA
samples (grey circles) from the indicated genotypes (DNA control). L253X/+ mRNA results are
presented as percent of total Crx mRNA (Mutant plus Normal transcripts) (mean ± SEM, n ≥ 3;
**** p<0.0001; Unpaired t-Test for mutant mRNA level relative to L253X/+ DNA control; n ≥
3).
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Figure 2.2: L253X/X retinas lack rod and cone responses to light and degenerate earlier
than Crx-/-. Electroretinogram (ERG) was used to measure rod (dark-adapted) and cone (lightadapted) responses to various light stimuli in 1 mo L253X/X and WT mice. (A, B) Comparison
of representative ERG traces at the highest light intensity: 0.89 log cd*s/m2 for dark-adapted
responses, and 2.67 log cd*s/m2 for light-adapted responses. (C) Bar graphs compare mean Awave and/or B-wave amplitude differences between the two genotypes at the highest light
intensity tested (mean ± SEM, n ≥ 3; * p≤0.05, *** p≤0.0005, **** p<0.0001; 2-Way Anova
with Sidak’s Multiple Comparisons Test). (D-F, H-J) H&E-stained paraffin-embedded sagittal
retinal sections from the indicated mice at 1 and 3 mo. Images were taken approximately 500um
from the Optic Nerve Head (ONH) at a 40X magnification (scale bar = 25um). (G,K)
Morphometry measures at five set distances (in microns) on either side of the ONH (mean ±
SEM, n ≥ 3; * p≤0.05, ** p<.01, *** p≤.0003; 2-Way Anova with Sidak’s Multiple Comparisons
Test).
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Figure 2.3: L253X/X has measurable gene expression differences relative to Crx-/-. (A)
Expression at P10 of the indicated photoreceptor genes was measured by qRT-PCR and
compared between L253X/X and Crx-/- at P10. The grey dash lines mark 2-fold differences (±1
log2 relative expression) between the two genotypes (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01,
**** p<0.0001; Unpaired t-Test with Welch’s Correction). (B-D) RHO immunostaining of
retinal sections of the indicated mice at 1 mo revealed less RHO expression in L253X/X retinas
than Crx-/- (signal in black, scale bar 25um). (E-G) DAPI counterstaining of the above sections
(signal in black).
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Figure 2.4: L253X/+ retinas exhibit reduced rod and cone light responses. ERG responses of
L253X/+ mice (black lines) and WT (gray lines) were tested at 4 adult ages, and dark-adapted
and light-adapted A- and B-wave amplitudes quantified. 1 mo (A, E, I), 2 mo (B, F, J), 3 mo (C,
G, K), and 5 mo (D, H, L) (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.0006, ****
p<0.0001; 2-Way Anova with Sidak’s Multiple Comparisons Test).
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Figure 2.5: L253X/+ retinas appear morphologically similar to WT up to 3 mo. H&E stained
retinal sections from L253X/+, L253X/X, and WT mice at the indicated ages (A-C, 1 mo; E-G, 2
mo; I-K, 3 mo) were imaged at 40X magnification (Scale bar 25um). Images were taken
approximately 500 microns from the ONH, where differences in layer thickness are less
significant. (D,H,L) ONL thickness was quantified by morphometry at five set distances (in
microns) on either side of the ONH (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.001,
**** p<0.0001; 2-Way Anova with Tukey’s Multiple Comparisons Test).
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Figure 2.6: L253X/+ retinas display dynamic changes in photoreceptor gene expression.
qRT-PCR analyses of L253X/+ expression levels (relative to WT mice) of the indicated rod/cone
genes are shown at P10 and 1 mo (mean ± SEM, n ≥ 3). Lines connecting expression levels of
each gene at the two ages show the dynamic changes in expression, and reveal four different
expression trends indicated here by line color and solidity, as described in Results. (B) Heatmap
depicting qRT-PCR-detected expression changes of the listed photoreceptor genes in L253X/+
relative to WT at the indicated ages. Data are clustered based on gene expression patterns (log2
[mean fold-change], n ≥ 3). Colored gene names indicate expression in specific photoreceptor
subtype(s). “TF” indicates transcription factors expressed by rods and/or cones that are essential
for cell fate specification.
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Figure 2.7: L253X retains minimal ability to transactivate Rhodopsin promoter in presence
of NRL . Dual luciferase assays showing dose-dependent increase in CRX transactivation
activity of normal or mutant (CRX1-254) in the presence of constant amount of NRL. (mean ±
SEM, n = 3; **** p<0.0001; 2-Way Anova with Bonferroni’s Multiple Comparisons Test)
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Supplemental Figure 2.1: L253X/+ retinas display variable excess total Crx mRNA. qRTPCR assays were used to quantify total Crx mRNA from mutant and WT control retinas at the
indicated ages. The results are presented as relative expression to WT. (mean ± SEM, n=3, circles
represent individual biological replicates; ** p< .01; 1-Way Anova with Tukey’s Multiple
Comparisons Test).
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Supplemental Figure 2.2: L253X/X retinas display normal ONL genesis but photoreceptor
layer-specific progressive thinning, while all L253X/+ retinal layers unaffected. H&E stained
retinal sections from P7 WT (A) and L253X/X (B) mice were imaged at 40X magnification (scale
bar 25um). Morphometry quantification of five retinal layers in L253X/X and L253X/+ mutants
along with WT controls at 1 mo (C-G), 2 mo (H-L) and 3 mo (M-Q). These layers include ONLouter nuclear layer, OPL-outer plexiform layer; INL–inner nuclear layer; IPL-inner plexiform
layer; and GCL- ganglion cell layer. (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.001,
**** p<0.0001; 2-Way Anova with Tukey’s Multiple Comparisons Test). (R) Expression levels
of 14 essential photoreceptor genes in P10 L253X/X and Crx-/- mutants and WT controls were
determined by qRT-PCR. The results are presented as expression changes relative to WT in a
log2 scale with 2-fold differences (±1) marked by grey dash lines (mean ± SEM, n ≥ 3; * p<0.05,
** p<0.01, **** p<0.0001; 1-Way Anova with Tukey’s Multiple Comparisons Test)
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Chapter 3
Graded gene expression changes determine phenotype
severity in mouse models of CRX-associated
retinopathies
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3.2 Abstract
Background: Mutations in the cone-rod-homeobox protein CRX are typically associated with
dominant blinding retinopathies with variable age of onset and severity. Five well-characterized
mouse models carrying different Crx mutations show a wide range of disease phenotypes. To
determine if the phenotype variability correlates with distinct changes in CRX target gene
expression, we perform RNA-seq analyses on three of these models and compare the results with
published data.
Results: Despite dramatic phenotypic differences between the three models tested, graded
expression changes in shared sets of genes are detected. Phenotype severity correlates with the
down-regulation of genes encoding key rod and cone phototransduction proteins. Interestingly,
in increasingly severe mouse models, the transcription of many rod-enriched genes decreases
decrementally, whereas that of cone-enriched genes increases incrementally. Unlike downregulated genes, which show a high degree of CRX binding and dynamic epigenetic profiles in
normal retinas, the up-regulated cone-enriched genes do not correlate with direct activity of
CRX, but instead likely reflect a change in rod cell-fate integrity. Furthermore, these analyses
describe the impact of minor gene expression changes on the phenotype, as two mutants showed
marginally distinguishable expression patterns but huge phenotypic differences, including
distinct mechanisms of retinal degeneration.
Conclusions: Our results implicate a threshold effect of gene expression level on photoreceptor
function and survival, highlight the importance of CRX in photoreceptor subtype development
and maintenance, and provide a molecular basis for phenotype variability in CRX-associated
retinopathies.
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3.3 Introduction
Rod and cone photoreceptors are the two primary light detecting cell types of the retina
and are essential for vision. Each cell type preferentially expresses a set of genes critical for
development and maintenance of its specialized function. This cell type-specific gene
expression is regulated by a network of transcription factors (reviewed in [Hennig et al., 2008;
Hsiau et al., 2007]). Disruptions in this regulatory network can have a dramatic effect on rod [J.
Chen et al., 2005; Corbo & Cepko, 2005; Daniele et al., 2005; Mears et al., 2001] and cone
[Roberts et al., 2005, 2006] development, function, cell-fate integrity and survival. The
homeodomain transcription factor CRX is expressed in both rods and cones and plays a central
role in mediating photoreceptor transcription. CRX works with rod-specific, cone-specific and
general transcription factors to control photoreceptor gene expression [S. Chen et al., 1997;
Hennig et al., 2013; Mitton et al., 2000; Onishi et al., 2009; G.-H. Peng et al., 2005; Tran &
Chen, 2014]. In particular, CRX and the rod-specific transcription factor NRL cooperatively
regulate rod gene transcription and have highly overlapping DNA-binding patterns [Brooks et
al., 2011; Corbo et al., 2010; Hao et al., 2012]. Loss of CRX dramatically impairs both rod and
cone photoreceptor gene transcription leading to failed photoreceptor maturation and rapid
degeneration [Furukawa et al., 1999], while the loss of NRL converts rods into cells with conelike transcription and functional properties [Brooks et al., 2011; Daniele et al., 2005].
Mutations in the human CRX gene have been associated with dominant forms of retinal
degenerative diseases such as Retinitis Pigmentosa (RP), Cone-Rod Dystrophy (CoRD) and
Leber Congenital Amaurosis (LCA), with varied age of onset and severity (reviewed in [Huang
et al., 2012; Rivolta et al., 2001; Tran & Chen, 2014]). Disease-causing mutations fall into at
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least four classes, based on mutation type, pathogenic mechanism and molecular properties of
the mutant protein: I) hypomorphic substitution mutations with reduced DNA-binding activity;
II) antimorphic substitution mutations with variable DNA-binding; III) antimorphic frameshift
mutations with intact DNA-binding and IV) antimorphic frameshift mutations with variable
DNA-binding (reviewed in [Tran & Chen, 2014]). While each class of disease-causing
mutations is associated with distinct clinical phenotypes, the underlying transcriptional changes
mediating these phenotypes are poorly understood.
In this study, we used mRNA sequencing (RNA-seq) to examine gene expression in the
developing and adult retinas of three Crx mutation Knock-IN mouse models that have distinct
retinal phenotypes [Tran et al., 2014]: CrxR90W (R90W), CrxE168d2 (E168d2) and CrxE168d2neo
(E168d2neo) (Figure 3.1, Table 3.1). The R90W mice carry a Class I mutation and their
phenotypes resemble mild late-onset dominant CoRD and recessive LCA. E168d2 and
E168d2neo mice carry the same Class III mutation but E168d2neo mice express the mutant
protein at a lower level, due to the retention of an intronic neomycin cassette. E168d2 mouse
phenotypes resemble severe dominant LCA, while E168d2neo mouse phenotypes resemble a less
severe dominant CoRD phenotype, due to reduced mutant protein expression. We assessed how
each Crx mutation impacted the expression of retinal cell-type specific genes and investigated
cellular pathways that may contribute to disease. We correlated these transcriptional changes
with the direct DNA-binding activity of CRX [Corbo et al., 2010] and NRL [Hao et al., 2012]
and the epigenetic landscape of rods and cones [Popova et al., 2012; Vierstra et al., 2014].
Additionally, we compared the expression profiles of these Crx Knock-IN mice to the previously
characterized Crx-/- and CrxRip (Rip) mouse models. Rip mice carry a Class IV mutation and
have a more severe dominant LCA phenotype than E168d2 mice [Roger et al., 2014]. Our
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results demonstrate that all five mouse models have graded changes in photoreceptor-specific
gene expression that correlate with the severity of their phenotypes. These graded changes
include reduced expression of direct CRX target genes required for rod/cone photoreceptor
function and survival, and derepression of ‘cone’ genes in rods through an indirect mechanism,
suggesting that rod cell-fate integrity is compromised in the more severe models.
Lastly, we identified threshold effects of gene expression changes on retinal phenotype.
Despite having only small differences in gene expression changes, heterozygous E168d2 and
E168d2neo mice showed drastically different phenotypes, including light-independent vs. lightdependent photoreceptor degeneration, respectively. These phenotypic and mechanistic
differences between the two models are likely attributed to slight shifts in gene expression
throughout several photoreceptor-specific pathways, particularly phototransduction and the
retinoid (visual) cycle. This highlights the delicate balance between photoreceptor gene
transcription, function and cellular integrity. These results demonstrate that the transcriptional
landscape in models of retinal degeneration can dramatically affect disease pathology. Effective
therapeutic design may therefore be highly context specific.
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3.4 Results
3.4.1 Crx mutations cause graded expression changes in shared gene sets,
correlating with phenotype severity
To assess the effects of Crx mutations on retinal gene expression we performed RNA-seq
on retinas of the Crx mutant mouse models R90W, E168d2 and E168d2neo, and age-matched
wild-type (WT) controls, in triplicate. As listed in Table 3.2, we analyzed heterozygous mutants
at both P10 and P21, but homozygous mutants at P10 only, as their retinas are severely
degenerated at later ages. Because they lack WT CRX to antagonize the antimorphic mutant
CRX protein, homozygous E168d2 and E168d2neo mice show essentially the same severe
phenotype at morphological, functional and gene expression levels [Tran et al., 2014] (Table
S1A). Thus, we only performed RNA-seq on E168d2/d2 to provide a reference for an extremely
severe phenotype. RNA-seq libraries were sequenced on the Illumina HiSeq2000 and each
generated more than 28 million mapped reads (Table S2). Sample quality was assessed by
principal component analysis (PCA) of the expression values of all genes that passed the 5
counts per million (CPM) threshold in any genotype (Supplemental Figure 3.1), and by visual
inspection of mapped reads at individual gene loci using Integrated Genomics Viewer (IGV)
[Robinson et al., 2011] (Supplemental Figure 3.2A,B). PCA plots (Supplemental Figure 3.1)
show that the genotypes clustered as expected with the E168d2/d2 samples showing the most
variation from WT controls at both ages tested. At P10 E168d2/+, E168d2neo/+ and R90W/W
samples clustered between WT and E168d2/d2, corresponding to their intermediate phenotypes.
In contrast, R90W/+ samples clustered with WT samples, consistent with their normal phenotype
at this age. At P21, despite increased replicate variability, differences between heterozygous
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mutant genotypes and WT are consistent with their phenotypes. Since the PCA analysis only
described sample differences as a whole, we further determined the relationship of gene
expression changes and phenotype differences, using multiple independent analyses of gene
expression. First, to determine differential expression, EdgeR [Nikolayeva & Robinson, 2014]
was used to compare the triplicate samples. Changes considered “significant” were 2-fold or
greater (FC ≥ 2) with a false discovery rate (FDR) ≤ 0.05 from the appropriate WT control,
unless otherwise noted. Additional filtering and analysis details can be found in the Appendix 2
Methods section. Expression changes in subsets of RNA-seq identified genes were further
validated using qRT-PCR (Table S1 A-C).

- Homozygous Crx mutant mice show drastically changed expression of a large number of
genes at P10 before photoreceptor degeneration
We first compared retinal gene expression in the homozygous mutants E168d2/d2 and
R90W/W at P10 to that in age-matched WT controls. As shown by the scatterplots (Figures
3.2A,B), both mutants displayed ≥ 2-fold expression changes for a large number of genes.
However, the number of genes affected in E168d2/d2 was much larger than R90W/W (Table
3.2). Among the changed genes, down-regulated genes outnumbered up-regulated genes (Table
3.2), consistent with the established role of CRX in the activation of transcription. Some of the
affected genes (white highlighted in Figures 3.2A,B) encode well-characterized proteins essential
for rod and cone identity, function and survival. Next, we compared the changed gene sets
between the two mutants. Even though E168d2/d2 and R90W/W have mechanistically distinct
mutant proteins and phenotypes [Tran et al., 2014], the significantly affected (FC ≥ 2 & FDR ≤
0.05) genes showed a high degree of overlap for both down-regulated and up-regulated gene sets
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(Figures 3.2C,D). In addition, for these shared genes the degree of change was generally greater
in E168d2/d2 than R90W/W, as seen by visually inspecting the positions of the highlighted genes
in Figure 3.2A vs B. These changes were confirmed to be consistent between replicates by
comparing the raw mapped reads for several of these genes (Supplemental Figure 3.2A).
Homozygous mouse retina RNA-seq results for several genes were also consistent with previous
qRT-PCR data [21] (Table S1B). These data suggest that photoreceptor gene expression in
R90W/W is less disrupted than in E168d2/d2, consistent with the phenotype differences between
the two models.

- Heterozygous Crx mutant mice have moderate expression changes in fewer genes than the
homozygous mutants at P10, with few independently affected genes
To determine if heterozygous mutants also share gene expression changes between
genotypes, we compared RNA-seq data from heterozygous mutants E168d2/+, R90W/+, as well
as E168d2neo/+. At P10, the heterozygous mutants showed fewer gene changes than the
respective homozygous counterparts (Table 3.2). Similar to the homozygous mutants, the
number of significantly affected genes in heterozygotes correlated with phenotype severity in the
order E168d2/+ > E168d2neo/+ > R90W/+. Figures 3.3A-C and Supplemental Figure 3.2A
show that, qualitatively, the white highlighted photoreceptor transcripts were most severely
affected in the E168d2/+ mutant, less affected in the E168d2neo/+ and showed no change
greater than 2-fold in the R90W/+ line. Furthermore, affected transcripts in heterozygotes also
showed a high degree of overlap between the genotypes (Figures 3.3D,E).
Next, we analyzed whether the degree of expression changes correlates with phenotype
severity. To gain quantitative results for the entire datasets, we compared the overall fold change
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(relative to WT) for the union of all affected genes (see Table 3.2 for total numbers) in
E168d2/+, E168d2neo/+ and R90W/+ mutants (Figures 3.3F,G). Both down-regulated (Figure
3.3F) and up-regulated (Figure 3.3G) groups showed a stepwise pattern of expression fold
changes: E168d2/+ > E168d2neo/+ > R90W/+. Thus, in addition to the number of affected
genes, the degree of expression changes also correlates with phenotype severity in heterozygous
mutants. While this difference in expression was statistically significant (Figures 3.3F,G), the
differences between the median log2 fold change for individual genes expressed in the different
heterozygotes were rather small. This is in contrast to the large phenotype differences between
these genotypes (see Table 3.1), demonstrating the importance of precisely regulated gene
expression for photoreceptor integrity. The expression changes of several genes in heterozygous
mouse retinas as determined by RNA-seq results were reproducible (Supplemental Figure 3.2A)
and consistent with previous qRT-PCR data [21] (Table S1B,C).
We also directly compared the data for overlapping and independently affected genes in
age-matched (P10) heterozygote and homozygote Crx mutant animals. Significantly fewer
down-regulated and up-regulated genes were seen in the heterozygous E168d2/+ and R90W/+
mutants than in their homozygous counterparts (Supplemental Figure 3.3). There was only a
small fraction of genes that was independently changed in either heterozygote mutant but
unaffected in the homozygotes (Supplemental Figure 3.3). These data are consistent with the
differences in phenotype severity between the heterozygous and homozygous mutants.
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3.4.2 Crx mutations specifically affect rod- and cone-enriched genes including
down-regulation of phototransduction genes
To ensure that decreased retinal function and impaired development of the Crx mutant
mice are not a result of perturbations to other non-photoreceptor cell types, we analyzed the P10
RNA-seq data for changes in expression of genes representing different types of retinal neurons.
For each cell type, we chose the ten genes with the highest specificity ratio [Siegert et al., 2012]
present in our data. The heatmap in Figure 3.4A represents the fold change from WT for each of
these genes in the P10 mutants, organized by the cell type they represent. The cell types that
showed the greatest gene expression changes in all mutants were rod and cone photoreceptors,
whereas large-scale changes in gene expression were not observed in other retinal cell types at
the age of P10.
We also specifically analyzed expression of genes important for retinal visual function, as
changes in this pathway in cell types other than photoreceptors could account for the decreased
function as measured by ERG [Tran et al., 2014]. Supplemental Figure 3.4 shows that nonphotoreceptor specific genes encoding proteins involved in visual function had little to no change
in expression in any of the mutants. In contrast, expression changes were seen in many known
photoreceptor-enriched components of the phototransduction cascade (Figure 3.4B). Nearly
every constituent was negatively impacted in E168d2/+, but remained virtually unaffected in
R90W/+. E168d2neo/+ adopted an intermediate expression level, again emphasizing the
stepwise and graded changes between the three genotypes.
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3.4.3 Insights from E168d2/+ and E168d2neo/+: small changes in gene
expression level strongly influence phenotype
Since the above analysis detected little difference between the two phenotypically distinct
mouse lines that both carry the same Crx mutation, E168d2/+ and E168d2neo/+, we expanded
our analyses to directly compare these two datasets. A scatterplot comparing E168d2/+ and
E168d2neo/+ shows only subtle expression differences (Figure 3.4C), further confirming the
analyses presented in Table 3.2 and Figure 3.3. Differences in gene expression levels were
within the 2-fold margin with only a few exceptions. To decipher the genes that are likely to
impact phenotype severity, we analyzed the 118 genes that passed the statistical threshold in the
direct comparison of E168d2/+ vs. E168d2neo/+ (FDR ≤ 0.05, no FC cut-off, represented in
white in Figure 3.4C). To confirm the validity of the results of this comparison, we also
calculated the Z-Score of each biological replicate from the mean expression level (Supplemental
Figure 3.5), which showed reproducible differences between the two genotypes. The list of
down-regulated genes in E168d2/+ was highly enriched for those relevant to photoreceptor
biology and function by Gene Ontology (GO) analyses (Figure 3.4D). In contrast, the upregulated genes showed only a modest enrichment for a single photoreceptor-relevant GO
category (Figure 3.4E). These findings suggest threshold effects of expression level changes on
photoreceptor phenotype, especially in those pathways represented in the down-regulated gene
set illustrated in Figure 3.4D.
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3.4.4 Heterozygous mutants show normal gene expression trends from P10 to
P21, but many genes fail to reach the normal level at P21
Crx mutant mice show early deficits in photoreceptor morphology and function
[Furukawa et al., 1999; Tran et al., 2014]. In heterozygous Crx knockout and R90W mice,
morphology and function recover at later ages, suggesting a transient developmental delay.
E168d2neo/+ mice also recover rod morphology but have abnormal cone morphology and only
partially recover rod and cone function in adulthood. E168d2/+ mice remain impaired in
adulthood with shortened outer segments and severely impaired retinal function [Tran et al.,
2014], suggesting a blockade in photoreceptor maturation. To determine if differences in
morphological and functional recovery are related to gene expression changes over time, we also
performed RNA-seq analyses on heterozygous R90W, E168d2 and E168d2neo mutants at P21
when photoreceptors are mature. The P21 gene expression data described a very similar scenario
seen in the P10 datasets: The three heterozygous genotypes displayed a graded degree and
number of genes affected in the mutants relative to the P21 WT control (Table 3.1, Supplemental
Figures 3.6A-E).
Next, we compared expression changes in the heterozygous mutants between P10 and
P21 relative to P10 WT expression levels. In WT mice, 678 genes showed expression changes
between P10 and P21 (FC ≥ ±2, FDR ≤ 0.5), as shown in a heatmap (Supplemental Figure 3.7A).
These age-dependent gene expression changes likely reflect retina terminal differentiation: Gene
Ontology analyses showed that the top 100 up-regulated genes were enriched for those important
for developing mature photoreceptor structure and function, including visual perception,
detection of light stimulus, photoreceptor outer segment formation and monovalent inorganic
cation transport (Supplemental Figure 3.7B). In contrast, the down-regulated gene set was
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composed of genes that are important for neurogenesis during development, including system
development, cell adhesion and regulation of cell proliferation (Supplemental Figure 3.7B). We
next analyzed age-dependent gene expression changes in the Crx mutant lines, primarily
focusing on E168d2/+ and E168d2neo/+ models, because of their distinct phenotype from WT
mice. Unexpectedly, both mutants showed a trend of changes similar to WT mice for P21 upregulated and down-regulated gene sets (Supplemental Figures 3.7A,C). However, in mutants,
expression of many members of these two gene sets did not reach the WT level at P21
(Supplemental Figures 3.7A,C). As expected, this defect was more prominent in E168d2/+ than
E168d2neo/+ mice. This suggests that the E168d2/+ mutants continue to develop after P10 and
recover some gene expression, but the degree of recovery is insufficient to achieve normal
photoreceptor maturation. Interestingly, R90W/+ also displayed slightly altered expression
levels of many dynamically changed genes. These subtle differences may eventually contribute
to the minor functional deficits observed for R90W/+ at 6 months of age [Tran et al., 2014].
Taken together, these data suggest that Crx mutant mice fail both in repressing developmental
genes and in activating genes required for photoreceptor maturation. These age-related gene
expression changes support the morphological and functional observations that Crx mutant mice
vary in their photoreceptor maturation rates.

3.4.5 Down-regulated and up-regulated genes in Crx mutants show distinct
epigenetic profiles in WT retinas
To determine the modality of CRX’s regulation of differentially expressed genes, we
further investigated their expression patterns and the epigenetic landscape of their proximal cisregulatory regions in WT mice. We first used hierarchical cluster analysis on P10 and P21
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datasets to find sets of genes that were similarly affected in all mutants. Figure 3.5A shows a
heatmap representing log2 fold change relative to age matched WT samples for any gene that
displayed significant change from WT (FC ≥ ±2, FDR ≤ 0.05) in any single genotype; the data is
arranged by hierarchical clustering (clustering branches are shown to the left of the heatmap).
By visual inspection of clustered data, we further subdivided affected genes into eight groups
based on similarity of altered expression patterns. These are designated as Groups 1-8 (shown to
the right of the heatmap) (see Tables S3 and S4 for lists and order of genes). Further analyses
focused on Groups 1, 2, 3 and 6, as these represented the largest and most consistent clusters.
Visual inspection of biological replicate data also confirmed the consistency of the expression
changes in these groups (Supplemental Figure 3.8). Group 1 genes were the most downregulated genes across all genotypes. Group 2 genes were decreased compared to WT levels, but
across the board were less affected than those in Group 1. Groups 3 and 6 were composed of
genes that were up-regulated in many of the genotypes. Group 6 genes generally were upregulated to a greater extent.

- The proximal cis-elements of down-regulated genes are enriched for CRX and NRL
binding
To determine which of the above four major gene groups are directly regulated by CRX
and its interacting rod-specific transcription factor NRL, we analyzed previously published CRX
and NRL ChIP-seq data [Corbo et al., 2010; Hao et al., 2012] obtained from adult mouse retinas
for all of the genes in these four clusters. Since CRX is expressed by both rods and cones, CRX
ChIP-seq data from both WT (predominantly rod) and Nrl-/- (predominantly cone) retinas were
included in our analyses. The WT NRL ChIP-seq data represents rod data, since NRL is not
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expressed in cones. The data are presented in heatmaps (Figure 3.5B, Columns 1-3), where each
gene within the group is represented by a single line. The data within each column reports the
average read depth of the indicated experiment +/- 1kb in 40bp bins centered on the transcription
start site (TSS). These results presented interesting contrasts between the various groups of
genes: First, Groups 1 and 2 displayed a significant amount of CRX binding in rods (Column 1)
and cones (Column 2) and NRL binding in rods (Column 3) around the TSS, while this binding
was virtually absent in Groups 3 and 6 (Figure 3.5B, Columns 1-3; Supplemental Figures 3.9AC). This suggests that the down-regulated genes in Groups 1 and 2 are enriched for direct
CRX/NRL targets, but not the up-regulated genes in Groups 3 and 6, consistent with the primary
role of CRX and NRL in transactivation. Second, the more extensively down-regulated genes in
Group 1 showed more CRX (Columns 1-2) and NRL (Column 3) binding than the less-severely
down-regulated genes in Group 2 (Figure 3.5B, Columns 1-3; Supplemental Figures 3.9A-C),
raising the possibility that Group 1 genes are more dependent on CRX/NRL transactivation
activity than Group 2 genes. Third, comparison of CRX binding in rods (Column 1) vs. cones
(Column 2) for Group 1 genes showed a high degree of CRX binding in both photoreceptor
subtypes, suggesting that this group contains genes that are activated by CRX in both rods and
cones. In contrast, Group 2 genes showed CRX binding largely in rods, suggesting these genes
are activated by CRX mainly in rods (Supplemental Figures 3.9A,B).

- Down-regulated genes become more “open” during postnatal retinal development
To determine which of the four major groups undergo epigenetic landscape changes
during photoreceptor development, we analyzed three different sets of previously published and
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publicly available epigenetic signature data (Figure 3.5B, columns 4-10). Results are presented
as heatmaps in a similar format as CRX and NRL ChIP-seq data.
We first analyzed retinal DNase I hypersensitivity (DHS) datasets at the age of P1, P7
and 8 weeks (8wk) (Figure 3.5B, Columns 4-6) from the ENCODE project [22]. Enriched DHS
is an indicator of ‘open’ chromatin and is a predictor of active transcription. Both downregulated and up-regulated genes showed dynamic changes in their epigenetic landscapes with
age. First, Group 1 genes showed increases in DHS signal from P1 to 8wk of age. This pattern is
not seen in Group 2 genes, in which high DHS signal was largely stable across the ages tested.
Group 3 and 6 genes, on the other hand, showed different patterns, in which DHS signal
decreased from P1 to 8wk of age. Second, comparing across groups at 8wk of age, DHS data
described Groups 1 and 2 as having more ‘open’ chromatin (higher DHS signal) around their
TSS than Groups 3 and 6 (Figure 3.5B, Column 6). These data suggest that the chromatin of
genes down-regulated in Crx mutants (Groups 1 or 2) have ‘open’ chromatin in the adult wildtype retina and the mostly strongly down-regulated genes (Group 1) are genes that develop a
more ‘open’ chromatin conformation postnatally. In contrast, up-regulated genes (Groups 3, 6)
tended to have ‘open’ chromatin in the early postnatal retina that became more ‘closed’ with age.
To determine if these dynamic DHS changes represented specific events for particular groups,
we included a random control group in our analyses. A random set of genes was chosen from the
UCSC gene list to match the size of the largest Group from the analysis (Group “Random”). As
illustrated by Supplemental Figures 3.9D-F, the Random group (grey lines) also showed a trend
of reduction in DHS during postnatal retinal development. Importantly, when compared to
Random genes, Group 1 genes were less ‘open’ at P1 and P7 (Supplemental Figures 3.9D,E, blue
line vs. grey line) but more ‘open’ at 8 weeks (Supplemental Figure 3.9F, blue line vs. grey line),
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verifying the trend visible by eye in the Figure 3.5B heatmaps. These results were consistent
with the observation that Group 1 genes largely increased their expression from P2 to P21,
during WT retinal development (Supplemental Figure 3.9K, based on published RNA-seq data by
[Roger et al., 2014]). Interestingly, Group 2 genes were more ‘open’ than Random genes at all
ages tested (Supplemental Figures 3.9D,F, dashed blue line vs. grey line), consistent with an
overall modest increase in their expression from P2 to P21 in WT mice (Supplemental Figure
3.9L). In contrast, Group 6 genes showed overall lower DHS than Random genes at all three
ages analyzed, while Group 3 genes showed similar DHS patterns as Random. Both Group 3
and 6 genes normally showed no change or a slight decrease in expression from P2 to P21
(Supplemental Figures 3.9M,N). This data suggests the DHS changes identified in Group 1
genes are dynamically regulated during retina development.

- Down-regulated genes undergo histone modification changes during postnatal retinal
development
Next, we analyzed these gene groups for the presence of active (H3K4me2) (Columns
7,8) and repressive (H3K27me3) (Columns 9,10) histone marks as determined by ChIP-Seq in
P1 and P15 WT retinas [23] within the 2 kb window centered on the TSS of each gene.
Consistent with gaining a more ‘open’ chromatin configuration, Group 1 genes gained the active
mark H3K4me2 and lost the repressive mark H3K27me3 between P1 and P15 (Figure 3.5B,
Columns 7-10; Supplemental Figures 3.9G-J, blue line vs. grey line). Group 2 genes, showed
similar changes in histone marks (increase in H3K4me2 and decrease in H3K27me3) from P1 to
P15. Group 2 genes also showed a higher level of the active mark H3K4me2 than Random
genes at P1, while the level of the repressive mark H3K27me3 was similar to Random at this age
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(Figure 3.5B, Columns 7-10; Supplemental Figure 3.9G-J, dashed blue line vs. grey line).
Overall, the data is consistent with a postnatal constitutively open chromatin configuration for
Group 2 genes as measured by DHS. Finally, Groups 3 and 6 showed no difference relative to
the Random group in either H3K4me2 or H3K27me3 occupancy through retina development
(Figure 3.5B, Columns 7-10; Supplemental Figures 3.9G-J, red lines vs. grey lines), consistent
with their overall constant low level of gene expression.
Together, the above analyses suggest that Group 1 genes undergo dynamic epigenetic
changes during retina maturation associated with their substantial transcriptional activation
during postnatal photoreceptor development. The expression pattern of these genes correlated
with CRX and NRL expression, and their regulatory regions were directly bound by CRX and
NRL in WT mice. These results suggest that Group 1 is enriched for genes that are inactive in
precursor cells and actively turned on by key photoreceptor transcription factors during
development. Thus, mutations in CRX have a profound negative impact on the expression of
these genes. Group 2 genes were similar to Group 1 in that their epigenetic landscape is
supportive of high transcriptional levels in the WT retina and are likely regulated directly by
CRX and NRL. Interestingly, these genes do not show the time dependent chromatin ‘opening’,
suggesting that CRX and NRL may not be necessary to initiate chromatin remodeling and could
account for the fact that Group 2 genes lose expression to a lesser degree than Group 1 genes.
Finally, Group 3 and 6 data suggest that these genes undergo chromatin remodeling in the WT
retina that results in a less permissive state. This is consistent with their low or even decreasing
expression over time. However, this process is not directly controlled by CRX or NRL, as ChIPseq binding of these two proteins was not observed in these Groups.
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3.4.6 Up-regulated genes are characteristic of cone photoreceptors, likely
resulting from de-repression in rods
Since CRX and NRL binding as well as epigenetic data implicate down-regulated genes
as being active CRX targets in rods, we investigated if differentially-expressed genes normally
have rod or cone cell-type-specific expression patterns. Using published data [Roger et al.,
2014] to classify these genes as either rod- or cone-enriched (or non-specific – N.S.), we found a
significant overrepresentation of rod genes in Groups 1 and 2, although a number of cone genes
were also found in Group 1 (Figure 3.6A and Table S3). This was expected considering the
mouse retina is rod-dominant and CRX acts as a transcription activator for genes critical for
photoreceptor structure and function. However, surprisingly, up-regulated Groups 3 and 6
contained a significant enrichment of cone transcripts (Figure 3.6A and Table S3).
To determine whether this up-regulation of cone gene expression is a general trend
beyond Group 3 and 6 genes, we expanded our analysis to all genes enriched in either rods or
cones in adult mice. Furthermore, to ensure the results are applicable to other classes of Crx
mutants, we also analyzed three previously published RNA-seq datasets from other Crx mutant
models, Crx-/-, Rip/+ and Rip/Rip. The results, presented by heatmaps (Figures 3.6B,C),
showed a broad switch in the global pattern of gene expression in all mutants, with loss of
expression of a large set of rod genes (Figure 3.6B) and increased expression of transcripts
normally enriched in cones (Figure 3.6C). There were exceptions: expression of a small number
of cone genes, indicated with an asterisk at the bottom of Figure 3.6C, was consistently
decreased in all the Crx mutants. These represented key cone-specific phototransduction genes
including Pde6h, Arr3, Opn1mw, Opn1sw, Gnat2 and others (Supplemental Figure 3.10B).
Their loss of expression was similar to rod-specific phototransduction components that also
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consistently decreased, including Rho, Gnat1, Cngb1, and Pde6g (Figure 3.6B marked by
asterisk, Supplemental Figure 3.10A). Again, rod-enriched genes and cone-enriched genes
displayed graded changes that reflected phenotype severity in our models (E168d2/d2: most
severe; R90W/+: least severe). These results also place the Rip model (Rip/+ and Rip/Rip) in
line with other Crx models, demonstrating even more severe expression changes than
E168d2/d2, although the RIP protein is thought to cause disease by a distinct molecular
mechanism [Roger et al., 2014].
Because RNA-seq was performed on whole-retina samples, the down-regulation of rod
genes and up-regulation of cone genes could represent a decrease in the number of rods and an
increase in cones. However, previously published histology showed that in fact the proportions
of these cell populations shift in the opposite direction, as the E168d2/+ retina has a very severe
and early depletion of cone photoreceptors, prior to any loss of rod photoreceptors [Tran et al.,
2014]. In fact, all Crx mutant mouse models including Crx-/- and Rip/+ show a similar trend of
rapid cone loss followed by slower rod degeneration. This result was also unexpected
considering the role of CRX in trans-activating cone as well as rod genes [S. Chen et al., 2004;
Tran et al., 2014]. This raised the possibility that the up-regulated cone genes were abnormally
derepressed in the mutant rods. To further understand the molecular mechanism underlying misexpression of cone genes in mutant rods, we assessed all rod- and cone-enriched transcription
factors for expression changes in the mutants. Consistent with overall expression changes, we
observed a general loss of rod transcription factors and enhanced expression of many coneenriched transcription factors (Supplemental Figures 3.11A,B). However, the reduced
expression of rod-specific factors that are essential for maintaining rod cell fate, such as Nrl and
Nr2e3, was rather minor or even absent in the heterozygous E168d2 and R90W mutants, unlike
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that reported for Rip mice [Roger et al., 2014]. Instead, these results suggest an unexpected role
for CRX in rods to repress cone-enriched genes, including a number of cone-enriched
transcription factors. To test whether CRX could play a direct role in repressing these coneenriched transcription factors, we examined the CRX ChIP-seq data (Supplemental Figures
3.11A-C) for evidence to support a direct interaction of CRX with up-regulated cone
transcription factors in rod cells. Some up-regulated cone TFs showed low ChIP signal in WT
retina, suggesting a potential repressive binding in rods, but the pattern was not consistent
(Supplemental Figure 3.11C). Thus, loss of repression of cone genes in mutants is likely a
secondary effect. In contrast, ~33% of rod genes were bound by CRX, significantly enriched
over random genes (~8%). Furthermore, when compared with NRL ChIP-seq data, >73% of
CRX-bound rod genes were also bound by NRL, but no enrichment of NRL binding was
observed for cone genes (data not shown), consistent with CRX’s interaction with NRL to
activate the expression of rod genes, but not cone genes.
To verify that these cone transcripts are being de-repressed in mutant photoreceptors that
normally would adopt a rod cell fate, we performed immunohistochemistry for several cone
targets on retinal sections from three E168d2 sublines and WT control mice at P10. The nuclear
receptor RXRg is preferentially expressed by cones in P10 WT retina, and is up-regulated in most
Crx mutants by RNA-seq and qRT-PCR [Tran et al., 2014] (Table S1A,B; biological replicate
RNAseq raw mapped sequencing reads displayed in Supplemental Figures 3.2A,B). As shown
in Figures 3.6D1-4, instead of the cone-expression pattern in normal retina (Figure 3.6D1),
RXRg immunoreactivity was detected in most outer nuclear layer (ONL) cells of the
homozygous and heterozygous E168d2 mutant retinas (Figures 3.6D2,D3), with a perinuclear
distribution similar to the pattern reported for rod transcription factors [Roberts et al., 2005].
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The ONL RXRg staining appeared stronger and more widely spread in E168d2/d2 than
E168d2/+ retinas. The enhanced RXRg immunoreactivity was not seen in E168d2neo/+ ONL
where the rods were not disturbed. Immunostaining of the second cone marker CNGB3
displayed similar patterns of enhanced ONL expression in affected mutant rods (Figures 3.6D5D8). We next assessed peanut agglutinin (PNA) binding (Figures 3.6D9-D12), which normally
stains the cone sheath including cone outer segments and pedicles. Figure 3.6D shows that,
despite the lack of cones and rod outer segments in E168d2/d2 retinas, a strong and uniform
PNA staining was seen across the outer margin of the entire retina (Figure 3.6D6), suggesting
that mutant rods adopt cone-like characteristics of their sheath. E168d2neo/+ retinas did not
show enhanced PNA binding at this age (Figure 3.6D12), while E168d2/+ showed an
intermediate PNA staining that was higher than in WT but much lower than in E168d2/d2 retinas.
Taken together, all three selected cone markers showed enhanced expression in mutant rods in
the order E168d2/d2 > E168d2/+ > E168d2neo/+, thus confirming RNA-seq findings of the
impact of Crx mutations on rod cell fate.
In summary, our RNA-seq analyses identified graded expression changes of shared gene
sets in seven available mouse models for Crx-associated disease. Using the data presented and
referenced in this paper [Hsiau et al., 2007; Roger et al., 2014; Tran et al., 2014], these models
can be ranked as illustrated in Figure 3.7, with the lightest bars representing the model with most
severely affected rod and cone gene expression. This order correlates with phenotype severity by
morphological and electrophysiological standards, and with changes in gene expression in rods
and cones. This correlation was seen not only for down-regulated rod and cone genes encoding
phototransduction components, but also for those up- and down-regulated gene sets that
highlight the partial rod to cone conversion of the developing photoreceptors. The schematic also
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predicts the level of photoreceptor identity and function in various models. Most importantly,
the different gene expression changes between some phenotypically distinct Crx mutant models
(such as E168d2/+ vs. E168d2neo/+) were rather modest, in contrast to their substantial impact
on the disease phenotype.

3.4.7 Testing the effect of gene expression changes on light dependent
degeneration
- E168d2neo/+ but not E168d2/+ mice are sensitive to light damage
To validate the phenotypic significance of the small differences in gene expression
between E168d2/+ and E168d2neo/+ mice (Figure 3.4C), we analyzed expression of genes
involved in the photoreceptor retinoid (visual) cycle that is responsible for the recycling of visual
pigment chromophore 11-cis-retinal by RNA-seq (Figures 3.8a and Supplemental Figure
3.2A,B) and qRT-PCR (Table S1C). This discrete set of visual cycle genes expressed in
photoreceptors also showed a similar pattern of expression changes across the mutant lines
(Figure 3.8A): R90W/+ showed little or no changes relative to WT, while E168d2/+ and
E168d2neo/+ showed reduction in gene expression levels. We validated the expression patterns
of three visual cycle genes: Rbp3, Rdh12 and Abca4 by qRT-PCR and results were consistent
with RNA-seq findings (Table S1C). We hypothesized that, as a result of these changes
combined with slight shifts in expression levels of phototransduction genes (Figure 3.4B), the
two E168d2 sublines may have different sensitivity to light-induced damage (LD). Exposing
mice to high intensity light for an extended period of time puts stress on the retina and can lead
to photoreceptor degeneration [Noell et al., 1966]. LD-related degeneration depends on three
interconnected pathways (Figure 3.8B): 1) the phototransduction pathway, 2) visual cycle in the
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retinal pigment epithelium (RPE) and 3) visual cycle in photoreceptor cells. Most mouse models
with disruptions to components of phototransduction are insensitive to LD [Grimm et al., 2000],
while mice with an impaired visual cycle in photoreceptors generally have increased sensitivity
to LD [A. Maeda et al., 2006, 2007, 2008; T. Maeda et al., 2009; Radu et al., 2003]. To test if
the transcriptional defects in E168d2/+ and E168d2neo/+ mice alter their sensitivity to LD, we
exposed 6 week old (wo) WT, E168d2/+ and E168d2neo/+ mice to a high intensity light (1213.5 KLUX; ~10-20x brighter than ambient light conditions) for 8 hrs. Following LD exposure,
mice were kept in 12 hr ambient light/dark cycle for 7 days before retinal function and
morphology were assessed. All the mice tested were backcrossed to the C57BL/6J background
for >10 generations, which is resistant to LD [Wenzel et al., 2001]. As expected, WT mice were
highly resistant to LD and displayed normal retinal morphology (Figure 3.8D vs. 3.8C, left
panels), normal ONL thickness as determined by morphometry (Figure 3.8E, left panel), and
normal retinal function as measured by ERG (Supplemental Figure 3.12A; black dashed lines vs.
black solid lines) compared to WT controls that were not exposed to LD. E168d2/+ mice
exposed to LD did not show differences in retinal morphology (Figure 3.8D vs. 3.8C, middle
panels) or ONL thickness (Figure 3.8E, middle panel) and showed only minor ERG differences
compared to normal light exposed E168d2/+ controls (Supplemental Figure 3.12A; red dashed
lines vs. red solid lines). In contrast, E168d2neo/+ mice exposed to LD showed shortened outer
segments and a loss of ONL nuclei, ~3-4 nuclei compared to ~10-12 nuclei in normal light
E168d2neo/+ mice (Figure 3.8D vs. 3.8C, right panels). Morphometry revealed significant
reduction in ONL thickness at the inferior -100 µm and superior 100 µm and 500 µm positions,
with the thickness at 500 µm being most affected (~58% reduced) (Figure 3.8E, right panel).
Retinal function was also affected with dark-adapted a-waves, dark-adapted b-waves and light81

adapted b-waves all showing reduced maximal response amplitudes compared to E168d2neo/+
controls kept in normal light (Supplemental Figure 3.12A; blue dashed lines vs. blue solid lines).
These data suggest that E168d2neo/+ mice are more susceptible to LD than either E168d2/+ or
WT mice, providing further insight into the distinct pathobiology of E168d2/+ and E168d2neo/+
mice.

- E168d2neo/+ sensitivity to light damage is linked to abnormal visual cycle in
photoreceptors
To determine if the increased sensitivity to LD in E168d2neo/+ mice reflects changes in
expression of visual cycle genes, mice were pre-treated with 13-cis retinoic acid (13-cis-RA;
Accutane) before LD exposure. 13-cis-RA interferes with the regeneration of visual
chromophore (11-cis-retinal) and is a strong antagonist of the RPE-driven phase of the visual
cycle [Sieving et al., 2001]. Inhibiting the visual cycle at the earliest stage reduces the
production of toxic retinoid intermediates in the retinoid pathway during LD (Figure 3.8B). This
treatment strategy was previously shown to effectively ameliorate retinal degeneration in mouse
models with impaired visual cycle [T. Maeda et al., 2009; Radu et al., 2003; Sieving et al.,
2001]. Retinas of WT mice pretreated with 13-cis-RA and exposed to LD were morphologically
indistinguishable from DMSO-injected controls (Figure 3.8F, two left panels). In contrast,
retinas of E168d2neo/+ animals pretreated with 13-cis-RA were almost completely protected
from the rapid degeneration observed in DMSO-injected E168d2neo/+ controls (Figure 3.8F,
two right panels). Retinas of 13-cis RA-pretreated E168d2neo/+ mice revealed significant
improvements in ONL thickness at the superior 500 µm and 1000 µm positions (Figure 3.8G,
right panel) compared to those DMSO treated. Retinal function was also better preserved in 1382

cis-RA pretreated mice. Amplitudes of dark-adapted ERG a-wave, dark-adapted b-wave and
light-adapted b-wave were all significantly restored in 13-cis-RA pretreated E168d2neo/+ mice,
compared to DMSO injected controls (Supplemental Figure 3.12B; green lines vs. blue dashed
lines). To validate that LD sensitivity is linked to intrinsic defects in the visual (retinoid)
pathway, we tested rod dark adaptation in WT and E168d2neo/+ mice. Following >90%
rhodopsin photobleach, the dark adaptation of E168d2neo/+ mouse rods was substantially
delayed, as compared to that in WT mice (Supplemental Figure 3.12C, blue line vs. black line).
Pretreatment of E168d2neo/+ mice with 13-cis-RA strongly delayed rod dark adaptation further
(Supplemental Figure 3.12C, red line vs. blue line), indicating that 13-cis-RA effectively blocked
regeneration of visual pigment by the RPE visual cycle. Together, these data suggest that the
increased sensitivity of E168d2neo/+ mouse retinas to LD is linked to intrinsic defects in the
photoreceptor visual cycle.
Finally, to determine if the degeneration of photoreceptors in E168d2/+ mice is at all
affected by ambient light conditions, we reared E168d2/+ mice under either normal 12 hr
light/dark cycle or in constant darkness. Retinal morphology of E1682/+ mice raised under
either light condition was indistinguishable at 3 and 6 months of age (Supplemental Figure 3.13),
suggesting that photoreceptor degeneration in E168d2/+ mice is independent of light conditions.
These results illustrate that photoreceptor degeneration in E168d2/+ and E168d2neo/+ mice is
mediated by discrete light-independent and light-dependent mechanisms, respectively.
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3.5 Discussion
3.5.1 Gene expression in animal models for CRX-associated retinopathies
Our RNA-seq results for mutant Crx E168d2 and R90W mouse retinas improve and
expand upon previously published genomic expression microarray studies and qRT-PCR on
these mouse lines [Tran et al., 2014]. The increased sensitivity of this platform allowed for the
detection of more differentially expressed genes, especially for genes with low expression level,
and also for the detailed analysis of the modest expression level differences between
heterozygous animals. In combination with RNA-seq data from Crx-/- and Rip mice [Roger et
al., 2014], a comprehensive dataset of retinal gene expression now exists for Crx mutant models
with a range of phenotypes that reflect human disease. We have used these datasets to identify
key changes in gene expression that correlate with disease severity.
Our results suggest that even relatively small changes in gene expression level can have a
profound effect on the delicate balance of cellular pathways critical for photoreceptor function
and survival, especially phototransduction and the visual cycle. Our RNA-seq analysis of retinal
gene expression in mutant Crx mouse models by several methods indicates graded changes in
photoreceptor gene expression at every level from overall expression patterns down to specific
cellular pathways. First, homozygous mice were always more severely affected than their
heterozygous counterparts (Supplemental Figure 3.3). Among homozygous and heterozygous
mice, expression changes from least to most severe consistently followed the pattern: R90W,
E168d2neo, E168d2. These patterns were observed for both down-regulated and up-regulated
genes. A high degree of overlap existed in the differentially expressed genes among models
(Figures 3.2, 3.3, and Supplemental Figure 3.6) and few genes displayed opposite expression
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patterns between models (Figure 3.5). This suggests that few unique gene targets exist between
models, and non-overlapping genes largely result from genes with similar trends in expression
that simply do not pass the significance threshold of the in silico analysis. Graded changes were
also observed for genes involved in retinal development; Crx mutants showed impairment in
both the activation and repression of genes that shift expression patterns from P10-P21
(Supplemental Figure 3.7). Despite having collected mRNA from the whole retina, we were able
to determine that the differentially expressed genes mostly occurred in rod and cone
photoreceptors by using known patterns of cell-type specific retinal gene expression (Figure
3.4A). This was consistent with CRX’s expression pattern and role in photoreceptor maturation.
Within photoreceptor-specific pathways involved in light response, namely rod and cone
phototransduction and the visual cycle, all Crx mutant models displayed graded down-regulation
(Figure 3.4B, Figure 3.8A). Aside from these pathways, down-regulated genes tended to be rod
genes, while up-regulated genes tended to be cone genes de-repressed in rods (Figure 3.6,
Supplemental Figure 3.11). We investigated genes that did not fall into either category (Table
S3) but did not find any other major trends beyond this. Expansion of this analysis by assessing
expression of all known rod or cone-enriched genes again showed a graded pattern of expression
changes in these genes (Figures 3.6B,C), including rod and cone-specific transcription factors
(Supplemental Figures 3.11A,B). Re-analysis of previously published microarray data [Tran et
al., 2014] showed the same trends of gene expression changes (data not shown). Finally, by
analyzing RNA-seq results from two previously published animal models, Crx-/- and Rip, we
were similarly able to detect graded expression changes in a common gene set (Figure 3.6). In
all, our analyses show graded changes in gene expression at several levels in Crx mutant mice
for both down-regulated and up-regulated genes.
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3.5.2 Different modalities for down-regulated and up-regulated gene
expression
While Crx mutant mice showed both down-regulated and up-regulated expression (Table
3.2), more genes were down-regulated in every mouse model tested. This is consistent with
CRX’s established role as a transcriptional activator, though CRX does act as a repressor in
certain contexts [White et al., 2013]. Utilizing available CRX [Corbo et al., 2010] and NRL
ChIP-seq [Hao et al., 2012] data sets and epigenetic data sets including DnaseI hypersensitivity
from the ENCODE project [Vierstra et al., 2014] and active (H3K4me2) and repressive
(H3K27me3) histone marks [Popova et al., 2012], we identified patterns in the proximal cisregulatory elements of differentially expressed genes. CRX and NRL binding were enriched at
genes that were down-regulated in Crx mutant models, suggesting these genes are direct targets,
while genes that were up-regulated were not enriched for CRX or NRL binding, suggesting these
genes are indirect targets (Figure 3.5). DNase hypersensitivity data showed that a group of
strongly down-regulated genes in mutant models shifted from ‘closed’ to ‘open’ chromatin from
P1 to 8 wk in WT rods, suggesting these genes are normally activated during postnatal retinal
development (Figure 3.5, Supplemental Figures 3.9D-F). In contrast, the data described that a
group of up-regulated genes became more ‘closed’, suggesting these genes are being repressed
during postnatal development (Figure 3.5B, Supplemental Figures 3.9D-F). The group of downregulated genes also showed an increase in the active histone mark H3K4me2 and a decrease in
H3K27me3 during postnatal development in WT retina (Figure 3.5B, Supplemental Figures
3.9G-J), indicative of active chromatin remodeling. Changes in these histone marks were not
observed for up-regulated genes, suggesting these genes are not subject to this type of active
chromatin remodeling. Together, these results suggest that genes down-regulated in Crx mutant
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models are direct targets of CRX and NRL that normally are activated during postnatal
development through chromatin remodeling, while up-regulated genes are indirect targets of
CRX and NRL that are normally repressed during postnatal development through an unknown
mechanism. CRX is known to recruit co-activators with positive chromatin remodeling capacity,
such as CBP/p300 and the STAGA complex [Palhan et al., 2005; G. Peng & Chen, 2007]. Thus,
CRX and its interacting co-activators may play an essential role in active chromatin remodeling
during development for the direct target genes represented by the down-regulated groups in Crx
mutants. Future profiling of epigenetic changes in these Crx mutant models will provide
additional support for this possibility.

3.5.3 Crx mutations affect rod and cone development and transcriptional
integrity
The graded expression changes in Crx mutant models have profound effects on the
development of their rods and cones as illustrated by Figure 3.7. Homozygous Crx-/-, E168d2,
R90W, Rip and Rip/+ mice do not form physiologically functional photoreceptors, due to a strong
reduction in both rod and cone phototransduction gene expression. Other models show
gradations in both retinal function and phototransduction gene expression. In all models studied,
the development and survival of cones are affected earlier and more severely than rods,
implicating CRX in the terminal differentiation of cones. Interestingly, in WT rods, CRX and
NRL appear to mediate both the activation of rod-specific genes and the repression of conespecific genes. The dual reduction in rod-gene expression and de-repression of cone genes in
Crx mutant rods coincides with rods adapting more cone-like properties including less condensed
chromatin and shorter outer segments [Roger et al., 2014; Tran et al., 2014]. In Rip/+ mice, this
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shift was found to coincide with loss of NRL expression by P21, indicating a complete loss of
rod cellular identity. The loss of NRL expression does not occur in E168d2/+ mice by this age,
but de-repression of cone-genes in rods is still observed. While E168d2 protein does not affect
the function of NRL in vitro [Tran et al., 2014], its effect on NRL in vivo is uncharacterized.
Our results provide evidence that even though RIP and E168d2 mutant proteins act through
different pathological mechanisms, the resulting pathologies arise from scaled changes in similar
sets of genes.

3.5.4 Gene expression dictates phenotypic thresholds
The animal models used in this study have wide-ranging phenotypes that match those
observed in human patients. The magnitude of overall gene expression changes correlated with
phenotype severity in every model tested, but not in a linear manner. Instead, there are
thresholds in gene expression that determine phenotypic presentation. An example of this
threshold effect is evident in the E168d2/+ and E168d2neo/+ mice. These mice have drastically
different phenotypes but have only small differences in gene expression. As we have previously
shown, the neomycin cassette retained in E168d2neo/+ mice suppresses an accumulation of the
mutant transcript by an unknown mechanism [Tran et al., 2014]. qRT-PCR results (Table S1A)
of the same biological samples used for RNA-seq confirm that the WT allele showed no
compensation and maintained approximately 50% of its normal expression. In contrast, the
results of RNA-seq (Supplemental Figure 3.14) and qRT-PCR (Tables S1A,B), combined with
previously published Western blots and immunohistochemistry [Tran et al., 2014], all support an
significant overexpression of mutant Crx mRNA and protein in E168d2/+ mice. This mutant
allele- specific overexpression was not evident in E168d2neo/+ mutants. This difference in
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expression of the dominant negative form of CRX resulted in very small difference in fold
change of down-regulated genes (median: -1.8 in E168d2/+ compared to -1.7 in E168d2neo/+
mice; Figures 3.3F,G). Despite this slight difference, E168d2/+ mice had much more severe
deficits in retinal function and photoreceptor degeneration. Under normal light conditions,
E168d2neo/+ mice had little photoreceptor degeneration in early adulthood. However,
E168d2neo/+ rods were highly sensitive to light damage while WT and E168d2/+ rods were
largely resistant (Figure 3.8). Targeting the visual cycle blocked sensitivity of E168d2neo/+
photoreceptors to LD, implicating this pathway in the degeneration phenotype. In contrast, the
degeneration of E168d2/+ photoreceptors was independent of light and the visual cycle.
Sensitivity to LD requires phototransduction and is mediated by the visual cycle, both of which
are affected in the E168d2 and E168d2neo mouse models. However, these results suggest that
the balance in function between these two pathways could be critical for determining sensitivity
to damaging light. Our data support the conclusion that phototransduction is too impaired and
OS structural changes are already too severe in E168d2/+ mice to allow for further lightmediated degeneration, while E168d2neo/+ photoreceptors largely preserve their structure and
substantial levels of phototransduction components to reveal visual cycle defects under intense
light. These results highlight that even minor tuning differences in photoreceptor gene
expression have a dramatic effect on the mechanisms of disease pathology. These findings could
have significant clinical importance as patients with CRX-associated retinopathies might have
different responses to environmental factors like damaging light levels, which would affect their
clinical outcome. These results also provide clues for potential therapeutic intervention to target
the visual cycle in patients with late-onset CRX-associated retinopathy.
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3.5.5 Conclusions
Linking genotype to phenotype for CRX retinopathies remains imprecise [45]. Genomic
assessment of retinal gene expression suggests that the range of phenotypes of Crx mutant mouse
models are driven by graded changes in photoreceptor gene expression. Since CRX has such
wide-ranging function in photoreceptor transcription, mutations that sometimes just slightly alter
the expression of many genes can have a profound effect on the resultant phenotype. We relate
retinal gene expression to phenotypic thresholds in rod and cone photoreceptor development,
cellular integrity, function and degeneration in several Crx mutant mouse models. We have
utilized publicly available genomic datasets to gain insight into cell-type specific expression
changes and the different modalities for gene down-regulation and up-regulation in these mice.
We have demonstrated how slight differences in gene expression can alter retinal susceptibility
to light-dependent degeneration in E168d2/+ and E168d2neo/+ mice. These findings provide
evidence that CRX-retinopathies stem from graded changes in photoreceptor gene expression,
which could significantly contribute to phenotypic variability.
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Table 3.1: Phenotype summary of heterozygous Crx mutant mice

(1)
(2)
(3)
(4)
(5)

Mouse
(1)

Mutation
class
(2)

CRX
expression (3)

WT

n/a

R90W

Rod

Cone

Disease
model

Phenotype
severity
(5)

Undetectable

n/a

n/a

++++

Undetectable

CoRD

mild

Undetectable

++

≥1yr

CoRD

moderate

++

1-6mo

+

1mo

LCA

severe

-

1-18mo

-

Undetectable

LCA

very severe

Function
(4)

Degeneration

Function
(4)

Degeneration

+

++++

Undetectable

++++

I

+

++++

Undetectable

E168d2neo

III

+

+++

E168d2

III

++

Rip

IV

+

Heterozygous mice harboring the indicated Crx mutations [Roger et al., 2014; Tran et al., 2014] are used for phenotype comparisons. "WT":
C57BL/6J wild-type control; "n/a": not applicable.
Classification described by [Tran & Chen, 2014].
Grading based on quantitative Western blots [Tran et al., 2014]. Note a 2-fold increase in E168d2 but normal level in others.
Grading based on reduction of ERG peak amplitudes [Tran et al., 2014]. "-": undetected ERG signals.
Severity based on combined morphological and functional deficits. "n/a": not applicable
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Table 3.2: List of RNA-seq experiments and number of genes with altered expression
Experiments & replicates (2)

Down-regulated genes (3)

Up-regulated genes (3)

Mouse (1)

(1)
(2)
(3)

P10

P21

P10

P21

P10

P21

WT

3

3

-

-

-

-

E168d2/d2

3

Not tested

425

-

248

-

R90W/W

3

Not tested

195

-

70

-

E168d2/+

3

3

136

150

61

43

E168d2neo/+

3

3

85

83

38

19

R90W/+

3

3

20

27

12

27

All mutant mice were backcrossed to C57BL/6J (WT) control for >10 generations and genotyped for common variants [Tran et al., 2014] .
Numbers represent biological replicates. Each replicate contains 4 pooled retinas from a pair of male and female
Numbers represent transcripts significantly altered (FC ≥2, FDR ≤0.05) relative to WT control. "-": not applicable
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Figure 3.1: Schematic diagram of WT and mutant CRX proteins made by the indicated
mouse models. The WT CRX protein shown on the top is 299 amino acids (A.A.) in length and
contains the indicated DNA-binding and transactivation domains (indicated by bars above
diagram) and several conserved motifs (marked by solid grey and black boxes). The substitution
mutation R90W lies within the homeodomain and reduces DNA-binding [Tran et al., 2014]. The
frameshift mutation E168d2 results in a C-terminus truncated CRX protein that retains DNAbinding capability but fails to activate transcription, and therefore is antimorphic [Tran et al.,
2014]. The frameshift mutation G255d1 ‘Rip’ results in a non-homologous C-terminal extension
(dark grey hashed box) creating an antimorphic protein that no longer binds DNA [Roger et al.,
2014]. The phenotypes of heterozygous mice carrying each of these mutations are summarized in
Table 1.
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Figure 3.2: RNA-seq analyses describe overlapping sets of affected genes in P10
homozygous Crx mutant retinas. (A-B) Gene expression [Log2 Count Per Million (CPM)] in
the indicated homozygous mutants (y-axes) is compared with the WT control (C57BL/6J, x-axes)
(A-B). White highlighting indicates prototypical photoreceptor transcripts. White diagonal lines
represent +/- 2 Fold Change. (C-D) Venn diagrams illustrate the numbers of significantly
affected genes that are shared or are uniquely changed in indicated mutants [fold change (FC) !
2, false discovery rate (FDR) " 0.05].
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Figure 3.3: RNA-seq analyses detect graded changes in gene expression in P10
heterozygous Crx mutant retinas. (A-C) Gene expression [Log2 CPM] in the indicated
heterozygotes (y-axes) are compared with the WT control (C57BL/6J, x-axes). White
highlighting indicates prototypical photoreceptor transcripts. White diagonal lines represent +/- 2
Fold Change. (D-E) Venn diagrams illustrate the numbers of significantly affected genes that are
shared or are uniquely changed in the indicated mutants (FC ! 2, FDR " 0.05). (F-G) Analysis of
the union of genes affected in heterozygous mutants (FC !2, FDR "0.05) presented as FC
relative to WT control. Significance calculated by Wilcoxon Rank-Sum Test with Bonferroni
correction. Notched Box Whisker plot describes median and quartiles of data.
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Figure 3.4: Crx mutant retinas show graded changes in photoreceptor-specific gene
expression. (A-B) Heatmaps present FC of gene expression in P10 Crx mutants relative to that
of WT age-matched controls in subsets of genes with highest cell type specificity ratios for the 6
retinal neurons (A) and photoreceptor-enriched genes involved in phototransduction (B). (C)
Changes in gene expression levels [Log2 CPM] are compared for E168d2/+ (x-axis) vs.
E168d2neo/+ (y-axis). Highlighted genes represent 118 transcripts significantly differently
expressed between the mutants (FDR !0.05, no FC cut-off; see Supplemental Figure 3.5 and
Table S4 for designations). (D-E) Top GO terms of down-regulated (D) and up-regulated (E)
gene sets in E168d2/+ compared to E168d2neo/+.
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Figure 3.5: Hierarchical clustering and epigenetic data reveal groups of similarly-regulated
genes. (A) Hierarchical clustering analysis of all genes that showed significantly altered
expression (FC !2, FDR "0.05) in at least one mutant genotype relative to age-matched WT
expression. Expression levels in the indicated genotypes at the indicated ages are indicated by
the blue-red heatmap. Eight groups of genes (indicated by the bars on the right) are clearly
defined by the results (see Table S4 for designations). (B) Heatmaps showing the epigenetic
landscape near the transcription start site (TSS) of genes in groups 1, 2, 3, and 6. Each row
represents +/- 1kb from the TSS (at center of panel) of individual genes contained within the
groups as noted on the left; rows are ordered within each group by decreasing Dnase I
hypersensitivity (DHS) at the TSS in the 8wk dataset. Columns 1 and 2: CRX binding
determined by ChIP-seq in adult WT and Nrl-/- retinas, respectively; Column 3: NRL ChIP-seq
in adult WT retinas; Columns 4-6: DHS of WT retinas at 3 indicated ages, Columns 7-8:
H3K4me2 ChIP-seq in WT retinas at P1 and P15, Columns 9-10: H3K27me3 ChIP-seq in WT
retinas at P1 and P15. Quantification is presented in Supplemental Figure 3.9.
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Figure 3.6: Crx mutants lose rod gene expression but up-regulate many phototransductionunrelated cone gene transcripts. (A) Classification of genes within groups 1, 2, 3, and 6 as
rod-enriched (dark grey), cone-enriched (light grey), or not specific to a particular cell type
(N.S., white) in the normal adult retina. Rod and cone-enriched genes are defined based on the
comparison of published P21 WT to NRL-/- RNA-seq data [Roger et al., 2014]. (Rod: FC !2,
FDR !0.05; Cone: FC "2, FDR !0.05; Fishers Exact Test, * p<0.05, ***p<0.0005). (B-C)
Heatmaps depict hierarchical clustering of FC relative to WT for all rod-enriched (B) and coneenriched (C) genes. Expression data from a published RNA-seq study describing the Crx Rip/+,
Rip/Rip, and Crx-/- mice are also separately presented in the order determined by the
aforementioned clustering. Regions noted in (B) and (C) with asterisks are presented in larger
format in Supplemental Figure 3.10 and represent many down-regulated genes involved in
phototransduction in rods and cones. (D) Immunohistochemical staining for RXR!, CNGB3, and
PNA in P10 WT and 3 CRX mutant retina sections. Scale bar: 100µm.
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Figure 3.7: Model of how Crx mutation-caused gene expression changes affect rod and cone
development. Left panel describes the formation of cones in a subset of the Crx mutants and
variable levels of those cells’ expression of phototransduction genes. Right panel shows how
development of rods in all models is related to their gene expression changes. It also emphasizes
the novel findings that Crx mutant rods display a graded phenotype of both the decreased
expression of proper rod genes, and the mis-expression of cone genes.
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Figure 3.8: Light-dependent photoreceptor degeneration in E168d2neo/+ mice. (A) Heatmap
presents P21 Crx mutants FC relative to WT for genes involved in photoreceptor visual cycle.
(B) Model for the RPE visual cycle: visual chromophore [11-cis-retinal (RAL)] is generated in
the retinal pigmented epithelium (RPE) and delivered to the photoreceptor; stimulation of 11-cis
RAL bound to an opsin protein activates the phototransduction cascade leading to photoreceptor
membrane hyperpolarization; this process isomerizes 11-cis RAL into all-trans RAL, which is
then recycled back into 11-cis-RAL through a series of enzymatic steps, known as the visual
cycle, in the photoreceptor and RPE. The drug 13-cis retinoic acid (13-cis-RA) blocks the
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synthesis of 11-cis-RAL, effectively reducing the burden on the retinoid cycle. (C-D) Retinal
morphology of 6 wo mice with indicated genotypes under normal light conditions: (C) (12 hr
room light-dark cycle) or (D) light damage (LD) treatments [8 hr 11.5-13.5 kilolux (KLUX)
bright light followed by 7 days of normal light-dark cycles]. Retinal morphology was assessed
by hematoxylin and eosin (H&E) staining of sagittal retinal sections through the optic nerve
(ON). Images were taken in the central superior retina (~500 µm from the ON). (E)
Morphometry quantification of ONL thickness for the samples presented in (C-D). Error bars
represent Standard error of mean (SE) from ≥3 biological replicates and significance was
calculated using two-way ANOVA. Data points that significantly differ from the control (p ≤
0.05) are marked by red asterisks. (F-G) Effect of 13-cis-RA pretreatment on LD in
E168d2neo/+ mutant mice: Retinal morphology (F) and morphometry (G) at 7 days following
LD where mice were pretreated with 13-cis-RA or DMSO as control. Note the significant
improvements of ONL thickness and photoreceptor OS length in the mice treated with 13-cisRA. OS- outer segment, ONL- outer nuclear layer, OPL- outer plexiform layer, INL- inner
nuclear layer, IPL- inner plexiform layer, GCL- ganglion cell layer. Scale bar: 50 µm.
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Supplemental Figure 3.1: P10 and P21 biological replicates clustered by Principal
Component Analysis. PCA plot shows expected distribution based on functional and
morphological phenotypes. PC1 and PC2 represent greater than 98% of the variance of the data
in both analyses.

102

A

B

Supplemental Figure 3.2: Browser images display RNAseq read depth of rod and cone
transcripts. P10 (A) and P21 (B) browser shots of RPM normalized mapped read count for
selected genes for each biological replicate show reproducibility of sequencing results between
samples.
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Supplemental Figure 3.3: Homozygous and heterozygous mutants show largely
overlapping datasets. Venn diagrams comparing significantly affected transcripts (FC !2. FDR
"0.05 relative to WT) in the indicated heterozygous and homozygous Crx mutant retinas.
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Supplemental Figure 3.4: Crx mutants show little change to other non-photoreceptor
phototransduction components. Heatmap depicts P10 FC relative to WT for genes involved in
phototransduction enriched in non-photoreceptor retinal cell types in the heterozygous mutants.
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Supplemental Figure 3.5: Biological replicates show consistency in expression changes
between genotypes. Heat meat showing the Z-scores comparing 3 biological replicates of genes
determined to be enriched in either E168d2/+ (A) or E168d2neo/+ (B) retinas. Genes are
arranged in rows, clustering dendrogram is shown on the left. Patterns of expression across
biological replicates are consistent, supporting the statistical significance of the difference
calculated by EdgeR RNA-seq analysis.
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Supplemental Figure 3.6: Crx mutants show graded changes in gene expression of
overlapping gene sets at P21. (A-C) Log2 CPM from P21 heterozygous E168d2/+ (A),
E168d2neo/+ (B), and R90W/+ (C) mice (y-axes) are compared to Log2 CPM from agematched WT C57Bl/6J (x-axes) mice. White letters highlight prototypical photoreceptor
transcripts. White diagonal lines represent +/- 2 Fold Change. (D-E) Venn diagrams illustrate the
numbers of overlapping and distinct significantly affected genes (FC !2, FDR "0.05).
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Supplemental Figure 3.7: Crx mutants do not abandon developmental program, but many
genes fail to reach proper expression levels. (A) Heatmap, ordered by the magnitude of
expression change between P10 and P21 in WT retina, depicts FC compared to P10 WT to
analyze developmental dynamics. (B) Top GO terms from analysis of top 100 genes that are
down- (left panel) and up- (right panel) regulated normally during late postnatal retinal
development (P21 WT vs. P10 WT; FC ! or "2, FDR !0.05). (C) Violin and boxplots quantifying
median FC from P10 WT of each mutant.
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Supplemental Figure 3.8: Biological replicates show consistent expression changes within
each genotype. Groups 1, 2, 3, and 6 genes (defined in Figure 5) presented as a heatmap with
calculated fold-change values for each biological replicate compared to the mean age-appropriate
WT value. All genes are ordered exactly as presented in Figure 5.

109

Supplemental Figure 3.9: Quantification of normal epigenetic marks near genes in Groups
1, 2, 3, and 6 distinguishes up- and down-regulated genes in Crx mutants. Control set of
equal sized random group of mm9 genes used as background control (grey in all). (A-C)
Quantification of CRX ChIP-seq [Corbo et al., 2010] in rod dominant WT retina (A) and cone
dominant Nrl-/- retina (B), and NRL ChIP-seq [Hao et al., 2012] in WT retina (C). (D-F) DnaseI
Hypersensitivity plots from WT retina at the three indicated ages [Vierstra et al., 2014]. (G-H)
H3K4me2 ChIP-seq of WT retina at the two ages [Popova et al., 2012]. (I-J) H3K27me3 ChIPseq of WT retina at the two ages. All represent normalized mean read depth of each library
centered on TSS of genes within Groups 1, 2, 3, and 6. (K-N) Analysis of WT expression of
each gene and average change in expression (blue line) from the age of P2 to P21 (raw data in
[Roger et al., 2014]), presented as Log2 CPM.
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Supplemental Figure 3.10: Loss of expression of key components of phototransduction.
Expanded view of areas marked with asterisk (*) in Figure 6. All data and presentation exactly
as described previously.
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Supplemental Figure 3.11: Changes in rod and cone enriched transcription factors are
consistent with general patterns of rod and cone genes expression in CRX mutants. (A-B)
Heatmap describes FC relative to WT in each Crx mutant for rod (A) and cone (B) enriched
genes annotated as transcription factors (Raw data [Roger et al., 2014]; WT vs Nrl-/- RNA-seq
FC ! or "2 & FDR !0.05; GO: 0003700). ChIP-seq data is presented for 4 kb window
surrounding TSS for each gene for CRX (in rods and cones) and NRL (in rods). (C) Analysis
detailing percent of rod enriched, cone enriched, or random set of genes with CRX ChIP-seq
peak within 2kb of TSS in WT retina. Note the significant enrichment of CRX binding in the rod
set over cone and random gene sets.
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Supplemental Figure 3.12: Retinal function is affected by light damage (LD) in
E168d2neo/+ but not E168d2/+ mutant mice. (A) Intensity-response plots for dark-adapted
ERG a-wave, dark-adapted b-wave and light-adapted b-wave from mice with the indicated
genotypes, with or without LD treatment. (B) Intensity-response plots for ERG responses
following LD for mice pretreated with either 13-cis-RA or DMSO. (C) Rod dark adaptation
measured by recovery of maximal rod ERG a-wave following >90% rhodopsin photobleach for
WT and E168d2neo/+ mice, with and without drug treatment. Error bars represent Standard
error of mean (SE, n!3). “*” marks the data point of significant difference (p "0.05) from the
control as determined by two-way ANOVA (see Appendix 2 Methods).

113

Supplemental Figure 3.13: E168d2/+ photoreceptor degeneration is light-independent.
Retinal morphology of E168d2/+ mice raised under 12 hr light-dark cycle (normal light) or
constant darkness (dark-reared) for 3 or 6 months. Note that the dark rearing did not improve
ONL thinning in the mutant retina. OS- outer segment, ONL- outer nuclear layer, OPL- outer
plexiform layer, INL- inner nuclear layer, IPL- inner plexiform layer, GCL- ganglion cell layer.
Scale bar: 50 µM.
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Supplemental Figure 3.14: Increased Crx expression in mutant lines at P10. (A) RNA-seq
derived raw CPM values for each biological replicate (red circles) and mean (black bar). Top
panel of spreadsheet lists the EdgeR calculated FC and FDR for each genotype relative to WT
control. Asterisk denotes samples where FDR < 0.05. (B) qRT-PCR analysis of transcript levels
of WT and mutant Crx alleles in each genotype. Note the same trend of Crx expression changes
in these mutants detected by both methods.
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3.6 Supporting Information
Supporting information including the following is available at:
https://genomebiology.biomedcentral.com/articles/10.1186/s13059-015-0732-z
Table S1
Table S2
Table S3
Table S4
Table S5

3.7 Data Availability
Raw RNA seq data and primary analysis are available in Gene Expression Omnibus (GEO)
under accession GSE65506.
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Chapter 4
Meta-analysis of epigenetic remodeling reveals CRX’s
mechanism of action in retinal development
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4.2 Abstract
Transcription factors (TFs) acting during development often direct chromatin remodeling
to allow for and promote gene expression. However, our knowledge of TFs is largely limited to
their regulatory activity in plasmid-based reporter assays. To overcome this limitation, we
investigated the importance of the photoreceptor TF CRX in remodeling the rod epigenome over
development. By performing ATAC-seq in WT and Crx-deficient retinas, and analyzing the data
alongside other genome-wide datasets, we determined that CRX is only required for remodeling
or sustaining activity of <1/3 of its binding sites. These CRX-Dependent sites are defined by
developmental epigenetic remodeling and the expression of nearby genes that rely on CRX.
Collectively, CRX acts as a master TF to execute rod differentiation by exerting distinct and
overlapping functions in chromatin rearrangement. Our study serves as a model for investigating
other cell type-specific TFs and highlights the importance of analyzing TF activities at multiple
levels.
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4.3 Introduction
The retina is the highly specialized portion of the central nervous system responsible for
initiating and processing visual signals before they are transmitted to the brain. The retina
consists of six major classes of neurons and one of glia, although numerous subtypes of these
classes have been described morphologically, functionally, and molecularly.[Baden et al., 2016;
Macosko et al., 2015; Shekhar et al., 2016; Siegert et al., 2012]
Rods and cones are two types of photoreceptors responsible for the initial conversion of a
photon of light into an electrical signal. Mouse retinas are rod dominant; rods constitute 80% of
the retinal cells while cones comprise only 2%.[Jeon et al., 1998; Macosko et al., 2015] Retinal
neurogenesis follows a stereotyped developmental program with overlapping waves of birthdates
of specific cell types.[Young, 1985] In mice, rods are born over a long time window that peaks at
postnatal day 0 (P0) and continues until P2.[Young, 1985] Postmitotic rod precursors undergo
differentiation over an extended 2-week period, during which the cells establish a rod-specific
gene expression profile, develop unique subcellular structures (OS and presynaptic terminals),
and eventually can perform phototransduction.
Precisely regulated gene expression is essential for rod structural/functional development
and survival, as even subtle perturbations can result in blinding diseases.[Lem et al., 1999;
Ruzycki et al., 2015] Rod gene expression is tightly regulated by a number of transcription
factors (TFs), acting in a cascade during development. [Reviewed in Swaroop, et al.[Swaroop et
al., 2010]] The homeodomain (HD) TF OTX2 specifies the photoreceptor lineage by turning on
the expression of Cone Rod homeobox (CRX) and its downstream TFs. CRX is an OTX-like HD
TF, whose expression coincides with the final mitotic event in rod and cone photoreceptors and
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is maintained into adulthood.[S. Chen et al., 1997; Furukawa et al., 1997] CRX binds to the
promoter of rod/cone genes and activates their expression via its transactivation domain.[S. Chen
et al., 1997, 2002] Two rod-specific TFs, NRL and NR2E3, act together with CRX to direct rod
differentiation by activating rod and silencing cone genes.[J. Chen et al., 2005; Mears et al.,
2001; Peng et al., 2005; Swaroop et al., 2010] General TFs involved in chromatin remodeling
including MEF2D, CBP/P300, and the STAGA complex are also a part of the CRX regulatory
network.[Andzelm et al., 2015; Hennig et al., 2013; La Spada et al., 2001] Together, these
factors direct the proper establishment of the rod epigenome and transcriptome.
CRX is essential for photoreceptor differentiation and functional development. A Crx
null mutation (Crx-/-) produces a recessive phenotype in the mouse retina where the immature
photoreceptor cells fail to differentiate and begin to degenerate at ~4 weeks of age.[Furukawa et
al., 1999] Mutations in human CRX have been associated with dominant blinding retinopathies
with varying severity and etiology [Reviewed in [Tran & Chen, 2014]]. Interestingly, in the
corresponding mouse models, distinct Crx mutations all affect the expression of a common set of
genes, but the degree of dysregulation correlates with phenotype severity.[Ruzycki et al., 2015]
The mechanism for this misregulation remains to be determined, but a better understanding of
CRX’s mechanism of action during photoreceptor development would provide insights into the
pathogenicity of CRX mutations.
Toward this goal, a number of studies have investigated the activity of CRX using
plasmid-based assays. Luciferase reporter assays in heterologous systems have been employed to
map the activation domain, demonstrate the synergy between CRX and NRL, and determine the
functional effect of CRX mutations.[S. Chen et al., 2002; Roger et al., 2014; Ruzycki et al.,
2017; Tran et al., 2014] Plasmid based systems have been adapted to report the activity of
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enhancers in vivo using GFP,[Corbo et al., 2010; Hsiau et al., 2007; Montana et al., 2011] but
these experiments are limited in scope as each construct must be tested individually. Recent
technological advances have overcome these throughput limitations. Massively Parallel Reporter
Assays (MPRAs) performed in the retina confirmed that hundreds of CRX bound regulatory
elements positively regulate transcription, while unbound regions did not.[White et al., 2013]
Additional experiments suggested that motif affinity directly contributed to this regulatory
potential.[White et al., 2016] However, a major limitation of all plasmid-based systems is the
lack of the genomic chromatin context. Studies have shown that sites known not to be bound in
the genome, when cloned in a plasmid reporter system, are bound by the TF simply based on the
raw sequence and motif.[Grossman et al., 2017] This suggests that chromatin plays a major role
in the specificity of TF binding. Additionally, plasmid-based systems only measure steady state
activity of the complement of TFs, but are unable to report developmental epigenomic regulatory
potential of key TFs.
These concepts have been studied separately. Chromatin immunoprecipitation with highthroughput sequencing (ChIP-seq) for CRX was performed in the adult retina.[Corbo et al.,
2010] Binding sites were enriched for a HD binding motif, and nearby genes represented many
known photoreceptor specific elements. However, use of this data alone assumes TF binding is a
binary control. Previous analysis of gene expression shows that many genes that lose expression
in Crx mutant mice are in close proximity to CRX binding sites.[Tran et al., 2014] However,
while this result displayed a very significant enrichment, it failed to explain why many more
genes that are also ‘bound’ by CRX are not affected.
Other experiments have sought to understand normal epigenetic development of rods and
cones.[Aldiri et al., 2017; Hughes et al., 2017; Mo et al., 2016; Yue et al., 2014] Dramatic
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developmental remodeling was described by ChIP-seq of histones and regulatory proteins and by
profiling of DNA methylation.[Aldiri et al., 2017] Other studies have profiled DNA accessibility
through development or compared mature rods vs cones.[Hughes et al., 2017; Mo et al., 2016;
Yue et al., 2014] These studies matched regulatory sites to CRX ChIP-seq data and predicted cofactors based on motif enrichment. However, the adult profiling of normal cells limited the
interpretation to a static prediction and was unable to directly attribute the activation of any site
to a particular factor.
To bridge this gap in the understanding of TF binding vs regulatory potential, here we use
ATAC-seq to show that CRX is only responsible for the epigenomic rearrangement of a subset
of its binding sites. These ‘Dependent’ sites reside within a variety of chromatin environments
and are highly correlated with the genes affected in mutant retinas. By applying this technique,
we clarify the role of this important TF in retinal development and disease and provide a model
for future studies of other TFs essential in the development of other cell types.
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4.4 Results
4.4.1 CRX binds ATAC sensitive regulatory sites
To determine active regulatory regions in the genome of mouse rod photoreceptors, we
performed whole retina ATAC-seq,[Buenrostro et al., 2015] a technique that profiles open
chromatin regions. We chose to profile at postnatal day 14 (P14), because all retinal cell types
are born by this age [Young, 1985] and photoreceptor specification is completed. Replicate
experiments on whole retina of C57BL/6J (WT) mice, where rods comprise ~80% of the
cells,[Jeon et al., 1998; Macosko et al., 2015] were consistent with available DNase1 data
profiling of adult (8wk) whole retina (Figure 4.1a), where areas enriched for ATAC data also
showed enrichment of signal by ENCODE DNase1 hypersensitivity datasets.[Yue et al., 2014]
We overlapped these regulatory sites (ATAC-seq peaks) with those sites bound by CRX
(detected by ChIP-seq).[Corbo et al., 2010] The majority (>98%) of CRX binding sites were
contained within ATAC-sensitive genomic regions, while many ATAC-sensitive sites showed no
CRX enrichment (Figure 4.1a, b). This comparison both supports the specificity of the CRX
ChIP and the unique role of CRX in binding a subset of regulatory sites to control gene
expression.
To understand the role of these CRX binding sites in the regulation of gene expression,
we first analyzed their distribution around the transcription start site (TSS) of each gene
expressed in the retina, in the context of that gene’s dysregulation in Crx-/- cells (Figure 4.1c,
left panel). While all ATAC-sensitive regulatory sites showed a strong preference to be located
near the TSS, there was no preference for genes that were determined to be up- or downregulated in the Crx-/- retina (top or bottom of plot as genes ordered by fold-change in WT/Crx-/127

; Figure 4.1c, right panel). We also plotted in the same manner the subset of ATAC regions
bound by CRX (Figure 4.1d). While these sites showed a similar distribution near the TSS of
expressed genes, they displayed a preference for genes that lose expression in the Crx-/- retina.
However, to our surprise, many CRX bound sites were near genes that had no transcriptional
changes. This data suggested that while CRX is a strong transcriptional activator,[S. Chen et al.,
1997] not every binding site has the same regulatory potential or dependency upon CRX activity.

4.4.2 Crx-/- retinas have an altered photoreceptor epigenome
To determine the functional implications of the loss CRX on the epigenome of
photoreceptors, we also performed duplicate ATAC-seq experiments on P14 Crx-/- retinas and
compared the results to those of WT retinas. Again, Crx-/- replicates were highly consistent with
one another (Figure 4.1a). Although many of the ATAC peaks qualitatively resembled WT
signal, some (e.g. those spanning Gnat1) appeared much weaker in Crx-/- than WT (Figure 4.1a).
Since no photoreceptor degeneration or cell death is detected in Crx-/- at this age,[Furukawa et
al., 1999; Tran et al., 2014] differential ATAC signals between the two mouse lines are
indicative of changes in the photoreceptor epigenome. Indeed, by quantitative comparison of WT
and Crx-/- datasets, Crx-/- retinas display a widely disturbed epigenome with both increased
(“up”) or decreased (“down”) activity at potential regulatory sites (Figure 4.2a). Roughly 25% of
ATAC peaks were altered, with virtually equivalent proportions “up” as those that were “down”
(Figure 4.2b).
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4.4.3 Crx-/- photoreceptors fail to close and open developmentally-modulated
regulatory sites
Previous DNase1 hypersensitivity data analyzed three stages of retinal development: P1,
P7 and Adult.[Yue et al., 2014] We can generalize these samples based on the overrepresentation of rods in the mouse retina to represent early progenitor, immature, and mature
rod photoreceptors, respectively. At a gross level, comparison to these datasets delineated
distinct patterns at our classified genomic sites (Figure 4.2c-e). Sites that were not changed
between WT and Crx-/- were generally open at all three stages (Figure 4.2d). However, sites that
are affected display contrasting dynamics over the course of development: The set that loses
activity in the Crx-/- retina normally would be activated, while the set that gains activity in the
mutant retina would be closed over normal development (Figure 4.2c vs 2e).
These sites also show differential tissue specificity. When compared to other DNase1
data, unaffected sites are also generally active in the brain and liver (Figure 4.2d). Again,
affected sites show contrasting patterns, where those lost in Crx-/- retinas are largely retina
specific (Figure 4.2e) while those that gain accessibility in mutant retinas are also very active in
the brain (Figure 4.2c). This data suggests that Crx-/- retinas maintain a majority of their basic
epigenetic state that would be similar in all cell types. However, they fail to turn on a highly
photoreceptor specific set of sites and to inactivate many sites that are used generally in
unspecified neurons.
We next tested what types of genes were likely regulated by these sites using GREAT
Gene Ontology (GO) analysis (Supplemental Table 4.1).[McLean et al., 2010] “Down” sites are
highly enriched for a number of categories of genes involved in “phototransduction,” “detection
of light,” and microtubule related processes. “Up” sites were enriched for categories that
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involved general development or differentiation of oligodendrocytes, somatic motor neurons, and
peripheral nervous system. There was also an enrichment for a single retinal related category
‘detection of visible light.’ Further investigation discovered the enriched genes to primarily be
cone related (Cnga, Cngb, and Gnat2, among others), which are present in developing
“immature” rods or transfated S-cones in the absence of NRL.[Brooks et al., 2011; Mears et al.,
2001]

4.4.4 CRX binding is strongly enriched at sites that lose activity in Crx-/To understand the primary role of CRX in this dynamic chromatin environment, we
classified ATAC sites based on the presence of an overlapping CRX ChIP signal (Figure 4.2f, g).
Nearly half of the ATAC peaks that are reduced in the Crx-/- retina are bound by CRX [CRX
Dependent] compared to a very small fraction (<1%) of those peaks that show increased signal
(Figure 4.2f, g and 4.2c vs e). There was also a significant enrichment of CRX binding within
ATAC sites that were unchanged in the Crx-/- retina [CRX Independent], although to a lesser
degree than the “down” group, (Figure 4.2d, f, g; Table 4.1).
We next sought to determine the relationship between changes in ATAC and local gene
expression. CRX bound ATAC sites that are decreased in Crx-/- compared to WT show a very
strong preference for the TSS of genes that lose expression (Supplemental Figure 4.1f vs d). A
similar trend was also observed for non-CRX bound ATAC sites that lose signal in Crx-/- retina
(Supplemental Figure 4.1e). Conversely, ATAC sites that are increased in the Crx-/-, nearly all
of which lack CRX binding, are greatly enriched near genes that increase in expression in the
Crx-/- retina (Supplemental Figure 4.1a, b). Both CRX bound and unbound sites that are
unchanged in the mutant retina show no strong association with any changes in gene expression
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(Supplemental Figure 4.1c, d). Together, these data show the strong correlation between activity
of local regulatory sites and gene expression, but indicate that only a subset of CRX bound sites
are affected upon the loss of CRX.

4.4.5 CRX acts within a variety of chromatin environments
We decided to explore the differences between these CRX binding sites that were either
lost [CRX Dependent] or maintained [CRX Independent] in the Crx-/- retina. Previous studies
have classified TF binding sites into promoter or enhancer classes based on distance from the
TSS. This approach is much more straightforward, but with new studies showing the breadth of
local regulatory domains, [Benayoun et al., 2014; Whyte et al., 2013] it likely does not reflect the
true biology or regulatory role of each site. Instead, we decided to distinguish binding sites based
on the local epigenetic state. CRX binding sites were located in four distinct chromatin
environments defined by ChIP-seq of H3K4me3 and H3K27Ac at P14 in WT retinas (Figure
4.3a, b). Groups A and C represent the largest proportion of the CRX binding sites and are
located in local regulatory domains and distal enhancers, respectively (Fig 3, Supplemental
Figure 4.2a). Group D represents CRX sites where neither active histone mark is present, these
are located similar to distal enhancer Group C, far from annotated genes (Supplemental Figure
4.2a). Group B includes a very small number of CRX sites that are near genes expressed at a
much lower level than the three other Groups (Supplemental Figure 4.2a, b). We found a
relatively equal representation of Dependent and Independent CRX sites within the three main
groups (Figure 4.3c), although Group A displayed some overrepresentation of Independent sites.
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4.4.6 CRX is required to activate a subset of local regulatory regions
To investigate the differential influence of CRX at local regulatory regions (Figure 4.3;
Group A), we first analyzed the temporal changes in the activation state as profiled by DNase1.
CRX Dependent local sites show strong retinal specificity and developmental activation (Figure
4.4a (left panel), Supplemental Figure 4.3a). This pattern is in stark contrast to Independent sites
that display strong signal also in brain and liver samples and retinal accessibility at all ages
(Figure 4.4a (right panel), Supplemental Figure 4.3b).
We next sought to understand whether these ATAC signals correspond to changes in
other epigenetic marks. To understand the epigenetic state of these sites over normal retinal
development, we analyzed data recently published by Aldiri et al.[Aldiri et al., 2017] By both the
analysis of individual ChIP datasets (data not shown) and the aggregate of this data in the HMM
classification of the binding sites (Supplemental Figure 4.4a, b), Independent sites were nearly
all classified as HMM classes 1-4 at E14.5 while Dependent sites displayed temporal remodeling
up to P7.
To determine whether the loss of CRX affected the local histone modifications at
Dependent sites, we performed ChIP-seq for H3K4me3 in WT and Crx-/- retinas. Peaks
containing CRX Independent sites largely maintained H3K4me3 presence in mutant retinas,
while peaks containing CRX Dependent sites display a significant loss of signal in Crx-/(Supplemental Figure 4.3c, d).
We sought to determine the effects of these epigenetic changes on gene expression.
RNAseq data profiling WT development and changes in Crx-/- was consistent with ATAC and
DNase1 data. Genes near CRX independent sites show very little developmental expression
changes and are relatively unaffected in mutant retinas. In contrast, those near Dependent sites
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increase dramatically over development but largely fail to do so in the Crx-/- (Figure 4.4b). Gene
Ontology (GO) analysis of these genes suggests Dependent genes are largely photoreceptor
related, while the Independent set is comprised of some genes with photoreceptor function, but
also genes with more general functions (protein transport, RNA processing, protein localization,
etc; Supplemental Table 4.1).

4.4.7 CRX is required to activate a set of distal enhancers
CRX also binds sites marked by H3K27Ac (Figure 4.3; Group C), traditionally thought to
be active distal enhancers. Dependent and Independent sets of enhancers both displayed dynamic
changes over development and a high degree of retinal specificity (Figure 4.5a and Supplemental
Figure 4.5a, b). However, by more careful comparison of the temporal dynamics of this
activation, we observed that Independent sites showed earlier activation than Dependent sites
(Supplemental Figure 4.5a vs b). We again analyzed other epigenomic data to determine if they
also would support this subtle temporal difference. HMM classification of the sites was nearly
identical by P14, but comparison of P0 and P3 data showed differences where Independent sites
were switching to more active classifications earlier than Dependent (Supplemental Figure 4.4c,
d).
To test whether ATAC signal changes correlated with the mutant epigenome, we
performed ChIP-seq for H3K27Ac at P14 in WT and Crx-/- retinas. As expected, Dependent sites
displayed a significant decrease in H3K27Ac deposition in Crx-/- retinas while Independent sites
largely maintained this mark (Supplemental Figure 4.5c, d).
Expression of the nearest gene to each enhancer also highlights differences between CRX
binding sites. Genes near both Dependent and Independent sites increased in expression over
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development in WT retinas (Figure 4.5b). However, this increase is attenuated for the Dependent
set, while there was no decrease observed in the Independent set (Figure 4.5b). GO analysis
showed a very clear distinction where Dependent genes are photoreceptor related, while
Independent genes have a variety of general functions (Supplemental Table 4.1).

4.4.8 CRX controls distal regulatory sites in the absence of active histone
marks
A significant number of CRX bound sites were not marked by either H3K4me3 or
H3K27Ac (Figure 4.3; Group D). When we analyzed the DNase1 and HMM data at these sites,
the pattern looked similar to Group C enhancers where CRX dependent sites opened later than
Independent and were more retina specific (Supplemental Figure 4.6a, d, e & Supplemental
Figure 4.4e, f). One notable difference was that HMM classification highlighted a subset of
Independent sites classified throughout development as Class 11 [Insulator] (Supplemental
Figure 4.4e).
Interestingly, gene expression data highlighted a different scenario than other groups. The
expression of the nearest gene to CRX Dependent sites displayed no significant differences
(Supplemental Figure 4.6b). While differences in gene expression were statistically significant in
the Independent set, the degree of change was very modest.

4.4.9 Base composition and conservation differentiate CRX sites
Our epigenome analyses identified distinct types of CRX sites, but raised the question
whether there are sequence characteristics ‘coding’ for these differences. As base composition,
such as CpG density, can determine the general regulatory role of genomic locations, we
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analyzed nucleotide frequency across CRX regulatory sites (Figure 4.6a). This analysis
uncovered several very interesting differences. First, Group A Dependent sites show a fairly
equal nucleotide distribution, especially within the central 200 bp of the CRX bound regulatory
site. This is in dramatic comparison to the Independent Group A sites that are within highly GC
rich regions. Group C and D distal regulatory elements did not show any obvious differences
between Independent or Dependent sites. Both have balanced content within the regulatory site,
but lie within AT enriched domains.
We also analyzed the extent to which the sequences were conserved across vertebrate
evolution (Figure 4.6b). All groups display a central region that is more conserved than the
surrounding environment (Figure 4.6b), supporting the importance of the ATAC and CRX ChIP
specified regulatory sites. Surprisingly, Independent sites of all three classes showed
significantly higher conservation than their Dependent counterpart. We also noted that Group D
Dependent sites and surrounding genomic regions were less conserved than Dependent Group A
or C regions.

4.4.10

CRX has different affinity for Dependent vs Independent sites
We next sought to determine whether the predicted binding affinity of CRX could

distinguish sites. In Group A proximal regulatory regions, significantly more Dependent than
Independent sites contained the canonical CRX site (Supplemental Figure 4.7a). This difference
was reflected in re-analysis of the CRX ChIP-seq, where quantification shows a higher read
depth at Dependent sites (Supplemental Figure 4.7b). Group C and D sites displayed the opposite
characteristics, where Independent sites were more likely to contain the CRX motif
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(Supplemental Figure 4.7a), although there was no difference in the intensity of the original ChIP
data (Supplemental Figure 4.7c, d).
We also predicted CRX occupancy using an algorithm that takes into account the relative
ratio of protein to DNA.[White et al., 2016; Zhao et al., 2009] At both low and high ratios (µ
values), Group A Dependent sites displayed higher binding occupancy than Independent sites
(Figure 4.6c, d). However, when Groups C and D were analyzed at a low protein:DNA ratio
(µ=0.5), Independent sites have a significantly higher occupancy score, consistent with the
traditional motif search data (Figure 4.6c). When analyzed at a high protein:DNA ratio, this
relationship inverted and Dependent sites instead showed higher predicted occupancy (Figure
4.6d). This suggests that Dependent distal regulatory sites have more low affinity CRX binding
sites that could additively contribute to CRX recruitment and perhaps inform functional
differences.

4.4.11
sites

Other TFs may compensate or be more influential at Independent
We also wondered whether binding sites for other TFs could differentiate CRX

Dependent vs Independent sites. We analyzed +100bp from the center of each CRX peak for
enrichment of sequences de novo (Table S2) and motifs included in the JASPAR database
(Supplemental Figure 4.8a). Both methods reported the highest enriched motif in all Groups to
be a canonical homeobox (Supplemental Figure 4.8a marked by *, Supplemental Table 4.2).
The most striking difference we noted by both methods was a unique enrichment of many
TF motifs in Group A Independent sites. Known TFs included KLF4, ELK1/4, E2F1, and NFYa
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(Supplemental Figure 4.8a, marked by **) while de novo motifs included promoter elements
(GC-box), NFY, NRF1, BHLH among others (Supplemental Table 4.2).
The other five sets shared enrichment of many known factors including GATA, LHX,
and NKX family motifs (Supplemental Figure 4.8a), although there were also notable
differences. Both methods suggested an enrichment of CTCF specifically in Group D
Independent sites (Supplemental Figure 4.8a, marked by ***; Supplemental Table 4.2), and
known motif analysis suggested that ESRRB and FOXC1 are enriched only in Dependent sites
(Supplemental Figure 4.8a, marked by ****). De novo methods also indicated strong unique
enrichment of NEUROD1, MEF2D, and MEIS1 motifs in Group C Independent sites
(Supplemental Table 4.2).
To confirm and explore the relevance of the motif analysis, we chose to focus on the
enrichment of MEF2D and CTCF sites. The CTCF motif was enriched only in Group D
Independent sites by both methods. As previously discussed, this set contains many sites with
Insulator function (Supplemental Figure 4.4e, HMM Class 11 purple). We reanalyzed CTCF
ChIP-seq data and confirmed that CTCF is enriched at Group D Independent sites throughout
development, and this binding was reasonably specific with minimal enrichment at Independent
Group A sites but none at any Dependent sites (Supplemental Figure 4.8c, d).
We also explored the enrichment of the MEF2D motif in Group C Independent sites
(Supplemental Table 4.2). Analysis of previously published ChIP-seq data[Andzelm et al., 2015]
showed that MEF2D binds both Dependent and Independent enhancers in WT retina, but this
signal is dramatically reduced only at Dependent sites in the Crx-/- retina (Supplemental Figure
4.8b). Together, these data support the relevance and interpretation of the motif enrichment
analyses.
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4.5 Discussion
By comparing the genome-wide changes of activity in WT vs Crx-/- retinas, we have
determined that the loss of CRX causes significant changes in activity at ~25% of all regulatory
sites. Even though CRX is an activating TF, sites that increase were as prevalent as those that
lose activity (Figure 4.2). By analyzing these sites alongside time course DNase1
hypersensitivity data, we have confirmed previously hypothesized mechanisms of CRXassociated disease, that the rod photoreceptors are stuck in a pre-developmental state; sites that
were supposed to close remain active, and sites that were supposed to progressively open did not
do so (Figure 4.2e-g). This model of CRX disease explains previous findings that Crx mutants
over express ‘cone’ related transcripts.[Ruzycki et al., 2015] Together with this data, recent
reports that suggest a more common developmental path of rods and cones than previously
recognized[Kim et al., 2016] support the model that Crx mutant retinas resemble a premature
state prior to the dramatic epigenetic switch toward rod photoreceptor identity.
Many of the peaks that lose activity are normally bound by CRX itself, consistent with
these sites being Dependent on its activity. CRX showed virtually no binding at peaks with
increased activity, but surprisingly did bind many peaks that were unchanged, or Independent
(Figure 4.2c, d). These CRX Dependent and Independent sites were located throughout the
genome. Our method that incorporated other aspects of the local epigenetic neighborhood,
including two active histones, clearly establishes distinct types of CRX binding sites beyond
simply TSS proximal and TSS distal. We propose this classification system is more informative
and biologically relevant to the function of individual TFs.
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CRX is activated in early born photoreceptors and maintains expression in mature cells.
Both developmental DNase1 and HMM classifications showed that all CRX Dependent sites
normally undergo dramatic activation over retinal development. By ChIP-seq, we showed that
H3K4me3 and H3K27Ac marks were lost at Group A and C Dependent sites respectively, and
by RNAseq that nearby genes were not properly activated over development in Crx-/- retina.
Together, this suggests that CRX is involved in this activation likely through its direct binding
and recruitment of other general TFs and co-regulators. Previous work has already shown clear
roles of such co-factors including CBP/P300, Ataxin7-STAGA, and DNMT1 among others in
retinal development.[Hennig et al., 2013; Nasonkin et al., 2013; Palhan et al., 2005; La Spada et
al., 2001]
Independent sites showed two very different patterns when data was analyzed (Figure
4.7). Group A (TSS proximal) Independent sites were open constitutively. These regions showed
no evidence of developmental remodeling, and were also active in other tissues. This suggests
that these sites are generally used regulatory elements, and GO analysis of the nearby genes
supports this interpretation as these genes were categorized as having very general cellular
functions. Conversely, Independent Group C and D sites did show temporal activation, but
quantitative analysis of the DNase1 and HMM data suggests they begin remodeling prior to CRX
expression and their respective Dependent group sites. The ability of the photoreceptor to
maintain or continue activating these Independent sites and properly express nearby genes
suggest that the binding of CRX here is not essential. However, we cannot formally exclude the
possibility that other homeodomain TFs (such as OTX2) compensate in the Crx-/- retina.
We analyzed the affinity of CRX by two distinct methods. Both predict that CRX binds
more efficiently to Dependent than Independent Group A sites, which was supported by analysis
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of ChIP-seq data (Supplemental Figure 4.7). We were surprised to find that Dependent distal
elements (Groups C and D) display less high but more low-quality binding sites. Differences in
activity relevant to binding affinity have already been predicted for CRX.[White et al., 2016]
This difference could inform a fundamental mechanism for CRX activity at enhancers, but
alternative biochemical experiments would be necessary to study binding efficiency, on/off rates,
and functional effects of these different types of sequences.
De novo motif analysis did not reveal any differences in the homeodomain site between
Dependent and Independent sites. This is not unexpected, as this motif is shared among many
homeodomain TFs expressed throughout the body, including others expressed in the retina
(OTX2 in particular). These results together suggest that CRX binding is directed by the
presence of a strong consensus HD motif, but this association cannot blindly be interpreted as an
important functional interaction (Figure 4.7). At proximal Independent regulatory sites, CRX
binding may simply be the byproduct of accessibility of the HD element used either by another
retinal HD TF, or more important in other cell types. Similarly, at distal Independent elements
the HD motif may be required only for activation in other neuronal cell types (Group C) or may
be recognized by another HD factor in the retina itself; only the precise mutation of these
elements in the genomic context could answer this question.
Previous work had noted that CRX bound within many GC rich genomic regions.[Corbo
et al., 2010] Our analysis discovered that these constitute proximal Independent regulatory sites.
While GC rich areas are normally thought to represent repressed CpG islands, other reports have
noted that ubiquitously expressed promoters display high GC content while cell type specific
promoters are AT rich.[Landolin et al., 2010] We expected that CRX Dependent sites would be
very highly conserved across species. While it was the case that the regulatory elements were
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more conserved than flanking sequences, Independent sites were more conserved than
Dependent counterparts. De novo and known motif analyses discovered that Independent sites,
especially Group A promoters, were enriched for a variety of TF motifs. Together, these data
suggest that Independent sites are active in other cell types of the body and are regulated by
shared or more general TFs.
Analysis of Dependent sites did suggest several CRX interacting partners, although
motifs for known partners NRL and NR2E3 that synergize or bind with CRX [S. Chen et al.,
2002; Peng & Chen, 2005] were not observed. This supports the model that while all three
factors are necessary for proper gene expression, CRX acts as the primary sequence specific
targeting factor for the three as a complex. Group C sites in particular displayed enrichment for a
number of other factors including NKX, ESRRB, and FOXC. These could represent new TFs
that either act in coordination with CRX to activate these enhancers, or could represent pioneer
factors that opened the sites to allow for CRX to bind and fully activate.
Our analyses have emphasized that every TF binding site is not equal. While CRX or any
other homeodomain TF may bind thousands of sites, only a subset of those sites (for CRX, <1/3)
require the TF to establish or maintain the local epigenetic state. We propose these elements and
the homeodomain motifs within Dependent sites are excellent candidates where non-coding
variants may cause human retinal disease. Our findings are based on an embryonic loss-offunction study. In this setting, CRX acts as an “acceleratory factor” required for enhancing
Dependent site activity. However, these experiments do not address if CRX is sufficient for
achieving the active chromatin state and when CRX’s epigenomic activity is required (plasticity
of the system). Ectopic expression of CRX in cultured HEK293 and Y79 retinoblastoma cells
failed to produce a rod-like epigenome, even with co-expression of NRL (Ruzycki and Chen,
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unpublished results), suggesting CRX is not a “pioneer” factor that can bind to fully closed sites
to mediate de novo chromatin remodeling for cell fate specification. Instead, CRX appears only
able to act on those sites that are “primed” for photoreceptor rearrangement in the precursor
cells. Indeed, even CRX Dependent sites do show some level of ATAC sensitivity, perhaps
evidence for prior opening by another factor, although we cannot exclude that this is the result of
compensation. Future studies, such as temporal knockout or ectopic expression of CRX in
developing or mature photoreceptors are needed to address the sufficiency and plasticity
questions, important for understanding and treating CRX-linked diseases.
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Table 4.1: ATAC-seq peaks lost in Crx-/- show enrichment for CRX binding in WT
Table 1

Up
No Change
Down

Total
CRX bound
6,259
33
32,105
3,883
4,586
1,992

%
0.5
12.1
43.4
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Figure 4.1: CRX binds a subset of active regulatory sites in the rod photoreceptor. (a)
Browser track displays ATAC-seq, DNase1 and CRX ChIP-seq read depth. (Scale bar 5kb) (b)
Venn diagram depicting number of CRX ChIP-seq-defined binding sites that overlap with
regulatory sites defined by ATAC-seq. (c, d) Meta-gene plots of all genes expressed in P21 WT
and Crx-/- retinas, ordered by [log2] fold-change (as depicted in plot on left). Black dots
represent the center of ATAC regulatory site relative to TSS of all ATAC peaks. c and of only
the subset bound by CRX. (d) Histograms of X and Y axes display density and distribution of the
data.

144

Figure 4.2: Loss of CRX affects many developmentally activated regulatory sites. (a, b)
Comparison of WT and Crx-/- ATACseq data shows highly disturbed epigenome in Crx-/retinas where significant numbers of sites display increased (red) or decreased (blue) signal. (c-e)
Read density heatmaps display reproducibility of ATAC experiments (WT1 & 2 vs Crx-/- 1 & 2),
overlap of CRX binding signal, and regulatory activity as defined by DNase1 in P1, 1wk, and
8wk retina, Brain, and Liver samples. (f) Scatterplot displays distribution of the subset of CRX
bound ATAC sites over the comparison of WT vs Crx-/- data. (g) Proportion of total sites within
each ATAC class bound by CRX (black) are displayed in pie charts.
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Figure 4.3: CRX binds within four chromatin environments. (a) Pie chart depicts number of
CRX binding sites that reside within Groups A-D as defined by overlap with (b) ChIP-seq data
of H3K4me3 and H3K27Ac datasets in P14 WT retina. (c) Size of circle represents number of
CRX sites within each group A-‘D,’ and displays distribution relative to ATAC-seq comparison
between WT and Crx-/-.
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Figure 4.4: CRX is only required for activity and remodeling of a subset of local regulatory
sites. (a) Plots display read density of DNase1 experiments centered on CRX binding site of
Dependent and Independent Group A sites. (b) Analysis of RNAseq of nearest gene to each
peak, displayed as boxplot of normalized RPKM values at P2 and P21 in WT and P21 in Crx-/-.
(Wilcoxon Rank Sum Test, Paired; * p < 0.05, ** p < 2.2x10^-5, *** p < 2.2x10^-10, **** p <
2.2x10^-16)
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Figure 4.5: CRX activates a subset of distal enhancers over development. (a) Plots display
read density of DNase1 experiments centered on CRX binding sites of Dependent and
Independent Group C sites. (b) Analysis of RNAseq of nearest gene to each peak, displayed as
boxplot of normalized RPKM values at P2 and P21 in WT and P21 in Crx-/-. (Wilcoxon Rank
Sum Test, Paired; * p < 0.05, ** p < 2.2x10^-5, *** p < 2.2x10^-10, **** p < 2.2x10^-16)
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Figure 4.6: Sequence analyses differentiate Dependent and Independent CRX sites. (a)
Nucleotide density and (b) conservation scores display differences between Groups A, C and D,
and between Dependent and Independent classes of CRX sites in each group. Both are calculated
in 20bp windows +/- 1kb from center of CRX peak. (Wilcoxon Rank Sum Test, * p < 0.05, ** p
< 2.2x10^-5, *** p < 2.2x10^-10, **** p < 2.2x10^-16). (c, d) CRX occupancy scores, as
defined by BEEML algorithm are displayed for two DNA:protein ratios (u values).
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Figure 4.7: Model of CRX mechanism of action. Model synthesizes new insights into
difference in CRX activity and mechanism of action at CRX Dependent vs Independent proximal
and distal regulatory sites. The model describes differences in activity state over time (left), and
distils motif analysis and base conservation data.
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Supplemental Figure 4.1: CRX bound ATAC peak signal changes correlate with expression
changes of nearby genes. (a, c, e - left panel) Meta-gene plots of all genes expressed in P21 WT
and Crx-/- retinas, ordered by [log2] fold-change (as depicted in plot on left). Black dots
represent the center of ATAC regulatory site relative to TSS of all ATAC peaks not bound by
CRX (a, c, e - right panel) and of only the subset bound by CRX (b, d, f). Peaks are divided by
their changes in ATAC signal- sites increased in Crx-/- relate to WT (a, b), those that are not
changed (c, d), and those that decrease in Crx-/- (e, f). Histograms of X and Y axes display
density and distribution of the data.
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Supplemental Figure 4.2: CRX binds in distinct regulatory environments. (a) Quantification
of the distribution of peaks within Groups A-D and their distance to the nearest TSS. (b)
Boxplots represent normalized expression (RPKM) of the nearest gene to each peak within
Groups A-D.
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Supplemental Figure 4.3: CRX is required to activate Dependent local regulatory elements
and to remodel chromatin. Plots display mean and SEM of DNase1 data presented in Figure
4.4a for Dependent (a) and Independent (b) CRX sites. (c) Scatterplot displays changes in
H3K4me3 deposition at all peaks (light gray). Black and red denote the subset of H3K4me3
peaks that contain Independent and Dependent CRX Group A sites. (d) Quantification of the fold
change of H3K4me3 deposition in WT vs Crx-/-. (Wilcoxon Rank Sum Test; **** p < 2.2x10^16)
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Supplemental Figure 4.4: Dependent and Independent sites show different chromatin state
dynamics. (a, c, e) Stacked bargraphs represent proportion of Group A-B sites that are contained
within each HMM defined chromatin state at 8 developmental ages. (b, d, f) Quantification of
data binned into HMM classes 1-4, 5-7, 8-10, and 11, for Dependent and Independent sites show
different dynamics of reorganization over development. Legend defines basic classification of
HMM classes.[Aldiri et al., 2017]
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Supplemental Figure 4.5: CRX is required to activate Dependent enhancer elements and
remodel chromatin. Plots display mean and SEM of DNase1 data presented in Fig.5a for
Dependent (a) and Independent (b) CRX sites. (c) Scatterplot displays changes in H3K27Ac
deposition at all peaks (light gray). Black and red denote the subset of H3K27Ac peaks that
contain Independent and Dependent CRX Group C sites. (d) Quantification of the fold change of
H3K27Ac deposition in WT vs Crx-/-. (Wilcoxon Rank Sum Test; **** p < 2.2x10^-16)
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Supplemental Figure 4.6: CRX is required to activate Dependent distal regulatory
elements. (a) Plots display read density of DNase1 experiments centered on CRX binding site of
Dependent and Independent Group D sites. (b) Analysis of RNAseq of nearest gene to each
peak, displayed as boxplot of normalized RPKM values at P2 and P21 in WT and P21 in Crx-/-.
Plots display mean and SEM of DNase1 data above for Dependent (d) and Independent (e) CRX
sites. (Wilcoxon Rank Sum Test, Paired; * p < 0.05, ** p < 2.2x10^-5, *** p < 2.2x10^-10, ****
p < 2.2x10^-16)
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Supplemental Figure 4.7: Sites display different presence of CRX motif and binding. (a)
Proportion of sites within each of the noted groups that contains the published CRX motif. (b-d)
Quantification of read depth of CRX ChIP-seq at Dependent (red) and Independent (blue) sites
within the specified groups. (Fisher’s exact test; *** p = 0.0001, **** p < 0.0001)
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Supplemental Figure 4.8: TF motifs explain nature of Independent site activation in
absence of CRX. (a) Heatmap shows unsupervised clustering of [-log10] transformed p-values
representing the significance of representation of the noted TF motif within the set of sites. (* ****) represent TFs referenced in details in the text. (b) Quantification of MEF2D ChIP-seq data
at Group C enhancer sites displays loss of signal specifically at Dependent sites (red) in the Crx/-. Independent sites (blue) show no change in signal. (c) Quantification of CTCF binding over
time (maximum peak intensity over development) and (d) relative to CRX bindings site at P21
display consistent signal at Group D Independent sites.
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Supplemental Table 4.1: GREAT analysis of CRX bound regulatory sites. Each table lists
the top 10 enriched GO categories for the specified group of sites.
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Group A Independent
# Term Name
sensory perception of light stimulus
protein transport
retina homeostasis
visual perception
establishment of protein localization
photoreceptor cell maintenance
RNA processing
peptidyl-lysine modification
photoreceptor cell differentiation
detection of light stimulus

Group C Independent
# Term Name
actin-mediated cell contraction
aspartate transport
C4-dicarboxylate transport
cell-cell junction organization
glycoprotein biosynthetic process
cell junction organization

Group D Independent
# Term Name
no terms significantly associated

Binom FDR Q-Val
5.91E-25
6.61E-25
1.44E-23
4.51E-23
1.74E-20
8.43E-13
1.61E-12
2.87E-11
7.26E-10
9.01E-10

Binom FDR Q-Val
0.000735145
0.001590798
0.002355205
0.002403853
0.003606846
0.007377643
0.015567533
0.016723291
0.023717345
0.027914745

Binom FDR Q-Val

Group A Dependent

# Term Name
visual perception
sensory perception of light stimulus
phototransduction
detection of light stimulus
retina development in camera-type eye
response to light stimulus
camera-type eye development
eye development
detection of abiotic stimulus
photoreceptor cell development

Group C Dependent

# Term Name
cilium organization
cilium assembly
cilium morphogenesis
microtubule-based process
peptidyl-serine phosphorylation
peptidyl-serine modification
regulation of myeloid cell differentiation
negative regulation of insulin receptor signaling pathway
establishment of organelle localization
positive regulation of myeloid cell differentiation

Group D Dependent

# Term Name
no terms significantly associated

Binom FDR Q-Val

Binom FDR Q-Val
0.000139599
0.011581789
0.013173136
0.017471496
0.031408027
0.038060625

Binom FDR Q-Val
4.08E-18
4.95E-18
1.91E-17
2.86E-17
7.57E-17
3.28E-15
1.98E-13
6.54E-11
1.40E-10
8.22E-10

Increased in Crx-/- (Up)
# Term Name
Binom FDR Q-Val
detection of visible light
2.66E-08
Notch signaling pathway
1.58E-07
oligodendrocyte cell fate specification
8.28E-07
somatic motor neuron differentiation
1.20717E-06
peripheral nervous system development
1.78783E-06
neuromuscular process controlling balance
3.88235E-06
smoothened signaling pathway involved in dorsal/ventral neural tube patterning
1.07764E-05
body fluid secretion
1.91156E-05
regulation of timing of cell differentiation
2.15899E-05
regulation of development, heterochronic
2.56657E-05

Binom FDR Q-Val
3.89E-22
1.07E-20
3.87E-20
9.66E-20
9.16E-16
2.82E-14
1.27E-13
5.86E-13
3.01E-12
4.46E-10

Reduced in Crx-/- (Down)

# Term Name
phototransduction
detection of light stimulus
sensory perception of light stimulus
visual perception
microtubule-based process
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
positive regulation of mRNA catabolic process
retina development in camera-type eye
regulation of Rab GTPase activity

Group A Dependent
Motifs per peak

0.020

Rank

Motif

‘a’
Dep

0.015
0.010
0.005
0.000

Best Match/Details

-1kb

Peak
Center
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Indp

‘c’
Dep
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Indp

‘d’
Dep

‘d’
Indp

P-value

+1kb

log P-pvalue % of Targets% of Background
STD(Bg STD)

downboth_1
0.020
0.015
0.010

1

0.005

Crx/MA0467.1/Jaspar(0.914)

0.000

1.00E-244

-5.63E+02

66.19%

12.18% 36.2bp (74.4bp)

1.00E-23

-5.37E+01

6.42%

0.90% 40.1bp (76.7bp)

1.00E-18

-4.31E+01

9.56%

2.59% 50.5bp (62.3bp)

1.00E-16
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1.00%

0.00% 42.3bp (36.2bp)

1.00E-13

-3.01E+01

6.56%

1.77% 48.6bp (75.1bp)

1.00E-12

-2.90E+01

1.28%

0.03% 60.7bp (54.4bp)

1.00E-12

-2.81E+01

1.00%

0.01% 40.7bp (12.5bp)

downboth_2
0.0010
0.0008
0.0006
0.0004

2

PITX3/MA0714.1/Jaspar(0.769)

3

RORgt(NR)/EL4-RORgt.Flag-ChIPSeq(GSE56019)/Homer(0.895)

0.0002
0.0000

downboth_3
0.0010
0.0008
0.0006
0.0004
0.0002
0.0000

downboth_4
0.00025
0.00020
0.00015
0.00010

4

0.00005

PH0130.1_Otx2/Jaspar(0.609)

0.00000

downboth_5
0.0015

0.0010

0.0005

5

LIN54/MA0619.1/Jaspar(0.761)

0.0000

downboth_6
0.00020
0.00015
0.00010
0.00005

6

SMAD2::SMAD3::SMAD4/MA0513.1/Jaspar(0.565)

0.00000

downboth_7
0.00015

0.00010

0.00005

7

POU6F2/MA0793.1/Jaspar(0.788)

0.00000

Group A Independent
Motifs per peak

0.020

Rank

Motif

0.015
0.010
0.005
0.000

Best Match/Details

-1kb

‘a’
Dep
Peak
Center

‘a’
Indp

‘c’
Dep

‘c’
Indp

‘d’
Dep

‘d’
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P-value

+1kb

log P-pvalue % of Targets% of Background
STD(Bg STD)

nochgnboth_1
0.020
0.015
0.010

1

0.005

OTX1/MA0711.1/Jaspar(0.963)

1e-452

0.000

-1.04E+03

46.35%

9.95% 36.9bp (75.6bp)

1.00E-152

-3.52E+02

31.89%

11.54% 51.3bp (69.7bp)

1.00E-144

-3.33E+02

25.36%

7.94% 51.4bp (74.1bp)

1.00E-118

-2.74E+02

7.25%

0.63% 53.2bp (74.8bp)

1.00E-103

-2.38E+02

65.97%

43.96% 55.0bp (75.5bp)

1.00E-46

-1.08E+02

9.64%

3.22% 55.7bp (71.1bp)

1.00E-32

-7.51E+01

3.31%

0.59% 48.0bp (60.8bp)

1.00E-28

-6.59E+01

18.73%

10.95% 53.6bp (68.7bp)

1.00E-24

-5.69E+01

12.87%

6.89% 53.3bp (75.5bp)

1.00E-22

-5.26E+01

6.71%

2.76% 45.9bp (63.9bp)

1.00E-20

-4.76E+01

3.02%

0.78% 56.4bp (69.0bp)

1.00E-20

-4.71E+01

2.72%

0.65% 51.0bp (58.5bp)

1.00E-18

-4.37E+01

9.18%

4.77% 53.1bp (65.2bp)

1.00E-17

-4.08E+01

5.95%

2.63% 49.3bp (81.6bp)

1.00E-16

-3.74E+01

5.74%

2.61% 56.8bp (70.0bp)

1.00E-16

-3.70E+01

0.42%

0.01% 44.4bp (35.9bp)

1.00E-15

-3.63E+01

2.81%

0.85% 52.9bp (76.1bp)

1.00E-15

-3.52E+01

2.05%

0.50% 43.6bp (72.5bp)

1.00E-12

-2.83E+01

3.39%

1.37% 61.8bp (63.6bp)

nochngboth_2
0.004
0.003
0.002

2

0.001

POL003.1_GC-box/Jaspar(0.918)

0.000

nochgnboth_3
0.004
0.003
0.002

3

0.001

NFY(CCAAT)/Promoter/Homer(0.911)

0.000

nochgnboth_4
0.0008
0.0006
0.0004

4

0.0002

GFY(?)/Promoter/Homer(0.985)

0.0000

nochngboth_5
0.010
0.008
0.006
0.004

5

Crem/MA0609.1/Jaspar(0.733)

6

NRF1(NRF)/MCF7-NRF1-ChIPSeq(Unpublished)/Homer(0.989)

0.002
0.000

nochngboth_6
0.0015

0.0010

0.0005

0.0000

nochngboth_7
0.0005
0.0004

7

0.0003

RORgt(NR)/EL4-RORgt.Flag-ChIPSeq(GSE56019)/Homer(0.927)

0.0002
0.0001
0.0000

nochngboth_8
0.0020
0.0015
0.0010
0.0005

8

BHLHE41/MA0636.1/Jaspar(0.901)

0.0000

nochgnboth_9
0.0015

0.0010

0.0005

9

ZBED1/MA0749.1/Jaspar(0.833)

0.0000

nochngboth_10
0.0010
0.0008

10

0.0006

Atf1(bZIP)/K562-ATF1-ChIPSeq(GSE31477)/Homer(0.959)

0.0004
0.0002
0.0000

nochngboth_11
0.0003

0.0002

0.0001

11

YY1(Zf)/Promoter/Homer(0.849)

0.0000

nochngboth_12
0.0015

0.0010

12

Pbx3(Homeobox)/GM12878-PBX3-ChIPSeq(GSE32465)/Homer(0.955)

0.0005

0.0000

nochngboth_13
0.0020
0.0015
0.0010
0.0005

13

STAT3/MA0144.2/Jaspar(0.849)

0.0000

nochngboth_14
0.0020
0.0015
0.0010
0.0005

14

FOXI1/MA0042.2/Jaspar(0.684)

0.0000

nochngboth_15
0.0010
0.0008
0.0006
0.0004
0.0002

15

ETV2/MA0762.1/Jaspar(0.671)

16

PAX3:FKHR-fusion(Paired,Homeobox)/Rh4-PAX3:FKHRChIP-Seq(GSE19063)/Homer(0.630)

0.0000

nochngboth_16
0.00025
0.00020
0.00015
0.00010
0.00005
0.00000

nochngboth_17
0.0005
0.0004
0.0003
0.0002
0.0001

17

Atf1/MA0604.1/Jaspar(0.710)

0.0000

nochngboth_18
0.0004
0.0003
0.0002
0.0001

18

PB0077.1_Spdef_1/Jaspar(0.664)

0.0000

nochngboth_19
0.0008
0.0006
0.0004
0.0002

19

NFY(CCAAT)/Promoter/Homer(0.668)

0.0000
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Group C Dependent
Motifs per peak

0.020

Rank

Motif

0.015
0.010
0.005
0.000

Best Match/Details

-1kb

‘a’
Dep
Peak
Center

‘a’
Indp

‘c’
Dep

‘c’
Indp

‘d’
Dep

‘d’
Indp

P-value

+1kb

log P-pvalue % of Targets% of Background
STD(Bg STD)

downonlyk27_1
0.020
0.015
0.010

1

OTX1/MA0711.1/Jaspar(0.928)

0.005
0.000

1.00E-244

-5.63E+02

68.30%

15.88% 37.0bp (73.4bp)

1.00E-75

-1.73E+02

24.94%

5.38% 42.9bp (72.0bp)

1.00E-31

-7.37E+01

22.48%

8.69% 50.4bp (73.7bp)

1.00E-30

-6.99E+01

9.95%

2.03% 42.1bp (74.3bp)

1.00E-19

-4.49E+01

3.93%

0.44% 45.4bp (60.4bp)

1.00E-19

-4.43E+01

12.29%

4.38% 48.0bp (71.2bp)

1.00E-15

-3.67E+01

38.57%

25.42% 56.1bp (66.9bp)

1.00E-14

-3.30E+01

2.95%

0.35% 51.7bp (61.9bp)

1.00E-13

-3.06E+01

6.27%

1.80% 51.8bp (65.3bp)

downonlyk27_2
0.004
0.003
0.002

2

PB0048.1_Nkx3-1_1/Jaspar(0.782)

0.001
0.000

downonlyk27_3
0.004
0.003
0.002

3

PH0045.1_Hoxa1/Jaspar(0.716)

0.001
0.000

downonlyk27_4
0.0015

0.0010

4

0.0005

MEF2B/MA0660.1/Jaspar(0.937)

0.0000

downonlyk27_5
0.0005
0.0004

E2A(bHLH),near_PU.1/Bcell-PU.1-ChIPSeq(GSE21512)/Homer(0.753)

5

0.0003
0.0002
0.0001
0.0000

downonlyk27_6
0.0025
0.0020
0.0015
0.0010

6

PH0130.1_Otx2/Jaspar(0.622)

0.0005
0.0000

downonlyk27_7
0.005
0.004

Smad3(MAD)/NPC-Smad3-ChIPSeq(GSE36673)/Homer(0.638)

7

0.003
0.002
0.001
0.000

downonlyk27_8
0.0005
0.0004

RORgt(NR)/EL4-RORgt.Flag-ChIPSeq(GSE56019)/Homer(0.961)

8

0.0003
0.0002
0.0001
0.0000

downonlyk27_9
0.0010
0.0008
0.0006
0.0004

9

TFCP2/MA0145.3/Jaspar(0.708)

0.0002
0.0000

Group C Independent
Motifs per peak

0.020

Rank

Motif

0.015
0.010
0.005
0.000

Best Match/Details

-1kb

‘a’
Dep
Peak
Center

‘a’
Indp

‘c’
Dep

‘c’
Indp

‘d’
Dep

‘d’
Indp

P-value

+1kb

log P-pvalue % of Targets% of Background
STD(Bg STD)

nochngonlyk27_1
0.020
0.015
0.010

1

OTX1/MA0711.1/Jaspar(0.944)

2

NeuroD1(bHLH)/Islet-NeuroD1-ChIPSeq(GSE30298)/Homer(0.961)

3

RORgt(NR)/EL4-RORgt.Flag-ChIPSeq(GSE56019)/Homer(0.947)

1e-437

0.005
0.000

-1.01E+03

77.17%

14.24% 36.1bp (72.7bp)

1.00E-37

-8.57E+01

13.66%

3.76% 52.2bp (67.2bp)

1.00E-34

-7.93E+01

9.07%

1.82% 45.5bp (64.7bp)

1.00E-31

-7.32E+01

4.49%

0.38% 45.6bp (64.3bp)

1.00E-19

-4.52E+01

6.58%

1.67% 40.9bp (73.8bp)

1.00E-17

-4.00E+01

19.24%

10.14% 54.1bp (68.3bp)

1.00E-15

-3.65E+01

4.89%

1.16% 52.2bp (63.4bp)

1.00E-14

-3.24E+01

10.57%

4.64% 52.8bp (65.6bp)

1.00E-13

-3.06E+01

2.79%

0.45% 52.7bp (68.7bp)

1.00E-12

-2.88E+01

3.29%

0.68% 44.3bp (65.7bp)

1.00E-12

-2.86E+01

6.98%

2.61% 52.2bp (69.9bp)

1.00E-12

-2.85E+01

14.56%

7.81% 55.8bp (67.2bp)

nochngonlyk27_2
0.0015

0.0010

0.0005

0.0000

nochngonlyk27_3
0.0010
0.0008
0.0006
0.0004
0.0002
0.0000

nochngonlyk27_4
0.0005
0.0004

4

Mef2d(MADS)/Retina-Mef2d-ChIPSeq(GSE61391)/Homer(0.961)

0.0003
0.0002
0.0001
0.0000

nochngonlyk27_5
0.0010
0.0008

5

MyoG(bHLH)/C2C12-MyoG-ChIPSeq(GSE36024)/Homer(0.653)

0.0006
0.0004
0.0002
0.0000

nochgnonlyk27_6
0.003

6

0.002

Meis1(Homeobox)/MastCells-Meis1-ChIPSeq(GSE48085)/Homer(0.894)

0.001

0.000

nochgnonlyk27_7
0.0006

7

0.0004

USF1(bHLH)/GM12878-Usf1-ChIPSeq(GSE32465)/Homer(0.959)

0.0002

0.0000

nochgnonlyk27_8
0.0015

0.0010

0.0005

8

RHOXF1/MA0719.1/Jaspar(0.622)

9

GATA3(Zf)/iTreg-Gata3-ChIPSeq(GSE20898)/Homer(0.699)

0.0000

nochgnonlyk27_9
0.0005
0.0004
0.0003
0.0002
0.0001
0.0000

nochngonlyk27_10
0.0006

0.0004

0.0002

10

Nr2e3/MA0164.1/Jaspar(0.699)

0.0000

nochngonlyk27_11
0.0008
0.0006
0.0004

11

0.0002

PH0040.1_Hmbox1/Jaspar(0.727)

0.0000

nochngonlyk27_12
0.0020
0.0015
0.0010
0.0005

12

GMEB2/MA0862.1/Jaspar(0.726)

0.0000
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Group D Dependent
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0.015
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0.005
0.000
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Indp

‘c’
Dep

‘c’
Indp

‘d’
Dep

‘d’
Indp

P-value

+1kb

log P-pvalue % of Targets% of Background
STD(Bg STD)

downneither_1
0.020
0.015
0.010

1

0.005

Crx/MA0467.1/Jaspar(0.886)

0.000

1.00E-64

-1.49E+02

75.30%

15.58% 37.0bp (76.3bp)

1.00E-18

-4.17E+01

24.10%

4.37% 45.2bp (72.7bp)

1.00E-14

-3.33E+01

8.43%

0.37% 35.3bp (71.3bp)

1.00E-13

-3.12E+01

13.86%

1.74% 42.9bp (73.1bp)

1.00E-12

-2.97E+01

13.86%

1.88% 57.7bp (74.2bp)

downneither_2
0.0025
0.0020
0.0015
0.0010

2

Crx/MA0467.1/Jaspar(0.690)

3

SCL(bHLH)/HPC7-Scl-ChIPSeq(GSE13511)/Homer(0.564)

0.0005
0.0000

downneither_3
0.0015

0.0010

0.0005

0.0000

downneither_4
0.0020
0.0015

Pitx1(Homeobox)/Chicken-Pitx1-ChIPSeq(GSE38910)/Homer(0.743)

4

0.0010
0.0005
0.0000

downneither_5
0.0015

0.0010

0.0005

5

ISL2/MA0914.1/Jaspar(0.680)

0.0000

Group D Independent
Motifs per peak

0.020

Rank

Motif

Best Match/Details

0.015
0.010
0.005
0.000

-1kb

‘a’
Dep
Peak
Center

‘a’
Indp

‘c’
Dep

‘c’
Indp

‘d’
Dep

‘d’
Indp

P-value

+1kb

log P-pvalue % of Targets% of Background
STD(Bg STD)

nochngneither_1
0.020

1

CRX(Homeobox)/Retina-Crx-ChIPSeq(GSE20012)/Homer(0.995)

2

CTCF(Zf)/CD4+-CTCF-ChIPSeq(Barski_et_al.)/Homer(0.908)

0.015
0.010
0.005

1.00E-107

-2.48E+02

77.08%

14.85% 38.5bp (77.1bp)

1.00E-32

-7.46E+01

13.44%

0.67% 44.2bp (69.2bp)

1.00E-14

-3.45E+01

4.74%

0.13% 48.8bp (59.8bp)

1.00E-14

-3.23E+01

25.30%

8.82% 51.3bp (70.8bp)

1.00E-13

-3.08E+01

1.98%

0.00% 41.1bp (0.0bp)

1.00E-12

-2.90E+01

6.32%

0.48% 45.1bp (78.1bp)

0.000

nochngneither_2
0.0015

0.0010

0.0005

0.0000

nochngneither_3
0.0006

0.0004

3

0.0002

YY2/MA0748.1/Jaspar(0.646)

0.0000

nochngneither_4
0.004
0.003
0.002

4

PB0048.1_Nkx3-1_1/Jaspar(0.754)

0.001
0.000

nochngneither_5
0.0004
0.0003
0.0002

5

0.0001

E2F8/MA0865.1/Jaspar(0.589)

0.0000

nochngneither_6
0.0010
0.0008
0.0006
0.0004

6

PHOX2A/MA0713.1/Jaspar(0.835)

0.0002
0.0000

Supplemental Table 4.2: De novo motif analysis identifies sequences enriched in different
sets of CRX bound regions. Data presented in columns A-C & E-I are generated by HOMER
(see Appendix 2 methods). Column D represents the scanning of the identified sequence back
across the 6 classes of CRX sites (+/- 1kb from peak center). The plot in line 1 depicts the layout
of the plot, and the y axis quantifies ‘motifs per bp.’
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Chapter 5
Organization of the photoreceptor genome
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5.1 Author Contributions
This project was conceived of by Shiming Chen and Philip Ruzycki to build upon past
work by former lab member Guang Hua Peng [Peng & Chen, 2011, 2012] and to address several
questions in the growing field of genomic organization as we think the rod photoreceptor is a
useful model system for this purpose.
I optimized Circularized Chromosome Conformation Capture (4C) and Fluorescence in
situ hybridization (FISH) protocols for retinal tissue. Irina Solovei, LMU München,
was very generous in sharing her protocols for FISH probe generation and tissue preparation. I
performed all 4C molecular biology, RNA-seq, and qRT-PCR and related data analyses.
Morphometry and FISH data collection and analyses were performed by myself and Courtney
Linne. This project is a work in progress, and the contents of the chapter will be submitted for
publication soon.
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5.2 Abstract
Purpose: The packaging of DNA is a highly regulated and critical process of cellular
differentiation. Euchromatin and heterochromatin territories must be determined to assure both
proper gene expression and repression. In mouse rod photoreceptors, this packaging is unique as
nuclei are inverted; euchromatin occupies only the outer ring of the nucleus while
heterochromatin is packaged densely into the nuclear core. While studies have generally
described this packaging in terms of gene-rich vs gene-poor, very little is known about the
organization at a molecular scale.
Methods: To interrogate fragments of DNA that interact with Rhodopsin (Rho), the highest
expressed gene in the cell, we have performed Circularized Chromosome Conformation Capture
(4C) and confirmed our analysis with DNA Fluorescence in situ Hybridization (FISH). We
generated a mouse model where Rho has been inactivated and assessed the effects on Rhocontacting loci using FISH and RNA-seq.
Results: 4C data suggested a majority of Rho interactions were very local, and restricted to a
stretch of multiple topologically associated domains (TADs) that are all segregated to the A
compartment (active territory). Distant trans interactions that were confirmed using FISH were
also within A compartment DNA and were highly enriched for active chromatin and known
photoreceptor regulatory elements. Inactivation of the Rho promoter resulted in a loss of distal
contacts, and an increase in gene expression within the interacting cis TADs.
Conclusion: This data shows that the rod photoreceptor genome, although very distinct at
microscopic resolution, is packaged into a very similar A/B compartment structure as other cell
types. This data also suggests that the active A compartment can be subdivided into distinct
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units, perhaps based on chromatin state. The inclusion of Rho into this sub compartment was
dependent upon the activity state of Rho. RNA-seq further suggested that within a compartment,
machinery is a resource that when otherwise not in use, can affect the expression of other genes.
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5.3 Introduction
At the molecular level, each chromosome is packaged into the nucleus to ensure proper
expression and repression of genes. Previous work has focused on the role of epigenomic gene
regulation on the relatively local state of the region surrounding a particular gene. New
technologies now allow for the interrogation of the compaction of DNA on a local scale
(promoter-enhancer interactions), and beyond to understand how 2 meters of DNA is folded to
fit into each nucleus.
The chromosome is first segregated into discrete topologically associated domains
(TADs), which serve as ‘genomic neighborhoods’ (~1Mb in size) thought to isolate and ensure
proper connections of enhancers and promoters.[Reviewed in [Bonev & Cavalli, 2016]] Indeed,
the disruption of a single TAD boundary has been shown to result in the improper spread of
repressive or active chromatin while their global depletion results in a gross change in genomic
organization; both experiments cause changes to gene expression. [Narendra et al., 2015, 2016;
Rao et al., 2017; Schwarzer et al., 2017] Many of these transcriptional changes were spurious
novel transcripts from enhancers, thought to result from the lack of a directed connection with its
proper promoter.[Schwarzer et al., 2017]
Both studies that depleted TADs genome wide by interfering with the boundary cohesin
protein found that the loss of TADs resulted in the strengthening of the next level of
“compartment domain” organization.[Rao et al., 2017; Schwarzer et al., 2017] Each chromosome
can be subdivided into 5-10Mb alternating fragments that segregate into either the A (active) or
B (inactive) compartments, synonymous with eu- and hetero- chromatin.[Lieberman-Aiden et al.,
2009] The segregation of a fragment into A or B is surprisingly well conserved across cell types,
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with only minimal switching of individual segments between compartments associated with cell
type specific gene expression.[Dixon et al., 2015; Schmitt et al., 2016] Within either
compartment, there is limited evidence of further sub-compartments (A1/2 & B1/2/3) that are
loosely defined by the epigenetic state of the contained DNA.[Rao et al., 2014]
The role of TADs and A/B compartments are still under debate as there is only limited
direct evidence for the local regulatory potential of a TAD and the mechanism of inclusion of a
fragment into a particular compartment or sub-compartment has not yet been elucidated.
However, the fact that interactions defined by epigenetic state can supersede compartment
domain structure upon the loss of TADs, suggests that these are opposing forces constantly in
play within the nucleus. Previous studies have been limited in their ability to test the
inclusion/exclusion of individual loci in A/B compartments, the effect of the exclusion of any
individual gene, and to this point there is little evidence of further specialization (finer
organization) within these compartments.
The rod photoreceptor presents an excellent system in which to test these questions. The
rod photoreceptor is a highly specialized neuron responsible for the initial conversion of a photon
of light into an electrical signal. Rods comprise ~80% of the cells in the mouse retina, [Jeon et
al., 1998; Macosko et al., 2015] making them an accessible system for cell fate, epigenetic, and
gene expression studies. Rod birth peaks at postnatal day 0 (P0), and the cells are specified by
P14 and fully differentiated by P21.[Young, 1985] During this prolonged developmental
window, studies have defined dramatic changes to the rod epigenome, gene expression, and even
to microscopically visible genomic organization. [Aldiri et al., 2017; Hughes et al., 2017; Kim et
al., 2016; Mo et al., 2016; Solovei et al., 2009]
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Mouse rods have an inverted nuclear architecture that is characteristic of many nocturnal
mammals,[Solovei et al., 2009] and the result of the lack of Lbr and Lmna expression, normally
required to tether heterochromatin to the nuclear lamina.[Hughes et al., 2017; Solovei et al.,
2013] This organization is perturbed in many models of photoreceptor disease. Several models
never assume the proper organization,[Corbo & Cepko, 2005; Hennig et al., 2013; Tran et al.,
2014] while others show misorganization that manifests with disease progression.[Helmlinger et
al., 2006] It is currently unknown why diseased rods would show clear changes in genomic
organization, but could be related to the many gene expression changes observed in retinas of
these mouse models.[Kim et al., 2016; Roger et al., 2014; Ruzycki et al., 2015]
To function properly, rods pack a modified cilia structure called the outer segment (OS)
with Rhodopsin, the photopigment essential for capturing light.(Reviewed in [Arshavsky et al.,
2002; Kefalov, 2012]) The rod sheds a portion of this structure every day, and thus must
maintain an extraordinary high rate of expression of this transcript. (~2% of the total RNA within
the cell- [Blackshaw et al., 2001]) The Rho locus thus must be highly epigenetically active, as
evidenced by strong ATAC, histone, and cell type specific transcription factor signals.[Aldiri et
al., 2017; Corbo et al., 2010; Hao et al., 2012; Mo et al., 2016]
In this work, we use the mouse photoreceptor to explore several principles of genomic
organization. We show that Rho is located within the A compartment, and it co-localizes with
other very epigenetically active areas across the chromosome. We also thoroughly characterize a
new mouse model where we have inactivated Rho, and determine the effects on its localization
and on expression of other genes within the A compartment.
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5.4 Results
5.4.1 Rho displays strong interactions with local stretch of ‘A’ compartment
DNA
We performed Circularized Chromosome Conformation Capture (4C) on P14 retinas of
WT and Nrl-/- mice. NRL is a TF essential for rod development and gene expression, that when
removed (Nrl-/-), the cells instead develop into functionally mature S-cones.[Mears et al., 2001]
We selected a bait region just upstream of Rho in the middle of a number of known regulatory
elements and within the larger H3K27Ac marked domain (Figure 5.1a). 4C raw read counts
showed the expected strong enrichment for fragments of DNA in very close proximity to Rho
(Supplemental Figure 5.1a). Raw data suggested that compared to Nrl-/-, WT retinas show more
interaction with an actively marked and CTCF bound enhancer 30kb upstream (marked by **).
When Rho is inactive in Nrl-/- mice, there was increased interaction with a regulatory site further
upstream also bound by CTCF as well as a broad relatively inactive region downstream of Rho
(marked by * and *** respectively).
We analyzed the 4C data with a novel scoring algorithm that ranks based on the
consistency of local coverage compared to a background average (see Appendix 2 Methods
section for more details). This analysis clearly identified a strong region of interacting DNA
within 1Mb in both libraries that corresponded well with the local TAD boundaries of the closest
related tissue analyzed by HiC, the mouse cortex (Figure 5.1b).[Dixon et al., 2012] Both libraries
also displayed significant interactions with a larger local ~5Mb region of Chr6 surrounding Rho
that extended beyond the boundaries of the local TAD. We wondered whether this larger region
represented another level of genomic organization. By computing the Pearson Correlation of the
HiC data, we determined that this extended region identified by our analysis included more than
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50% of a linear stretch of DNA segregated to the A compartment (termed cis), but the
interactions abruptly stopped before the flanking B compartment DNA segments (Figure 5.1c-d
and Supplemental Figure 5.1b).
Our analysis also noted positive associations between Rho and other fragments of DNA
beyond these boundaries. These trans interacting fragments were also predominantly located
within A compartment chromatin (Figure 5.1c and Supplemental Figure 5.1b), but represented
only a small subset of the rest of A compartment DNA (Figure 5.1e). Together, A Compartment
DNA represented a significant majority of the DNA identified as interacting with Rho (Figure
5.1f).

5.4.2 Distal interactions are dependent on Rho activation
To test the effect of local epigenetic state on this genomic organization, we created two
new mouse lines that lack either ~200bp of the Rho promoter (PPR-/-) or the Rhodopsin
Enhancer Region (RER-/-) that lies 2kb upstream (Figure 5.2a). As expected, deletion of PPR
completely abrogated expression of Rho, and largely inactivated the locus as measured by
ATAC-seq (Figure 5.2). Surprisingly, even though previous data has suggested the RER is a very
strong enhancer,[Corbo et al., 2010; Nie et al., 1996] its deletion had no effect on local
epigenetic state or gene expression (Figure 5.2). Morphometric analysis showed that the PPR-/retina displays dramatic shortening of the OS as early as P14, (Supplemental Figure 5.2c) but
cells do not die until after P21,(Supplemental Figure 5.2e vs h) consistent with the previously
published Rho-/- that removed exon 2 [Humphries et al., 1997; Toda et al., 1999]. This analysis
also confirmed that loss of the RER has no effect on photoreceptor morphology (Supplemental
Figure 5.2).
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We chose four sites spanning Chromosome 6 to test and verify our 4C analysis. Regions
1 and 3 represent positive interactions as determined by 4C that lie 86 and ~9 Mb away
respectively (Figure 5.3a). Both 4C peaks included a number of genes active in photoreceptors,
but we chose to generate FISH probes using BACs that spanned the most epigenetically active.
Site 1 includes a cluster of very highly expressed miRNAs (mir182/183/96) and the lncRNA
Rncr4, the loss of which cause severe retinal defects [Krol et al., 2015] (Supplemental Figure
5.3b). Site 3 includes many regulatory elements and active genes, but we chose to focus on Ptms
which has a very strong enrichment of H3K27Ac (Supplemental Figure 5.3d). Sites 2 and 4 both
represent control fragments that were not identified by 4C analysis. Site 2 includes the Tcrb
locus that lies within a distal B compartment stretch of Chromosome 6, and is not near any
retinal active regulatory sites (Supplemental Figure 5.3c). Finally, site 4 includes the cone
photoreceptor expressed Pde6h gene. This gene is classified within the A compartment, but is
inactive in rods (Supplemental Figure 5.3e).
We performed FISH and measured the distance between pairs of probes in P14 retinal
sections of a number of mouse models. In WT and RER-/- retinas, the Rho locus is epigenetically
and functionally normal. These were compared to mutants in which Rho is inactive and not
expressed including the PPR-/- and models lacking transcription factors important in rod
differentiation and gene expression (Nrl-/- and Crx-/-).
FISH results first and foremost confirmed our novel 4C analysis (Figure 5.3b-e). We
noted strong co-localization between Rho and regions 1 (mir182) and 3 (Ptms), but not with
regions 2 (Tcrb) and 4 (Pde6h) in WT rods. This pattern was the same when analyzed in the
phenotypically normal RER-/-, but positive interactions were lost in PPR-/-, Nrl-/- and Crx-/retinas.
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We wondered whether regions 1 and 3 that showed strong interactions with Rho in WT
and RER-/- rods would also show interactions independently with each other. Region 1 displayed
a higher rate of association with region 3 than with inactive region 2, even though 2 is much
closer on the linear genome. Importantly, this interaction was unaffected in PPR-/- or either TF
mutant (Figure 5.3f-g). Together, these data support our novel 4C data analysis, and suggest that
the long-range interactions of Rho are dependent upon its activity or chromatin state, but that
Rho is not responsible for ‘recruiting’ or establishing the state of other genes.

5.4.3 Distal interactions enriched for highly active chromatin
To better understand the nature of the regions identified as interacting with Rho, we
analyzed the ChromHMM state within P14 retina.[Aldiri et al., 2017] As expected, the cortex
defined A Compartment was enriched for active chromatin and facultative heterochromatin. The
B compartment was specifically enriched for Class 9 (empty) which likely reflects the
constitutively repressed nature of such DNA (Figure 5.4a). This stark distinction suggests that
mouse cortex and rod photoreceptors have a very similar compartmental organization even
though their nuclei are organized very differently at the microscopic scale.
We also compared the regions defined by 4C data as interacting with Rho. These regions
showed even stronger enrichment for active HMM states (Figure 5.4a). Further subdivision of
these interactions as cis or trans displayed a stronger enrichment for highly active promoter and
enhancer chromatin within trans loci (Supplemental Figure 5.4a).
We chose several aspects of this data to explore further. As trans interacting regions
displayed stronger enrichment for the most active HMM states, we wondered whether a new
class of very active regions of the genome would be enriched within the interacting sites. These
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‘Super Enhancers’ (SEs) [Hnisz et al., 2013] were indeed highly enriched within trans contacted
regions (Figure 5.4b). In fact, Rho, Ptms, and mir182/183/96 are all specifically contained within
SEs. We also found significant enrichment at both cis and trans interacting regions for binding of
the photoreceptor master TF CRX and regions termed insulators (CTCF bound), but no
enrichment for repressed chromatin (Figure 5.4c-e). We wondered whether there was any
specificity for Dependent or Independent CRX sites (see Chapter 4 of this dissertation). Trans
interacting fragments showed very significant enrichment for CRX Group A (promoter
proximal) Dependent and Independent sites, but interestingly only Independent Group C (active
enhancer) sites (Supplemental Figure 5.3b-e). Together, these comparisons suggest that Rho
interacts with regions with dense CRX and CTCF binding sites and fragments that are also
highly epigenetically active.

5.4.4 Inactivation of Rho affects expression of other genes
As Rho is the most transcriptionally active gene in the rod photoreceptor, we wondered
what effect its inactivation would have on other genes. RNA-seq data profiling P14 WT and
PPR-/- retinas showed very similar gene expression between the two models, with few genes
other than Rho affected more than 2-fold (Figure 5.5a, Rho marked in red). We compared the
expression of annotated transcripts identified as interacting with Rho with all transcripts on
Chromosome 6 and found a modest but significant increase in gene expression. We binned the
genes into those within the cis A Compartment vs trans interactions, and found that this signal
largely originated from genes within the cis Compartment (Figure 5.5b). While the A
Compartment as a whole showed no significant difference from the B Compartment (Figure
5.5c), we further binned this data to the 11 linear segments of the A Compartment (A1-A11).
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Contacted genes within A2 and A5 showed significant changes from other genes within that
segment as well as the chromosome on a whole, but the number of genes within each was very
small (Supplemental Figure 5.5).
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5.5 Discussion
5.5.1 General principles of genomic organization
By analyzing the organization of the highly active Rho gene within the rod photoreceptor
nucleus we have uncovered several novel insights into genomic organization. First, although the
rod nucleus is inverted and microscopically differently from virtually every other cell type in the
body, it’s genome still organized at the molecular scale into a very similar TAD and A/B
Compartment structures. This is both surprising and reassuring as even though it varies so
dramatically, the forces working to maintain these structures are still in play and likely
important.
We have shown through comparison of the interactions of Rho with other active regions
of the genome in WT and mutant retinas, that this organization depends on the activity of the Rho
locus. Even though we predict in the PPR-/- retina that CRX and NRL could still bind enhancer
elements and other nearby regulatory sites, the activity of the locus is necessary for the colocalization. We showed the clear loss of this activity by ATAC-seq, but future ChIP
experiments for H3K27Ac would be necessary to prove that the broad ‘Super Enhancer’ domain
is in fact disrupted.
The discovery that the loss of the RER had no effect on Rho expression was very
surprising. This enhancer has been studied extensively previously and it has proven to be very
active at increasing transcription both in vitro and in vivo.[Corbo et al., 2010; Nie et al., 1996]
However, as browser shots display, (Supplemental Figure 5.1 and Figure 5.1) there are many
other regulatory elements that may compensate. Future work will be necessary to test the role of
these elements individually and in combination (see preliminary results in Appendix 1).
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5.5.2 Rho interacts with other active regions of its chromosome
By analyzing the nature of the regions of Chr6 identified as interacting with Rho in trans,
we determined that Rho is in contact with regions of DNA that are also very active. As depicted
in the model (Figure 5.6a), these regions are highly enriched for Super Enhancers, CTCF binding
sites, and regulatory elements bound by photoreceptor master TF CRX. This analysis of the 4C
data used a relatively broad window to score, further analyses comparing smaller windows to
determine if more discrete signals are more relevant or selective for these important genomic
regulatory elements.

5.5.3 Promoters do not act independently
Finally, by comparing the transcriptome of the PPR-/- mutant with WT litter mate
controls, we have determined that the loss of such a strong promoter as that of Rho can affect the
expression of other genes. These effects were extremely modest, but the significant increase in
expression of genes within the local A compartment suggests that the machinery that would have
been active at the Rho promoter was instead available to be used at other promoters in proximity
to Rho (Figure 5.6b). This finding is not surprising, as past experiments have previously shown
the association of certain active genes with nuclear speckles.[Brown et al., 2008; Khanna et al.,
2014; Lamond & Spector, 2003]
Together, our data supports the model put forward in Figure 5.6 where genes, like Rho,
are within physical proximity with other regions of the chromosome that are most similar
epigenetically. Especially on a local scale, the activity of a promoter is actually in constant
balance with every other promoter. When a strong promoter such as Rho is removed, the
machinery can be mis-used by others. Future work will be necessary to test this in other cell
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types that display such strong expression of individual genes and to determine any functional
consequences of these small changes to gene expression.
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Figure 5.1: Rho displays strong interactions with local DNA in both WT and Nrl-/- retinas
(a) Browser tracks display relevant epigenetic marks in the P14 WT retina and the fragment of
DNA used at the 4C bait (red). Raw (gray) and analyzed (blue and purple) 4C data display strong
association of Rho with local TAD structure as defined in cortex (bracketed in matrix in black)
(b), and with larger A compartment DNA when data is analyzed as Pearson Correlation matrix
(c) (area enlarged in Supplemental Figure 5.1b highlighted in orange). Proportion of cis (d) and
trans (e) linear segments of A Compartment that are identified as interacting with Rho. (f)
Proportion of interacting regions within A compartment compared to permutation of fragments
(see Appendix 2 Methods) (**** p<0.0001; Fisher’s Exact Test).
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Figure 5.2: Disruption of the Rho promoter affects local epigenetic landscape
(a) ATAC-seq of P14 retinas displays epigenetic accessibility changes in mutants. Red marks
deleted sequences in the RER-/- and PPR-/- strains. (b) ddPCR analysis of Rho expression (Actb
as stable reference) in P14 retinas. (**** p<0.0001; ANOVA with Tukey’s multiple comparison
test)
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Figure 5.3: FISH confirms Rho interactions with distal fragments of its chromosome
(a) Browser track displays raw and scored 4C data from WT and Nrl-/- retinas for all of
Chromosome 6. A/B Compartments are labelled by analysis of cortex HiC data (blue and yellow
respectively). Regions selected for further analysis are marked ‘1-4’ above track. (b-g) Analysis
of FISH data quantified as the proportion of probe-pairs co-localized (centers of mass within
0.5um). Representative images of WT (b’-g’) and PPR-/- (b’’-g’’) are displayed below
associated data. (mean + SEM, **p<0.01, **** p<0.001, **** p<0.0001; ANOVA with Tukey’s
multiple comparison test)
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Figure 5.4: Rho trans interactions are enriched at active segments of the genome
(a) Heatmap displays relative enrichment of P14 retina ChromHMM state [Aldiri et al., 2017] in
all of Chromosome 6 compared to Compartments A/B and those regions identified by 4C as
interacting with Rho. (b-e) Bargraphs show quantification of the proportion of Super Enhancers,
CRX binding sites, CTCF binding sites (ChromHMM state 11), and repressed chromatin
(ChromHMM state 10) covered by cis and trans 4C positive regions. Expected values represent
permutation of the marks within that cis or trans genomic region (see Appendix 2 Methods).
(*p<0.05, *** p<0.001, **** p<0.0001; Fisher’s Exact Test)
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Figure 5.5: Loss of Rho expression affects other genes that interact with Rho
(a) Scatterplot displays very consistent expression of all genes except Rho (highlighted in red) in
WT and PPR-/- retinas at P14 as measured by RNA-seq. Red lines denote 2-fold change.
Analysis of fold-change of genes (PPR-/- vs WT) that interact with Rho by 4C (b) and all genes
within Chromosome 6 A and B Compartments (c). (Wilcoxon Rank Sum test)
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Figure 5.6: Model of Rho genomic interactions and effects of loss
Model describes local interactions of Rho in WT retina that are lost when Rho is inactivated and
the competition between these genes for transcription and activity associated proteins.
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Supplemental Figure 5.1: 4C detects interactions of Rho within its TAD and local region of
A compartment
(a) Browser tracks display relevant epigenetic marks in the P14 WT retina and the raw 4C data
from WT and Nrl-/- retina. (b) Raw and scored 4C data from WT and Nrl-/- retina with A/B
compartment designation and Pearson Correlation matrix of cortex HiC.
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Supplemental Figure 5.2: Morphometric analysis of PPR-/- and RER-/- retinas
Measurement of thickness of indicated layers at P14 (a-c), P21 (d-f), and P200 (g-i) in WT, RER/-, PPR-/-, and PPR+/- retinas. (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.001, ****
p<0.0001; 2-Way Anova with Tukey’s Multiple Comparisons Test).
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Supplemental Figure 5.3: BAC selection for FISH analysis
Browser shots display relevant epigenetic data and raw and scored 4C data surrounding Rho (a)
and regions 1-4 (b-e) selected for FISH experiments. Location of BAC is indicated by red /
orange bar above gene track.
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Supplemental Figure 5.4: Trans interacting regions show very strong enrichment for active
epigenetic state
(a) Heatmap displays relative enrichment of P14 retina ChromHMM state [Aldiri et al., 2017] in
all of Chromosome 6 compared to Compartments A/B and cis and trans regions identified by 4C
as interacting with Rho. (b-e) Bargraphs show quantification of the proportion of types of CRX
sites (see Chapter 4 of this dissertation) covered by cis and trans interactions. Expected values
represent permutation of the marks within that cis or trans genomic region (see Appendix 2
Methods). (*** p<0.001, **** p<0.0001; Fisher’s Exact Test)
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Supplemental Figure 5.5: A Compartment segments show differential effects upon loss of
Rho activity
(a) Browser track displaying the locations of the 11 linear segments of Chromosome 6 that are
designated as A compartment DNA (blue vs yellow compartment track). (b) Plot displays the
Fold Change (log2) between WT and PPR-/- retina of individual genes and the median of 4C+
genes (blue) and those not contacted (green) located within each of the segments. Each 4C+ set
is also compared to the changes in expression of all Chromosome 6 genes. (black dots represent
individual genes; blue, green and gray bars represent median; * p< 0.05, ** p<0.01; Wilcoxon
Rank Sum Test)
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Chapter 6
Conclusions and Future Directions
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In this dissertation I have thoroughly investigated and demonstrated novel insights into
the following: The disease inheritance and mechanism of a new model of CRX-associated
disease (Chapter 2), the principles of gene mis-regulation across several classes of CRXassociated retinal diseases (Chapter 3), the role of CRX in establishing the epigenome of a
mature photoreceptor and its specific function at individual regulatory elements (Chapter 4), and
the organization of the genome within the rod photoreceptor nucleus and the regulating
principles of this structure (Chapter 5).

6.1 A cohesive understanding of CRX related diseases
In Chapters 2 and 3, I expanded our knowledge of the diversity of and shared mechanism
between CRX disease models.[Ruzycki et al., 2017, 2015] Mutations to CRX result in a broad
range of phenotypic severity in human patients, the diversity of which has been carefully
modelled and characterized in several knock-in or naturally occurring mutant mice.[Roger et al.,
2014; Tran et al., 2014] By analyzing and comparing the transcriptomes of several Crx mutant
mouse models, I determined that the severity of the phenotype directly corresponds with the
effects on transcription of a core set of rod photoreceptor genes. The classification of the L253X
mutant as a dominant Class III mutant shed new light on this phenotypic continuum, and further
supports the understanding that very small changes to the transcriptome can have clinically
relevant effects on photoreceptor development and maintenance.
This research serves as the basis for several new lines of investigation. First, the
classification of L253X as a Class III mutant expands our understanding of dominant CRX
disease. Class III mutants are categorized by a premature termination codon that causes
hyperstability of the mutant transcript. We discovered that the late L253X mutation does cause an
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increase in transcript stability, but to a lesser degree than that observed in the more severe
E168d2 model. The only difference between these mutant transcripts is the length of the apparent
UTR, suggesting that distinct elements additively contribute to hyperstability. High throughput
analysis of deletion libraries could uncover the mechanism of this hyperstability. Experiments
testing the effects of variants of the Crx UTR on the stability of a transcript should elucidate the
RNA encoded stabilizing elements or the structural form of the folded RNA structure that makes
this RNA resistant to degradation.
Second, this data suggests that even though patients may have very different mutations
and phenotypes, a potential therapeutic ‘target’ or strategy can be similar for all CRX related
disease. Gene therapy now offers a viable option to deliver a copy of normal CRX to mutant
photoreceptors in vivo. Our findings demonstrate that very small perturbations to the target gene
set can have dramatic effects on phenotype which suggests that even inefficient gene therapy
treatments could benefit Class I and less dramatic Class III mutants like the L253X model. Future
efforts to treat severe Class III mutations may require a combined augmentation based genetherapy with concurrent knockdown of the hyperstable mutant transcript.

6.2 A comprehensive genomic map of CRX regulatory
activity
Previous efforts to understand the in vivo molecular mechanism of CRX have focused
primarily on the transcriptional changes in mutant animals. Studies have shown that genes that
lose expression are strongly enriched for those that are near CRX bound regulatory elements.
However, no study had asked the reciprocal question and discovered that there are actually more
CRX bound regulatory elements near genes that show no expression changes. In Chapter 4, I
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discovered that CRX binds within a variety of chromatin environments, and is only responsible
for the activity of a small subset (~1/3) of these sites. These ‘CRX Dependent’ sites represent
those that are near genes that lose expression in the Crx mutant retinas. By comparing these with
the ‘CRX Independent’ sites that show no change in activity upon the loss of CRX, I discovered
several key factors including developmental activation, conservation, and motif enrichment that
distinguish a CRX Dependent vs Independent site.
These findings influence how we understand the global role of a transcription factor (TF).
In this case, we are studying CRX, but the fact that a TF does not necessarily have a functionally
relevant role at every ChIP-seq defined binding site is important for the study of all TFs
regardless of the cell type. The work presented here shows that, especially for developmentally
important TFs, ATAC-seq is an important and useful tool to elucidate this functional role.
ATAC-seq is relatively inexpensive, highly reproducible, and the data corresponded well with
downstream read-outs of activation state such as histone ChIP-seq data. Future experiments
should be designed to understand the effects of other retinal TF mutant models. In particular, a
thorough combined analysis with data from Nrl-/-, Nr2e3rd7/rd7, among others would allow for a
better understanding of the relationship between these key factors and could explain the shared
or unique activity of each at the many co-bound regulatory sites. Experiments that profile at
higher developmental resolution (daily from P3-P10) may determine a finer resolution to the
temporal activation state of CRX Dependent vs Independent sites than that described in my
work. This high-resolution approach may also be mandatory to understand the role of NRL as
Nrl-/- results in a different transcriptional program to activate in the absence of this positive rod
signals prior to P14.
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The TF network of the rod photoreceptor that includes CRX, NRL, and NR2E3 is largely
based on developmental and cell fate decision analyses. The findings presented in Chapter 4
show that CRX is required developmentally to activate certain sites, but raise the question
whether CRX is also required to maintain that activity in the mature photoreceptor. By
generating a conditional Crx allele and utilizing a tamoxifen responsive Cre line, future
experiments could allow the rod to develop normally but deplete CRX only after epigenetic and
functional maturity. A time course of ATAC-seq over the subsequent weeks would define the
role of CRX in maintaining a mature epigenome. A similar experiment was performed testing the
effect of adult loss of Nrl. Authors determined that while expression of many genes was lost,
DNA methylation remained unchanged.[Montana et al., 2012] This result suggests that the
epigenome was left unperturbed, perhaps due to the sustained expression of CRX. Our
conditional deletion of Crx will test this question and determine whether NRL and/or NR2E3 can
compensate and continue to promote gene expression alone upon loss of CRX.
Finally, these data highlight a core set of CRX regulatory sites. We predict that the
mutation of these sites would have unique consequences on rod photoreceptor development but
largely spare other neuronal or unrelated tissues. We predict that this finding is directly relevant
to the understanding of non-coding variants in human disease. As more families with retinal
specific disorders undergo whole genome sequencing, we propose that these sites represent a list
of high priority sites to analyze for variants, especially within the CRX homeodomain motif.
Additional experiments could investigate this hypothesis by employing a CRISPR screening
technique in mice. By constructing a dual guide RNA library to remove the regulatory elements,
mass electroporation of this library into the retina of a Rho-GFP mouse would test for the
functional relevance of each regulatory site in the development of a mature rod photoreceptor (as
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marked by GFP expression). This experiment could further define the most relevant binding sites
that globally affect photoreceptor development and maintenance.

6.3 The rod photoreceptor as a model for genomic
organization
Previous work in the retina had thoroughly described the unique inverted nuclear
organization of the mouse rod photoreceptor nucleus.[Solovei et al., 2009, 2013] Meanwhile,
studies have made tremendous strides in the past several years to understand the organization of
DNA within the nucleus primarily using cell culture systems. In Chapter 5, I described ongoing
work where I use the rod photoreceptor as a model to understand organizing principles of the
genome in vivo. My data suggests a complex relationship between expressed genes and has
uncovered basic principles governing the inclusion of genomic regions within a highly active
sub-compartment of the nucleus.
This study suggests a number of future experiments to further understand genomic
organization in the rod photoreceptor. First, although the analysis presented here suggested the
relevance of HiC data from a related neuronal tissue (cortex), such a whole genome ‘all vs all’
approach comparing rods and cones (WT vs Nrl-/-) would be useful. This data could highlight
key differences between the two cell types and display the general nature of compartmental
organization upon inversion of the rod nucleus. Future experiments could attempt to ‘recover’ a
conventional organization by expressing LBR or LMNA/C under a rod photoreceptor specific
promoter. Full morphological and functional characterization would determine whether the
inversion of the nucleus is required for proper gene expression, while molecular assessment by

201

4C, HiC or FISH would report any effects on TAD/Compartmental organization or
establishment.
Our 4C and FISH data suggested a strong association of Rho with other active regions of
the chromosome that were lost when Rho was inactivated (in the PPR-/- retina). However, our
data that assessed the relative position of Rho and other genes did not have the resolution to
determine what interactions Rho gained. Future 4C or HiC experiments comparing PPR-/- and
WT photoreceptors would first ensure that the rest of Chromosome 6 maintains the same
conformation, and determine whether Rho has been relegated to the B compartment or just out of
a highly active A sub-compartment. Our data only showed a strong correlation between
chromatin state and association with Rho, but did not test any active mechanism for this
organization. Previous efforts to perform dual IHC/FISH experiments failed in retinal tissue
sections. However, new FISH variations have not yet been tested. These experiments could be
useful to determine how close Rho is to the nuclear lamina, or its proximity to nuclear speckles
or densities of other active chromatin associated proteins in WT vs PPR-/- cells.
Our data suggested that, when Rho was inactivated, genes within close proximity showed
excess transcriptional activation. This is evidence that local genes compete for transcriptional
machinery. Rho is a relatively unique gene in that it is so highly expressed relative to all other
transcripts in the cell. However, epigenetically it looks quite similar to other highly active
chromatin regions (super enhancers in particular). Future experiments could test whether similar
effects are observed when other highly expressed genes or ‘super enhancer’ regions are
inactivated in rods or even in other cell types.
Finally, on a ‘local’ chromatin scale, this study has challenged the conventional
understanding of Rho expression regulation and the function of upstream enhancers. We
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generated the RER-/- mutant mouse and discovered that the RER has very little if any
contribution to bulk Rho expression. Gene expression was only assessed at P14, so additional
experiments will be necessary to test whether the RER is necessary for proper expression earlier
in development or in adult photoreceptors. Alternatively, the more distal CBR1 could be
compensating for the loss of the RER. Ongoing experiments will test the combined and unique
activities of the CRB1 and RER regulatory elements (see preliminary data in Appendix 1).

6.4 Conclusions
The work presented in this dissertation has investigated the mechanisms that establish
and the importance of the rod photoreceptor epigenome. My results have specific implications
for the understanding of retinal development and disease pathogenesis as well as broadly
applicable principles important for the understanding of gene regulation and genomic
organization. In the retina, I have elucidated the role of the TF CRX, implicated in a number of
severe blinding disorders. These experiments provide a better understanding of the disease
mechanisms of distinct classes of CRX mutations and identify specific non-coding elements in
the genome that are likely critical for proper CRX directed photoreceptor gene expression. More
broadly, this work suggests that all TFs involved in cellular development likely have complex
and diverse roles, and their binding at a particular site cannot be interpreted as important or
indicative of activity. Finally, my work presented here regarding genomic organization offers
further support that we cannot think of each gene as being controlled independently; expression
is influenced by that of nearby genes, and this organization within the nucleus is highly regulated
and likely a fundamental and important part of cellular development and homeostasis.
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Appendix 1
The role of the Rhodopsin enhancers
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Early efforts to understand the very high rod photoreceptor specific expression of
Rhodopsin focused on the discovery and classification of the promoter and nearby
enhancers.[Chen & Zack, 1996; Corbo et al., 2010; Nie et al., 1996] These experiments
discovered three highly conserved ~200bp elements termed the proximal promoter region (PPR),
Rhodopsin enhancer region (RER; 2kb upstream of PPR), and the CRX bound region 1 (CBR1;
4kb upstream of PPR). All elements drove strong retinal expression by plasmid reporter assays,
and the PPR and RER showed similar specificity in transgenic animals.[Jimeno et al., 2006; Nie
et al., 1996] All elements have since shown strong in vivo binding of both important transcription
factors CRX and NRL (Figure A1.1).[Corbo et al., 2010; Hao et al., 2012]
In Chapter 5 of this dissertation, I presented an experiment where we used CRISPR-Cas9
to create germline knockout mouse lines lacking either the PPR or the RER (PPR-/- and RER-/respectively). We analyzed both the epigenome and transcriptome of these mice by ATAC-seq
and ddPCR and were surprised to find that there was no detectable defect in the RER-/- retina.
While PPR-/- mice displayed dramatic loss of Rho expression, thinning of the outer nuclear layer
(ONL), and loss of local ATAC-seq signal at nearby regulatory elements, RER-/- mice showed
no detectable differences from WT (Chapter 5: Figure 5.2 and Supplemental Figure 5.2).
We noticed that the PPR-/- retina still displayed strong ATAC-seq sensitivity at the
CBR1, but this signal was largely lost at the RER (Figure A1.1). This data suggests that, at P14,
the activity of the RER is dependent upon promoter activation, but the state of the CBR1 is
independent. Interestingly, in the RER-/-, the CBR1 and PPR were both fully activated,
(consistent with normal Rho expression) suggesting that the RER alone was not essential for the
activation of the CBR1 or PPR.
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Together, this data suggest that the CBR1 may compensate for the loss of the RER. To
test this question, we again used CRISPR-Cas9 to generate two new mouse lines; the first lacks
only the CBR1 (CBR1-/-) and the second lacks both the RER and the CBR1 (RER-/-;CBR1-/-)
(Figure A1.1).
Experiments are ongoing to determine the epigenomic consequences of the loss of the
CBR1 alone or in conjunction with the RER. However, initial results do strongly support a role of
the CBR1 in Rhodopsin gene expression regulation. To test Rhodopsin expression, I collected
retinas at P14 from all mouse lines and performed ddPCR. Results show that the loss of the
CBR1 alone leads to a ~40% reduction in Rho expression (Figure A1.2). Surprisingly the
combined loss in the RER-/-;CBR1-/- retina showed no additional deficit in expression.
In conclusion, these results suggest that the CBR1 is critical for proper Rho expression,
but leave the role of the RER unanswered. Ongoing experiments will test the epigenomic
landscape of CBR1-/- and RER-/-;CBR1-/- retinas at P14, and expression of Rhodopsin at earlier
and later time points in development.
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Figure A1.1: Epigenetic landscape of Rhodopsin
Browser tracks display relevant epigenomic data showing temporal activation of PPR, RER, and
CBR1 (by DNase1) and steady state mature profiles of other data. ATAC-seq tracks show
changes in ATAC-seq sensitivity as a result of perturbations to Rho regulatory elements. Areas
deleted in various lines are marked with red box.
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Figure A1.2: Disruption of CBR1 affects Rho expression
ddPCR analysis of Rho expression (Actb as control) in designated mouse lines at P14. All
samples are littermate controls (n=3; mean + SEM; ; *** p<0.01, *** p<0.001;One-way
ANOVA).
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Chapter 2 Methods
Nomenclature for the TVRM65 mutation
There are several annotated transcripts for the murine Crx locus. The previously
published amino acid change in the TVRM65 mouse was based on isoform 2 (NM001113330.1)
that encodes a CRX protein with 323 amino acids.[Chau et al., 2000; Won et al., 2011] However,
the major transcript in the retina is isoform 1 (NM_007770.4), which encodes a CRX protein
homologous to human CRX, with 299 amino acids. Thus, here we refer to the TVRM65 mutation
as p.L253X, based on isoform 1 numbering.

Mice
Crx-L253X (TVRM65) mice[Won et al., 2011] were obtained from Jackson Laboratory
(Bar Harbor, ME, MGI ID: 4867395). Mice were mated and maintained with C57BL/6J (JAX
Stock number 000664), and confirmed free of rd1 and rd8 mutations by PCR genotyping. Crx
null mice (Crx-/-) were provided by Dr. Constance Cepko, Harvard University (Boston,
MA)[Furukawa et al., 1999] and back-crossed onto C57BL/6J for more than 10 generations. All
mice were housed in a barrier facility in the Division of Comparative Medicine of Washington
University School of Medicine. All procedures involving the use of mice were approved by
Washington University’s Animal Care and Use Committee and followed ARVO guidelines for
the Use of Animals in Ophthalmic and Vision Research.

PCR Genotyping, RNA Purification and Reverse Transcription, and qRTPCR
Genotyping, RNA purification and reverse transcription, and qRT-PCR were performed
as previously described.[Tran et al., 2014a] Primer sets for genotyping and RT-PCR are listed in
Supplemental Table 1. For qRT-PCR, all primers were tested for proper amplification efficiency
prior to use. Relative gene expression was normalized to the retinal constitutively expressed
genes Ubb, Tuba1B, and Gapdh. Data for 3 biological replicates were then analyzed using the
Delta Cq method in QBase software (Biogazelle, Ghent, Belgium). The results are presented by
the heatmap.2 function of the R gplots package (v3.0.1).
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Droplet digital PCR (ddPCR)
Confirmatory genotyping and allelic expression data were generated using the droplet
digital PCR system (BioRad, Hercules, CA). A 20ul ddPCR reaction mixture containing
custom-designed normal and mutant primer/probe sets (see Supplemental Table 2) was prepared
according to manufacturer’s directions, droplets generated, and nano-reactions cycled on a
C1000 Touch Thermal Cycler (BioRad). The average number of allelic transcripts per biological
replicate (n=3) was then determined with the QX 200 Droplet Reader and QuantaSoft Analysis
Pro (BioRad).

Transient Transfection Luciferase Reporter Assays
HEK293T cells (ATCC CRL-11286) were cultured in Dulbecco’s Modified Eagle
Medium with 10% fetal bovine serum and Penicillin/Streptomycin. Cells were transfected using
conventional CaCl and Boric Acid Buffered Saline Method in 6-well plates as previously
described.[Chen et al., 2002; Tran et al., 2014a] Experimental plasmids and transfection
amounts included BR130-luc [2 ug] (a Rho promoter-luciferase reporter)[Chen et al., 2002],
pRL-CMV [1 ng] (transfection normalization control) and protein expression vectors PED-NRL
[100 ng], pcDNA3.1-hCrx, Crx1-254, and Crx-E168d2. Cells were harvested 48 hours post
transfection and assays performed using the Dual-Luciferase Reporter Assay System (Promega,
Madison, WI).

Electroretinogram (ERG) and Statistical Analyses
ERGs and statistical analyses were performed as previously described in [Tran et al.,
2014a]. Briefly, tests were performed on a UTAS-E3000 Visual Electrodiagnostic System
running EM for Windows (LKC Technologies, Inc., Gaithersburg, MD) while mouse body
temperature was maintained at 37±0.5°C with a heating pad controlled by a rectal temperature
probe (FHC Inc., Bowdoin, ME). Pupils were dilated with 1.0% atropine sulfate (Bausch &
Lomb, Tampa, FL) and dilation and corneal hydration maintained during testing by positioning
the platinum wire loop recording electrodes in a mixture of atropine and 1.25% hydroxypropyl
methylcellulose (GONAK; Akorn Inc., Buffalo Grove, IL). Mice were tested without knowledge
of genotype. Bilateral flash ERG responses were obtained; the set of recordings giving the higher
amplitudes was correlated with genotype info for statistical analyses including two-way ANOVA
and post-hoc multiple comparison tests were performed using Prism (GraphPad, La Jolla, CA).
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Quantitative Western blot analysis
Western Blots were performed as previously described.[Tran et al., 2014a] Experiments
were performed using three biological replicates (15ug total protein extract from homogenates of
two retinas). Membranes were probed with mouse monoclonal anti-CRX antibody M02
(Abnova, 1:200) and anti-GAPDH antibody (Sigma G9545, 1:10,000), visualized with donkey
anti-rabbit 680nm and donkey anti-mouse 800nm IRDyes (LI-COR, Lincoln, NE) (1:10,000),
then imaged and quantified using the Odyssey Infrared Imager and ImageStudio 6 software (LICOR).

Histology, Morphometry, Immunohistochemistry, and Statistical Analyses
Histology, morphometry, immunohistochemistry and statistical analyses were performed
as previously described.[Tran et al., 2014a] 4um sagittal sections of paraffin-embedded eyecups,
cut through the optic nerve head, were either stained with hematoxylin and eosin (H&E) or
prepared for immunofluorescence staining. Slides containing sections were incubated overnight
with primary antibody at 4oC (1:400 anti-Rhodopsin monoclonal RetP1, Sigma), washed, and
incubated with secondary antibody (1:500 Alexa 568-goat-anti-mouse, Invitrogen) for 2 hours at
room temperature. Coverslips were mounted with Vectashield Hard Set mounting medium with
DAPI (Vector Labs, Burlingame, CA). All imaging was performed using a Leica DM5500B
microscope and Leica DFC365FX camera (Leica Microsystems, Buffalo Grove, IL).
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Chapter 3 Methods
Mice
Mice were housed in a barrier facility operated and maintained by the Division of
Comparative Medicine of Washington University School of Medicine. All mice used in this
study were backcrossed to C57BL6/J mice obtained from Jackson Laboratories (Bar Harbor, ME,
Stock number 000664) for at least 10 generations. Each line was genotyped for common rd1,
rd8, and Rpe65 variants that affect retinal structure and function; all lines were negative for rd1
and rd8 and contain the C57BL/6J RPE65450M isoform. The Crx mutant lines E168d2,
E168d2neo and R90W and their genotyping procedures were published previously [Tran et al.,
2014b].
All procedures involving mice were approved by the Animal Studies Committee of
Washington University in St. Louis (IACUC 20120246, expiration date 01/18/2016).
Experiments were carried out in strict accordance with recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health (Bethesda, MD), the
Washington University Policy on the Use of Animals in Research; and the Guidelines for the
Use of Animals in Visual Research of the Association for Research in Ophthalmology and
Visual Science (http://www.arvo.org/animals/).

RNA collection & library preparation
For each genotype and time point: three biological replicates were analyzed, and each
replicate consists of four retinas from one male and one female mouse. P21 WT samples
represent a randomized sampling of WT littermates of Crx mutants. Retinas were immediately
processed for RNA using the PerfectPure RNA tissue kit (5 Prime). The quantity and quality of
the RNA was assayed using a Bioanalyzer (Agilent). Samples with a minimum RIN score of 8.0
were then selected for library construction. Library construction was performed by the Genome
Technology Access Center (GTAC) (Washington University in St. Louis). mRNA was isolated
by poly-A selection using Oligo-dT beads (mRNA Direct Kit, Ambion). mRNA was then
fragmented by incubation at 94C for 2.5min in an alkaline buffer (40mM Tris Acetate pH 8.2,
100mM Potassium Acetate, 30mM Magnesium Acetate) and reverse transcribed using Super
Script III enzyme (Invitrogen) and random hexamers to yield double stranded cDNA. The
cDNA was blunt ended using Klenow DNA polymerase, followed by addition of an A base and
ligation of Illumina sequencing adapters to the 3’ ends. All enzymes including DNA
polymerase, Klenow DNA polymerase, Klenow exo-, RnaseH, T4 DNA polymerase, and T4
Polynucleotide Kinase were purchased from New England BioLabs (NEB). Ligated fragments
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were amplified for 12 cycles using primers incorporating the unique index tags before sequenced
on the Illumina Hi-Seq 2000 using single reads extending 42 bases.

RNA sequencing data analysis
1x42bp reads were aligned to the mouse genome (version mm9) with the sequence
aligner TopHat2 (Versison v2.0.5) using the following parameters: -a 5 -m 1 -i 10 -I 500000 -r
100 –p 4 --microexon-search –no-coverage-search -x 20 --segment-length 25. Dependencies
included Bowtie (v0.12.8) and Samtools (v0.1.18). Bedgraph files were generated using
BEDTools (v2.23.0) and visualized using IGV (Broad Institute). The HTSeq package (Version
0.6.1p1) was used to assign aligned reads to the gene annotation reference track (UCSC Genes
Track, UCSC Table Browser, NCBI37/mm9, accessed July 16, 2014). This generated a raw read
count per gene which was used in EdgeR [Nikolayeva & Robinson, 2014] for detecting
differentially expressed genes. For each of the genotype comparisons, genes that did not pass the
filter criteria of counts per million (CPM) ≥5 in all replicates of at least one comparison group
were removed prior to the analysis. Filtered count data was normalized by the EdgeR default
normalization method, TMM, and differential expression analysis for each of the comparison
groups were performed by the exact test. P-values were subjected to Bonferroni and Hochberg
multiple testing correction to include false discovery rate (FDR). Downstream analysis was
performed using custom Perl and R scripts. Principal Component Analysis was performed using
the princomp function in the stats R package (v3.1.1). Gene expression heatmaps were
generated using the heatmap.2 function of the gplots R package (Version 2.16.0). As several
heatmaps have included too many genes to properly label each row, we have included a
supplemental file that lists the genes included in each heatmap in the order in which they were
presented (Table S4).
Raw RNA-seq data was also obtained from previously published work: Gene Expression
Omnibus (GEO) accession: GSE52006 [Roger et al., 2014]. This data was aligned also using
TopHat and analyzed as described above using HTSeq and EdgeR.

Epigenetic data analysis
Data was obtained from GEO under accession numbers GSE20012 [Corbo et al., 2010],
GSE38500 [Popova et al., 2012], and GSM1014198/GSM1014175/GSM1014188 [Vierstra et al.,
2014]. NRL ChIP seq [Hao et al., 2012] was downloaded from the NEI Data Share website,
accessible through the following link (http://datashare.nei.nih.gov/dataShareMain.jsp). Data
were analyzed based on mouse reference genome (NCBI37/mm9) and UCSC known gene table.
Heatmaps and line graphs depicting epigenetic data were generated using the UCSC defined TSS
for each gene and the UNIX software package HOMER (Version 4.7) [Heinz et al., 2010].
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Heatmaps were generated by importing the HOMER generated counts back into R, ordering by
adult DNase1 level at the TSS, and visualized by the heatmap.2 function in the gplots R package.

Gene Ontology Analysis
Gene ontology analysis (GO Analysis) [Ashburner et al., 2000] was performed using the
online g:Profiler tool [Reimand et al., 2011]. Terms were filtered to only include the best per
parent term.

Light damage (LD) and 13-cis-RA treatment
For light damage (LD) analysis, mutant mice and littermate controls were dark adapted
overnight. Eyes were dilated with 1% Cyclogyl and 2.5% phenylephrine hydrochloride. Mice
were then placed in darkness for 30 min before LD. LD was performed in a temperature
controlled rat cage with the top removed and lined with reflective material to provide even
illumination. Exposure was performed using white fluorescent light and the intensity was
measured using a lux meter. Light intensity was 11-13.5 KLUX in all experiments. Mice were
placed into cages containing moistened food pellets, and each animal received damaging light for
8 hrs. Mouse pupils were re-dilated and the cage position was rotated every 2 hours.
For 13-cis-RA treatments, 13-cis-retinoic acid (RA) (Isotretinoin, Accutane) (SigmaAldrich, R3255) was reconstituted in DMSO to a concentration of 0.013 mg/µl. 40 mg/kg 13cis-RA or an equal volume of DMSO vehicle control was injected into the mouse's
interperitoneal cavity 12 hrs before LD and mice were dark-adapted overnight. Mice were redosed with 40 mg/kg 13-cis-RA 30 min before LD.
Following all LD experiments, mice were returned to a 12 hr light-dark cycle under
normal ambient light conditions (~100 LUX) for 7 days. After 7 days, retinal function was
tested by electroretinography (ERG). The peak amplitude responses for rod-driven dark-adapted
a-waves, rod ON bipolar cell-driven dark-adapted b-waves and cone bipolar cell-driven lightadapted b-waves were measured for a series of increasing light intensities as described below.
Mice were then sacrificed and eyes were collected for retinal histology assessment (see below).
Images were taken in the central superior retina (~500 µm from the optic nerve (ON)), which is
the area of the retina that is most strongly affected by LD [38].

Histology, immunohistochemistry and microscopy
Histology analyses of hemotoxylin and eosin-stained (H&E) paraffin-embedded retinal
sections were performed as described previously [Tran et al., 2014b]. For ONL morphometry,
20X composites of whole retinal sagittal sections stained with H&E were analyzed using ImageJ
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software [Schneider et al., 2012]. The distance from the ON was determined by drawing a
curved line along the outer limiting membrane. The ONL thickness was measured at 100 µm,
500 µm, 1000 µm, and 1500 µm from the ON and 200 µm from the peripheral edge on both the
superior and inferior retina. Results are presented by a ‘spider graph’. The between-group
differences in ONL thickness were determined by testing overall genotype*distance interactions
(p<0.05, n≥3) of each treatment. Statistical comparison of data at each distance was performed
using two-way ANOVA for repeated measurement data, followed by a post-hoc test to adjust pvalue for multiple comparisons between each genotype and the WT control group SAS 9.3 (SAS
Institutes, Cary, NC).
Fluorescence immunohistochemistry was performed on frozen retinal sections. Eyes were
enucleated and fixed for 30 minutes in 4% paraformaldehyde (PFA) on ice. Eyes were washed
in PBS and left overnight in 30% sucrose in PBS at 4 °C. 50% volume of OCT was added and
rocked at room temperature for 1 hr. Eyes were then transferred to 100% OCT for 1 hr before
frozen in OCT on dry ice. Blocks were cut onto polylysine (Thermo Scientific) slides and stored
at -80 °C. For staining, slides were removed and allowed to dry for 30 min before 10 min 4%
PFA fixation. Slides were washed (2 x 5 min) with PBS and blocked at room temperature with
5% nonfat dry milk/2% bovine serum albumin (BSA)/10% normal goat serum (NGS) for 2 hrs.
Slides were washed (3 x 5 min) with PBS before overnight incubation with primary antibody at 4
°C. Antibodies were diluted as below in PBS with 1% BSA and 0.5% Triton X-100. Slides
were washed (3 x 5 min) in PBS. Secondary antibodies (and PNA antibody) were diluted in the
same buffer as primaries, applied to the slides, and incubated for 1 hr at RT, and washed again (3
x 5 min) with PBS before the application of coverslip.
Primary antibodies and dilutions used are as follows: rabbit anti-RXRγ (1:500, Santa
Cruz Biotechnology, sc-555), rabbit anti-CNGB3 (1:500, from Xi-Qin Ding, University of
Oklahoma), peanut agglutinin (PNA) conjugated to Rhodamine (1:500, Vector Labs). Secondary
antibodies (1:400): goat anti-rabbit or mouse IgG antibodies coupled to Alexa Fluor A488 and
Rhodamine 568 (Invitrogen). All slides were counterstained with hard-set mounting medium
with DAPI (Vectashield).
Brightfield and fluorescent imaging was performed using either an Olympus BX51
microscope and Spot RT3 Cooled Color Digital camera (Diagnostic instruments Inc.) or a Leica
DM5500B microscope and Leica DFC365FX camera (Leica Microsystems, Buffalo Grove, IL)

Electroretinography (ERG)
Mice were dark-adapted overnight and anesthetized with intraperitoneal injection of a
mixture of ketamine (80 mg/kg) and xylazine (15 mg/kg). Pupils were dilated with 1% atropine
sulfate. A passive-heating pad maintained animal’s body temperature at 37 oC. Scotopic ERG
responses were measured from both eyes using corneal platinum-ring electrodes held in place by
a drop of Gonak solution. Full-field ERGs were recorded with the UTAS-E 3000 system (LKC
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Technologies, Inc.), using Ganzfeld-derived test stimuli of calibrated white light intensity. The
amplitude of ERG a-wave was determined from the baseline to the primary negative peak of the
photoresponse. The amplitude of ERG b-wave was measured from the a-wave peak to the
maximum of the secondary positive peak. Photopic ERG recordings were performed under room
illumination (~ 25 cd·s m-2) after 5–10 min of light adaptation.
The rate of rod dark adaptation was determined from the recovery of maximal ERG awave amplitude after 30-second exposure to light bleaching of > 90% of rhodopsin (delivered by
520 nm LEDs focused at the surface of mouse eye cornea and producing ~ 2.5 x 108 photons µm2 -1
s ), using test flashes of ~ 470 cd·s m-2 at indicated times after the bleach. In these experiments,
mice were re-anesthetized subcutaneously every 30–40 min with a smaller dose of ketamine
(~50% of the initial dose). In addition, at the same times a drop of 1% atropine sulfate was added
to the eye surface to keep pupils dilated, and a 1:1 mixture of PBS and Gonak solutions was
applied to the eyes to protect them from drying and maintain electrode contacts during extended
recording sessions.

qRT-PCR
RNA used for assays included RNA used for Illumina RNAseq library preparation and
additional biological replicates. For each genotype, n≥3 biological replicates, each replicate
consisting of four retinas from one male and one female mouse, were collected. RNA isolation,
cDNA preparation, and qRT-PCR reactions were performed as previously described [21].
Briefly, retina tissue was immediately processed for RNA using the PerfectPure RNA tissue kit
(5 Prime) and quantified. cDNA was synthesized from 1 µg of RNA using the Transcriptor First
Strand cDNA Synthesis kit (Roche Applied Science). A 10 µl QRT-PCR reaction mixture
containing 1× EvaGreen with Low Rox reaction mix (BioRad), 1 µM primer mix, and diluted
cDNA was prepared and run on a BioRad CFX thermocycler in triplicate. Data was analyzed
using QBase software (Biogazelle). Relative gene expression was normalized
to Ubb and Tuba1b and fold-change from WT was determined. Kruskal-Wallis and Dunn's
Multiple Comparison tests were used to determine significant fold change differences from WT
(P<0.05). Primer sets were designed using MacVector software and synthesized by IDT DNA
technologies (Table S5).
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Chapter 4 Methods
ATAC-seq library prep and sequencing
ATAC-seq was performed as published in Buenrostro, et al.[Buenrostro et al., 2015]
Briefly, retinas were dissected from P14 WT and Crx-/- mice and washed in PBS. Tissue was
dissociated at 37C using 2% Collagenase in TESCA buffer for 13 min, and the reaction stopped
by the addition of 2X volume of DMEM + 10% FBS. DNase1 (0.5 Units) was added for the final
3 minutes to minimize clumping of cells. Cells were counted with hemocytometer, and 50,000
re-suspended in TD buffer for a 1 hour incubation with TDE1 at 37C. Remaining library prep
was performed as published. Libraries were pooled and sequenced using the Illumina 2500.

Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assay was performed as previously
described.[Tran et al., 2014b] In summary, 6 pooled P14 C57BL/6J Wild type, or Crx-/- mouse
retinas per sample were dissected and chromatin was cross-linked with 1% formaldehyde in PBS
for 10 minute at room temperature. Crosslinked cells were lysed and fragmented by sonication.
Chromatin fragments were immunoprecipitated with the Histone H3 (acetyl K27 - ab4729)
(Abcam, Cambridge, UK) and trimethyl-Histone H3 (Lys4) (Millipore, 07-473) antibodies, or
normal rabbit / mouse IgG (Santa Cruz Biotechnology, Dallas, TX) bound to Protein A beads
(Millipore, 16-125), or A/G beads (Santa Cruz Biotechnology). After extensive washing, the
immunoprecipitated chromatin was eluted, heated to 67°C to reverse the cross-links, and the
DNA purified by ethanol precipitation. Libraries were prepared using the DNA SMART ChIPSeq Kit (Clonetech, Mountain View, CA). 10ng of ChIP DNA was used as input for each
sample.

Mapping of ATAC-seq and ChIP-seq data
Libraries were de-multiplexed according to barcodes inserted in the P7 adaptor, and
mapped to mm9 using Novoalign (V3.04.06). Alignments were cleaned using Samtools (V1.3.1);
duplicate and reads mapping to mitochondrial genome were removed. All other processing for
visualization in IGV was performed using samtools and bedtools (V2.24.0). For visualization,
bedtools slop function was used to extend reads 300 bp.
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Peak Calling and Genotype Comparison
Peak calling was performed using MACS2 (V2.1.0.20140616). Peak calling was
performed on replicate samples independently. Only peaks that replicated in both samples were
kept, by comparing peak files using the bedtools intersect function. Intersecting peaks were
merged using bedtools merge function. Peaks were analyzed for number of reads within each
library using bedtools coverage, and statistical comparison for ATAC-seq data was performed
using EdgeR (V3.18.1). Histone read count for FC analysis was computed by normalizing all
libraries to RPM before subtraction of read count of appropriate input sample within same
region..

Detection of overlapping ChIP, ATAC, and ChromHMM location
All co-localization detection of genome-wide datasets was performed using the bedtools
intersect function. ChromHMM bed files were graciously provided by Dr. Issam Aldiri, St.
Jude’s Children’s Research Hospital.

Read coverage epigenetic analysis
Heatmaps and line graphs depicting epigenetic data were generated using the UNIX
software package HOMER (V4.7).[Heinz et al., 2010] Heatmaps were generated by importing
the HOMER generated counts back into R, and visualized by the heatmap.2 function in the
gplots (V3.0.1) R package.

Motif calling
Known motif analysis was performed using Transcription Factor Affinity Prediction
(TRAP) web Tools.[Manke et al., 2008] Analysis was performed on Jaspar vertebrate matrix file,
with mouse promoter background model, and multiple test correction was Benjamini-Hochberg.
Heatmap visualizes the –log(10) converted corrected p-value of each TF motif. De novo motif
analysis was performed using the HOMER findmotifsgenome tool (V4.7).

BEEML calculation of affinity
Analyses were performed as in White et al (2016).[White et al., 2016] Custom scripts to
calculate TF occupancy were graciously provided by authors.
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Nucleotide density and motif density
All analyses were centered on the CRX ChIP peak and utilized the HOMER
annotatepeaks function. Matrix outputs from de novo motif analysis were tested for motif density
using the HOMER annotatepeaks function in 20bp windows.

Gene Ontology (GO) analysis
Gene Ontology (GO) analyses were performed using the GREAT tool (Ver 3.0).[McLean
et al., 2010] Peak files used were centered on the CRX binding site, and associations were with
the settings ‘single nearest gene- no limit on distance.’ These same associations were used as the
basis of regulatory site- gene determination for RNA-seq comparisons.

RNA-seq
RNA-seq data was obtained from GSE52006. Data was analyzed as described previously
in [Ruzycki et al., 2015]. Briefly, 1x42bp reads were aligned to the mouse genome (version
mm9) with the sequence aligner TopHat2 (Versison v2.0.5) using the following parameters: -a 5
-m 1 -i 10 -I 500000 -r 100 –p 4 --microexon-search –no-coverage-search -x 20 --segmentlength 25. Dependencies included Bowtie (v0.12.8) and Samtools (v0.1.18). Bedgraph files
were generated using BEDTools (v2.23.0) and visualized using IGV (Broad Institute). The
HTSeq package (Version 0.6.1p1) was used to assign aligned reads to the gene annotation
reference track (UCSC Genes Track, UCSC Table Browser, NCBI37/mm9, accessed July 16,
2014). This generated a raw read count per gene which was used in EdgeR [Nikolayeva &
Robinson, 2014] for detecting differentially expressed genes. For each of the genotype
comparisons, genes that did not pass the filter criteria of counts per million (CPM) ≥5 in all
replicates of at least one comparison group were removed prior to the analysis. Filtered count
data was normalized by the EdgeR default normalization method, TMM, and differential
expression analysis for each of the comparison groups were performed by the exact test. P-values
were subjected to Bonferroni and Hochberg multiple testing correction to include false discovery
rate (FDR). Downstream analysis was performed using custom Perl and R scripts.

External Datasets
Other data used in this study were retrieved from the following accession locations on NCBI:
CRX ChIP-seq: GSE20012
CTCF ChIP-seq: GSE87064
DNase1: Retina P1 GSM1014188, Retina P7 GSM1014198, Retina 8wk GSM1014175;
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Liver GSM1014195, Brain GSM1014151
RNA-seq: GSE52006
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Chapter 5 Methods
4C Cell Collection
P14 retinas were dissected and dissociated at 37C using 2% Collagenase (Sigma Aldrich,
St. Louis, MO) in TESCA buffer (50mM TES ph7.4, 0.36mM CaCl2) for 15 minutes. DNase1
(0.5 U) was added for an additional 3 minutes to avoid clumping of cells. Reaction was stopped
by addition of 2X volume 37C DMEM+10% FBS and incubation for 5min at RT. Cells were
strained through a 40um filter, before fixation in 2% Formaldehyde at room temperature (RT) for
10 minutes. Reaction was stopped by addition of cold glycine to a final concentration of 0.125M
on ice. Cells were pelleted, re-suspended in PBS+1%FBS+1%EDTA, and counted using a
hemocytometer. Aliquots of cells were pelleted and stored at -80C.

4C Template Preparation
4C libraries were prepped essentially as described in [van de Werken et al., 2012]. 10^7
cells were thawed and resuspended in 500ul Cutsmart buffer (NEB, Ipswitch, MA). Cells were
permeabilized using SDS and Triton-X100 before addition of 400U NcoI-HF restriction enzyme
(NEB). Digestion was left overnight at 37C. After cutting efficiency was established, DNA was
ligated with 100U T4 DNA Ligase (NEB) for 1 hour at 37C. After ligation, cells were decrosslinked using Proteinase K (Qiagen, Hilden, Germany) and heated to 65C overnight. DNA
was recovered by phenol-chloroform extraction. The DNA was again digested by addition of
100U MspI (NEB) overnight at 37C. Reaction was cleaned by phenol-chloform precipitation,
and again ligated with 100U T4 DNA Ligase (NEB) overnight at 16C. DNA was retrieved by
ethanol precipitation and cleaned using Qiaquick PCR purification columns (Qiagen).

4C Inverse PCR
4C Inverse PCR was performed essentially as described in [van de Werken et al., 2012]
with slight modifications. To increase the specificity of the inverse PCR, a nested approach was
employed. Initial PCR was performed with the following primers: [FGCATCACAACCTGTCCCTGC, R- GTTCCCAAACAAGACACCTGC]. 200ng 4C template
was amplified using using Klentaq enzyme (DNA Polymerase Technology, St. Louis, MO) for
25 cycles divided over 8x50ul reactions. The products were cleaned using PCR purification
columns (Qiagen). Second PCR to add Illumina tails was performed using the following primers:
F-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAGTGCAATCGAGGCTCCATG,
R- CAAGCAGAAGACGGCATACGAGATGCTAAGCAAACATCTAGGAATCCCG
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Elution from first PCR were again split into 8x50ul reactions and amplified using using Klentaq
enzyme (DNA Polymerase Technology) for 10 cycles. Products were cleaned using PCR
purification columns (Qiagen). Finally, libraries were size-selected by gel electrophoresis (2001600bp) and cleaned using the QiaexII Gel Extraction Kit (Qiagen). Libraries were pooled and
sequenced (1X50bp) by the Genome Technology Access Center (GTAC) at Washington
University, St. Louis using the Illumina HiSeq 2000 (Illumina, San Diego, CA).

4C data analysis
Reads were demultiplexed and mapped to the mouse genome (mm9) using bowtie
(V1.1.1) with options (-S -v 2 -y -k 1 -m 1 -p 3 –trim5 [length of inver PCR primer sequence]).
Resultant bam files were converted to bed format by Samtools (V1.3.1) and processed to count
reads per known NcoI fragment using custom perl scripts. Raw data was then visualized using
the IGV Browser [Robinson et al., 2011]. Scoring of distant interactions was performed using
custom perl scripts. Current scoring methods focused on either binary or quantitative methods of
analyzing 4C data. We chose to integrate these two methods together as follows: A running
window test/background approach was employed to score the enrichment of our designated score
within the test window compared to the much larger background area. All data presented in this
Chapter used a 50/500 analysis of restriction enzyme fragments. This represents an enrichment
area of approximately 100kb/1Mb and was determined empirically. We tested a range of
windows and all highlighted similar areas of interaction. Smaller windows displayed more noise,
and thus for this analysis we focused on a wider window.
Score= 1/(standard deviation(read coverage of contained fragments)/(total reads
within window/number of fragments tested)) * (# positive fragments)
For each window, the score of the test window was divided by that of the background. All scores
for the chromosome were shuffled 10K times to determine FDR 0.01 threshold.

HiC data usage/programs
HiC data was visualized (observed and observed pearson) using Juicebox [Durand et al.,
2016] with data generated by Dixon et al[Dixon et al., 2012]. Compartment analysis was
performed as described previously [Dixon et al., 2015]. Briefly, observed/expected matrix at
1Mb resolution for Chromosome 6 was retrieved from Juicebox. Data was processed in R
(V3.4.1), where Pearson Correlation matrix and principal component analyses were performed
using the ‘cov’ and ‘eigen’ functions.

225

ATAC-seq library prep and sequencing
ATAC-seq was performed as published in Buenrostro, et al.[Buenrostro et al., 2015]
Briefly, retinas were dissected from P14 WT and Crx-/- mice and washed in PBS. Tissue was
dissociated at 37C using 2% Collagenase in TESCA buffer for 13 min, and the reaction stopped
by the addition of 2X volume of DMEM + 10% FBS. DNase1 (0.5 Units) was added for the final
3 minutes to minimize clumping of cells. Cells were counted with hemocytometer, and 50,000
re-suspended in TD buffer for a 1 hour incubation with TDE1 at 37C. Remaining library prep
was performed as published. Libraries were pooled and sequenced using the Illumina 2500.

RNAseq library prep mapping and genotype comparison
Retinas were dissected from P14 mice and immediately frozen on dry ice. Samples were
stored at -80C. When all samples had been collected, retinas from 2 mice (1M, 1F) were pooled
and RNA was collected using the 5Prime PerfectPure RNA Tissue Kit (Fisher Scientific).
Libraries were prepared, sequenced and data analyzed as described in Chapter 3 Methods. All
data represent comparisons between 3 WT and 4 PPR-/- biological replicate samples.

4C Interaction enrichment and RNA analyses
All overlap of 4C data with previously published datasets were performed using bedtools
(V2.24.0) intersect function. Expected values were computed by merging adjacent 4C positive
regions, and permuting these either over the whole chromosome, within only their same
compartment, or only within the cis/trans areas of the A compartment using the bedtools shuffle
function. RNAseq analysis was performed by determining the TSS of each gene, which was used
to overlap with 4C positive and AB compartment regions using bedtools intersect.
External datasets used in these experiments include the following
- CRX ChIP-seq: GSE20012
- CTCF ChIP-seq: GSE87064
- ChromHMM classifications generated in [Aldiri et al., 2017]; bed files generously
provided by the authors
- DNase1Retina 8wk: GSM1014175;
- WT P14 H3K27Ac and H3K4me3 ChIP-seq were generated and discussed within
Chapter 4 of this dissertation
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Droplet digital PCR (ddPCR)
Gene expression analysis was performed using the digital PCR system (BioRad,
Hercules, CA). A 20ul ddPCR reaction mixture with ddPCR Supermix for Probes (no dUTP;
(BioRad) containing Rho and Actb probe sets (Mm01184405_m1 and Mm02619580_g1
respectively; Thermo Fisher Scientific, Waltham, MA) was prepared according to
manufacturer’s directions, droplets generated, and nano-reactions cycled on a C1000 Touch
Thermal Cycler (BioRad). The average number of allelic transcripts per biological replicate
(n=3) was then determined with the QX 200 Droplet Reader and QuantaSoft Analysis Pro
(BioRad).

FISH Probe Generation
BAC cultures were obtained from the CHORI BACPAC repository (Oakland, CA).
Clones used are listed below. E. coli were grown under normal conditions and BAC DNA
harvested using the Nucleobond Xtra BAC Purification Kit (Machery-Nagel, Duren, Germany).
5ug of BAC DNA was used for probe generation using the Nick Translation Kit with either
Digoxigenin-11-dUTP or Biotin-16-dUTP (Roche, Basel, Switzerland). Probe was cleaned using
PCR purification columns (Qiaquick, Qiagen, Hilden, Germany) and resuspended in 100ul EB
and frozen.
Rho
RP24-288F10
mir182
RP24-314K9 / RP23-385J22
Ptms
RP24-330J12
Pde6h
RP23-79O6
Trcb
RP23-421M9

FISH Tissue Preparation and in situ hybridization
Retinas were dissected into 4% PFA and fixed overnight at 4C. Tissue was washed in
PBS and dehydrated using a sucrose (in PBS) gradient at 4C as follows: 10% 1hr, 20% 1hr, 30%
overnight. An equal volume OCT (Tissue-Tek, optimum cutting temperature formulation;
Sakura, Netherlands) was added and incubated at 4C for 8 hours before tissue was transferred to
100% OCT for overnight incubation at 4C. Tissue was frozen with dry ice in OCT and stored at 80C for later use. Tissue sections (20um) were cut by cryostat and stored on slides also at -80C.
Slides were removed from -80C and dried on a hot plate (37C) for 1 hour. OCT was
removed by 5min incubation with PBS, and tissue was briefly fixed to the slide to avoid release
(5min 4% PFA), before slides were once again washed with PBS (5min). Slides were
equilibrated in 10mM Sodium Citrate (pH 6) for 5 minutes before transferred into the same
buffer at 95C and incubated for 5min. The coplin jar was removed from the double boiler and
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allowed to cool at room temperature for 1 hour. Slides were transferred to 2XSSC (5min) and
equilibrated in 2XSSC+50% Formamide (Millipore-Sigma, St. Louis, MO) for 5min. Slides were
incubated on hot plate with 2XSSC+50% formamide for 3 minutes before being submersed into
ice cold (-20C) 70% EtOH for 2 min. Slides were then further dehydrated in 90% EtOH (2min)
and 100% EtOH (5min) before being allowed to dry at room temperature for 15min. Probe
mixture for each slide was prepared as follows: 2ul DIG labelled probe, 2ul Biotin labelled
probe, 2ul salmon sperm DNA (Invitrogen, Carlsbad, CA), 11ul formamide, and 6.6ul 3.3X
FISH buffer (6.6XSSC, 33% Dextran Sulfate (Fisher Scientific, Hampton, NH)). This mixture
was pre-incubate for 30min at 37C. Hydrophobic barriers were drawn on slides, allowed to dry,
and slides were pre-warmed on 37C hotplate. Probe was on a coverslip to the tissue, and
coverslip was affixed to the slide with rubber cement to prevent dessication. Slides were
incubated at 37C in humidified chamber for 72 hours. Slides were removed from incubator,
rubber cement removed and washed in 2XSSC at 37C for 5 min. Slides were transferred to 60C
Wash 1 (0.4XSSC, 0.3% NP40) for 5 minutes, followed by room temperature Wash 2 (2XSSC,
0.1% NP40) for 5 minutes. Slides were again washed in 2XSSC for 5 min at room temperature
before application of Rhodamine labelled anti-Digoxigenin (Roche) and Alexa Fluor 488
conjugated Streptavidin (Life Technologies, Carlsbad, CA) in blocking buffer (2XSSC, 0.2%
Tween20, 1% BSA) and incubated at 37C for 1hr. Slides were washed 3x10min in wash buffer
(4XSSC, 0.2% Tween20), followed by 2x5min in 2XSSC. Coverslips were applied using
Vectashield hard-mount media with DAPI (Vector Labs, Burlingame, CA).

FISH imaging and analysis
Slides were imaged at 100X magnification on a Leica DM5500B microscope with Leica
DFC365FX camera (Leica Microsystems, Buffalo Grove, IL) with at least 40 optical sections (zstep 0.194um). Stacks of images were first processed using the Leica software deconvolution
algorithm before export. 21 sections from the center of the stack were imported to the ImageJ
image analysis program (all analysis was performed using Fiji [Schindelin et al., 2012]). Images
were converted to a stack and a large region of interest was cropped that included only the outer
nuclear layer (mainly rod photoreceptors). Channels were split, and filtered using the Mean 3D
and 3D Fast Filters (TopHat) functions of ImageJ. Positive probe locations and centers of mass
were then determined in red and green channels using the 3D Objects Counter. Center of mass
information was saved in text files, and custom perl scripts were used to determine and report
distance between nearest independent pairs of probes in 3-dimensional space.
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Table A2.1: Number of FISH experiments completed for each probe set

Rho - mir182
Rho - Tcrb
Rho - Ptms
Rho - Pde6h
mir182 - Ptms
Tcrb - Ptms

WT
4
1
4
3
2
1

RER-/- PPR-/3
6
1
1
4
4
2
3
2
2
1
1
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Crx-/3
1
4
3
2
1

Nrl-/3
1
4
2
2
1
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